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ABSTRACT
Elevated intracellular levels have been reported to induce neuronal death during 
acute CNS ischaemia. Despite several proposed mechanisms, the precise molecular 
events that induce Zn^^ neurotoxicity remain currently unclear. The present study 
utilised the murine hippocampal neuronal cell line, HT-22, to dissect the mechanism 
of cytotoxic Zn^^ insults.
Increased extracellular Zn^^ concentrations induced both dose- and time-dependent 
cytotoxicity. Exogenously applied Zn^^ (200pM) increased intracellular Zn^^ levels 
as assessed by FluoZin-3 fluorescence and rapidly induced cell death. Zn^^ 
cytotoxicity was attenuated by the Zn^^ chelators, Ca»EDTA andN,N,N’,N’-Tetrakis 
(2-pyridylmethyl) ethylenediamine (TPEN), but was unaffected by either KCl, or the 
L-type or T-type voltage-sensitive Ca^^ channel inhibitors, nimodipine and mibefradil 
respectively.
In contrast to staurosporine, an inducer of apoptosis, Zn^^-induced cell death was 
insensitive to the pan-caspase inhibitor, zVAD-fmk, and was not accompanied by 
significant caspase 3 activation. Intriguingly, Zn^^ significantly reduced the 
mitochondrial membrane potential despite an apparent absence of reactive oxygen 
species (ROS) generation, although significant intracellular glutathione depletion was 
observed. Furthermore, pre-treatment with either of the antioxidants, trolox or N, N ’- 
diphenyl-1,4-phenylenediamine (DPPD), limited Zn^^ cytotoxicity during 6hr, but not 
24hr Zn^^ exposure paradigms. Both the energy substrates pyruvate and oxaloacetate 
however, afforded neuroprotection against Zn^^ cytotoxic insults without influencing 
acute intracellular Zn^^ uptake.
It is concluded that HT-22 neurons are vulnerable to Zn^^ cytotoxic insults via a 
mechanism involving mitochondrial perturbation and energy inhibition, although 
independent of caspase-mediated apoptosis, but involving cellular oxidative stress.
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CHAPTER 1 
GENERAL INTRODUCTION
1.1 The Physiological role of
Zinc assumes many important roles in the body, consequently it is an essential trace 
element (Kruse-Jarres, 2001). Foods rich in zinc include wholegrains, meat, fish and 
shellfish, and the recommended daily allowance (RDA) is 15mg/day (Golub et al., 
1995). As will be described, zinc is integral to a number of biochemical structures 
and participates in a wide variety of metabolic functions. Zinc is also vital for the 
correct performance of many aspects of the immune response as reviewed by Fraker 
and King (2004). These include antigen-specific reactions and non-specific responses 
(Kruse-Jarres, 2001), cytokine production by leukocytes, and stimulation of 
lymphokine production by T-cells (Rink and Kirchner, 2000).
It is to be expected that zinc deficiency would therefore be associated with severe 
clinical side effects. Acrodermatitis enteropathica is an autosomal recessive disorder 
characterised by zinc malabsorption and severe zinc deficiency (Neldner and 
Hambidge, 1975). Symptoms attributed to acute zinc malnutrition include growth 
retardation, skin lesions, poor appetite and anorexia, diarrhoea, immune system 
dysfiinction and central nervous system (CNS) dysfunction (Wallwork et al., 1983; 
Sandstead et al., 1998; Golub et al., 1999; Costello and Grumstrup-Scott, 2000). 
Behavioural changes associated with zinc deficiency include reduced activity and 
responsiveness to stimuli, and decreased neuropsychologic performance (Sandstead et 
al., 1998; Golub et al., 1999, 2000). Changes in zinc status also affect gene 
regulation, for example those involved in zinc uptake and release as will be described 
below, as well as many genes involved in host defence such as cytokine receptors 
(Cousins et al., 2003).
Zinc may also play a significant pathological role. It is well established that excessive 
glutamate receptor activation induces neurodegeneration during acute CNS injury 
(Choi et ah, 1987; Ross et ah, 1995). Ischaemic insult including stroke, mechanical 
head trauma or epilepsy induces neuronal depolarisation and excessive release of 
glutamate from presynaptic neurons and reversal of the glutamate uptake system 
(Atlante et al., 2001). Binding of glutamate to its respective receptors induces 
degeneration of postsynaptic neurons via a mechanism coined excitotoxicity by Olney 
et al (1971) (cited in Olney (2003)) (see section 1.2.1).
As detailed below (section 1.1.4.1), Zn^^ co-localises specifically with glutamate in 
the synaptic vesicles of excitatory neurons (Beaulieu et ah, 1992), with the highest 
Zn^^ concentrations observed in the hippocampal mossy fibres (Choi and Koh, 1998). 
The co-localisation of Zn^^ with glutamate implies that it may participate in 
excitotoxicity and therefore increased extracellular Zn^^ levels may also participate in 
inducing neuronal death (see section 1.2.5) (Koh et ah, 1996). Indeed, Zn^^ influx 
and accumulation is observed specifically in degenerating postsynaptic neurons 
following ischaemic injury (Tonder et ah, 1990; Koh et ah, 1996; Suh et ah, 2000b). 
Furthermore, mossy fibre Zn^^ release was demonstrated following stimulation of the 
hippocampal dentate granule cells or the perforant pathway (Howell et ah, 1984; 
Aniksztejn et ah, 1987). Zn^^ may therefore be integral to the cell death cascade 
elicited following ischaemia (see section 1.2) (Koh et ah, 1996; Choi and Koh, 1998; 
Suh et ah, 2000b).
1.1.1 Zn^^-containing proteins
is often found associated with proteins, performing both structural and functional 
roles, although it has a broad spectrum of functions depending on the specific 
interaction with the protein. Importantly, Zn^^ lacks redox activity and will therefore 
not directly induce free radical generation, making it suitably inert for inclusion 
within proteins (Berg and Shi, 1996). Zn^^ has been shown to stabilise tertiary protein 
structure maintaining the correct active peptide conformation (Frederickson, 1989). 
Frequently, zinc is found in gene regulatory proteins, for example within the zinc 
finger domain (2 cysteine residues and 2 histidine residues) of transcription factors, 
zinc clusters in the fungal transcription factor GAL4 (galactose metabolism activator) 
and zinc twists in glucocorticoid and other steroid receptors (Vallee et al., 1991). 
Significantly, zinc finger proteins may be encoded by as much as 1% of the human 
genome, and recognise very specific DNA sequences (Klug, 1999). In addition to 
protein stabilisation, Zn^^ can also maintain RNA and DNA structure (Frederickson, 
1989).
In a functional capacity, Zn^^-containing proteins may play a role in transportation or 
sequestration of free Zn^^ to maintain Zn^^ homeostasis in the brain. These may be as 
intracellular zinc binding ligands including tubulin, S I00A and B, and calmodulin 
(Frederickson, 1989) or extracellular zinc binding ligands including glutathione 
(GSH), albumin and histidine (Frederickson et al., 2000).
1.1.2 Zn^-containing enzymes
More than 300 characterised enzymes contain Zn^^ (Berg and Shi, 1996) and of these 
carbonic anhydrase was the first to be identified (Keilin and Mann, 1940). If
positioned at the active site, Zn^^ may be necessary for catalytic enzymatic function 
via direct interaction with the substrate. Zinc metalloenzymes are vital for normal 
cellular metabolism and the majority of cellular zinc is found within these proteins. 
They are found in the cytosol (phosphodiesterase), nucleus (nucleic polymerase), 
mitochondria (cytochrome c oxidase), golgi apparatus (peptidases), and associated 
with membranes (phospholipase C) amongst other locations, assuming important 
functions including nucleic acid and protein synthesis, and energy metabolism. In a 
structural role, Zn^^ is bound very tightly in a proteinaceous claw sequestering it 
against potential reactions (Frederickson, 1989). In a catalytic role, Zn^^ is held in a 
trihedral arrangement with the substrate interacting with the available fourth site 
(Frederickson, 1989).
One important group of Zn^^-containing enzymes is the protein kinase C (PKC) 
family of serine/threonine kinases. These enzymes participate in cellular signal 
transduction pathways regulating cell growth, differentiation and death (Chou et al.,
2004). Each PKC molecule contains four zinc atoms within the lipid-binding 
regulatory domain (Quest et al., 1992). Within this domain are two cysteine-rich 
finger-like motifs, each of which bind two zinc atoms and regulate diacylglycerol 
binding. Zinc deficiency is associated with decreased cellular zinc content and 
subsequently reduced PKC activity and enhanced apoptosis (Chou et al., 2004).
1.1.3 Metallothioneins and Zn^  ^regulation
Zn^^ binds to apothionein to form a significant group of cysteine-rich proteins known 
as metallothioneins (Cuajungco and Lees, 1997). Metallothioneins are monomeric 
two domain proteins with twenty highly conserved cysteine residues. They bind
seven Zn^^ ions (Zn?MT) co-ordinated by sulphur ligands in two separate metal- 
thiolate clusters (Kzn = 2 x 10'^  ^M'^ atpHT.O) (Kagi and Schaffer, 1988; Hasler et ah, 
2000). Metallothioneins are proposed to participate in the storage of trace elements 
including zinc and sequestration of toxic metals such as mercury or cadmium in the 
kidney or liver (Brady, 1982).
Metallothioneins may also fonction as Zn^^ chaperones, shuttling Zn^^ from 
metallothionein to newly synthesised apoproteins, and also sequestering Zn^^ back 
from metalloproteins (Jacob et ah, 1998; Palmiter, 1998). One zinc atom from the P- 
domain of the metallothionein complex appears particularly susceptible to release and 
may be transferred by ligands including glutathione or citrate in response to changes 
in the redox environment (see chapter 4) (Jacob et ah, 1998). In this way, 
apothionein could play a significant role in enzyme reactivation through Zn^^ 
sequestration from inhibitory sites (Maret et ah, 1999). Metallothioneins may also 
shuttle Zn^^ from the cytosol to the nucleus in response to changing zinc requirements 
(Roesijadi, 2000).
1.1.3.1 Metallothionein isoforms
The presence of metallothioneins in the brain may be essential for zinc homeostasis. 
Metallothioneins have a molecular weight of 6-7kDa, and comprise a single 61-68 
amino acid polypeptide chain (Ebadi, 1986). Three isoforms, MT-I, MT-II and MT- 
III, are found in the brain and their expression has been shown to be upregulated 
following intracerebral Zn^^ injection (Ebadi, 1986). MT-IV however, is only 
expressed in specific stratified squamous epithelia (Quaife et ah, 1994). MT-I and 
MT-II show ubiquitous expression, which can be upregulated in response to stress
stimuli including reactive oxygen species (ROS) and cytokines (Kagi, 1991; Hidalgo 
et al., 2001). MT-III and MT-IV expression is however, relatively unaffected by these 
stress stimuli (Hidalgo et al., 2001). Significantly, MT-I/MT-II double knockout mice 
are viable and reproduce normally, suggesting that the role of metallothioneins is non- 
essential under non-pathological conditions (Michalska and Choo, 1993; Masters et 
al., 1994a).
1.1.3.2 MT-lIIin the hippocampus
MT-III is particularly prominent in brain regions densely populated with zinc- 
containing neurons, notably hippocampal glutamatergic neurons (discussed in section 
1.1.6) (Masters et al., 1994b), and is believed to regulate hippocampal Zn^^ levels and 
prevent toxicity through a ‘buffering’ action (Weiss et al., 2000). For example, MT- 
III gene knockout mice demonstrate enhanced susceptibility to kainate-induced 
seizure and consequently higher levels of hippocampal CA3 damage compared to the 
wildtype counterparts despite no change in the levels or locality of histochemically 
reactive Zn^^ (Erickson et al., 1997; Lee et al., 2003). Overexpression of MT-III 
conversely, protects CA3 but not CAl neurons against kainate-induced death 
(Erickson et al., 1997). MT-III may therefore have differential effects in specific 
hippocampal regions (discussed section 1.2.6.1).
MT-III also has a unique biological activity as a growth inhibitory factor through 
which it was first isolated in human brain extracts (Uchida et al., 1991 ; Hasler et al.,
2000). In Alzheimer’s disease brains the levels of MT-III are decreased, and the 
subsequent decrease in growth inhibitory factor activity corresponds to the enhanced 
occurrence of the pathological marker, neurofibrillary tangles (Uchida et al., 1991).
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However, in comparison, neither MT-I nor MT-II demonstrated growth inhibitory 
activity (Uchida et ah, 1991).
Recently, a specific role for MT-III in synaptic vesicle trafficking upstream of vesicle 
fusion has been described (Knipp et ah, 2005). The small GTPase Rab3 A associates 
with synaptic vesicle membranes and modulates the neuronal synaptic vesicle exo- 
endocytotic cycle (Takai et ah, 2001). Rab3A displays conformational changes 
between the GDP- and GTP bound state which regulates interactions with effector 
molecules (Takai et ah, 2001; Knipp et ah, 2005). Following vesicle fusion, Rab3A 
hydrolyses GTP and Rab3A#GDP translocates to the synaptic vesicle (Knipp et ah,
2005). The co-addition of recombinant Rab3A and MT-III to neurons exposed to 
300pM Zn^^ insults afforded significant neuroprotection, suggesting that these two 
factors may interact to inhibit Zn^^-induced death (Liu et ah, 2004b). Furthermore, 
MT-III and Rab3A co-localise in hippocampal neurons, and ZnyMT-III reversibly 
binds to the C-terminal effector binding site of the Rab3A#GDP conformation (Lee et 
ah, 2003; Knipp et ah, 2005). ZnyMT-III binding to Rab3A#GDP at the vesicle 
membrane may therefore deliver or indeed recycle Zn^^ for vesicle loading by zinc 
transporter-3 (ZnT-3) (discussed in section 1.1.5) (Knipp et ah, 2005).
1,1.33 MTF-1
Metallothionein expression is regulated by the six zinc-finger containing, Zn^^- 
inducible transcription factor, MTF-1 (Metal-responsive transcription factor-1) 
(Westin and Schaffher, 1988; Andrews, 2000). It is proposed that Zn^^ interaction 
with the MTF-1 zinc fingers reversibly influences the DNA binding ability and 
therefore transcriptional activity of MTF-1 (Andrews, 2000). Following Zn^^ co-
ordination therefore, MTF-1 binds to cw-acting metal response elements (MRE) in the 
promoter located 5’ to the metallothionein gene (Westin and Schaffher, 1988). MTF- 
1 thus upregulates metallothionein expression in response to increased free Zn^^ 
(Andrews, 2000). Significantly, apothionein inhibits MTF-1 activity possibly by 
sequestering Zn^^, thus allowing a mechanism for MTF-1 regulation (Zhang et al., 
2003).
MTF-1 is also proposed to induce the upregulation of ZnT-1 (zinc transporter-1) and 
the y-glutamylcysteine synthetase heavy chain through MRE motifs in their promoter 
regions (Palmiter and Findley, 1995; Gunes et al., 1998; Langmade et al., 2000). 
Indeed, during zinc supplementation, both in vivo and microarray analysis have 
demonstrated ZnT-1 and MT-I upregulation, a function attributed to MTF-1 induction 
(McMahon and Cousins, 1998; Cousins et al., 2003). Importantly, MTF-1 knockout 
mice do not survive gestation and embryos show an absence of MT-I and MT-II 
transcription (Gunes et al., 1998), despite the survival of MT-I/MT-II double 
knockout mice which only demonstrate enhanced sensitivity to metal stress (Masters 
et al., 1994a). In addition to a lack of MT-I and MT-II expression, MTF-1 knockout 
mice also show decreased transcription of the y-glutamylcysteine synthetase heavy 
chain which controls glutathione (GSH) biosynthesis, and a-fetoprotein which may 
participate in heavy metal or ROS scavenging (Gunes et al., 1998; Lichtlen et a l,
2001). Accordingly, MTF-1 knockout mice have increased sensitivity to H2O2 or 
cadmium (Gunes et al., 1998). This suggests that multiple MTF-1 target genes 
contribute to the lethal phenotype observed in MTF-1 knockout mice (Lichtlen et a l, 
2001).
1.1.4 in the brain
Within the brain, zinc is classed among the twenty most frequently occurring 
elements. Zn^^ gains access to the brain across the blood-brain barrier bound to 
microligands including cysteine and histidine in the serum (Frederickson, 1989). As a 
fraction of dry weight, zinc is usually more abundant in the grey matter (60 -70ppm) 
compared to the white matter (25-30ppm). Concentrations in the grey matter are 
estimated at 150-200pM under normal physiological conditions (Frederickson, 1989). 
The hippocampal mossy fibres contain the highest zinc levels (136-145ppm) (Choi 
andKoh, 1998).
1.1.4.1 The three zinc pools
Within the CNS, three separate ‘pools’ of Zn^^ have been described; protein bound- 
zinc, vesicular zinc and free zinc. Approximately 85-95% is found associated with 
proteins, often performing a structural role in enzymes of the brain. Zn^^ is integrated 
within the protein structure during synthesis and is therefore histochemically 
unreactive i.e. is not available for staining via histochemical procedures such as 
Timm’s stain. The second pool of chelatable histochemically reactive Zn^^ accounts 
for 5-15% of brain zinc (Frederickson, 1989) and is found exclusively within the 
nervous system specifically co-localised with glutamate within presynaptic vesicles of 
excitatory synaptic boutons (Beaulieu et al., 1992). The final zinc pool is the ionic 
form, Zn^\ found free in the cytoplasm or interstitial fluid, although it is 
undetermined whether this pool occurs under normal physiological conditions 
(Frederickson, 1989). Extracellular free Zn^^ concentrations are proposed to attain 
approximately 500nM in the brain (Frederickson, 1989).
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1.1.5 transporter proteins
Zinc cannot passively traverse the plasma membrane (Taylor et ah, 2003). Cytosolic 
Zn^^ concentrations are therefore maintained by Zn^^ transporter proteins which 
regulate intracellular Zn^^. Two families of Zn^^ transporter proteins have been 
described; CDF (Cation Diffusion Facilitator) and ZIP (Zinc regulated 
transporter/iron regulated transporter-like Protein) (reviewed in Liuzzi and Cousins 
(2004)). CDF transporters reduce cytosolic Zn^^ concentrations by regulating Zn^^ 
extrusion or passage to intracellular compartments. ZIP transporters increase 
cytosolic Zn^^ concentrations by promoting cellular Zn^^ uptake or Zn^^ release from 
intracellular compartments (Taylor and Nicholson, 2003). None of the transporters 
utilise ATP and therefore act via facilitated diffusion, secondary active transport, or 
symporters (Liuzzi and Cousins, 2004).
i. i. 5.1 CDF transporters
Within the CDF family, ten homologous zinc transporters have been reported, 
designated ZnT-l-ZnT-10 (Seve et ah, 2004) belonging to the solute-linked carrier 30 
{SLC30) gene family (Devergnas et ah, 2004). The CDF transporter family have a 
general predicted structure comprising six transmembrane domains with intracellular 
amino and carboxyl termini, and a histidine rich potential metal binding domain 
(figure 1.1) (Gaither and Eide, 2001b). ZnT-5 or human ZnT-like transporter 1 
(hZTLl), has also recently been characterised with twelve transmembrane domains 
and extracellular amino and carboxyl termini (Cragg et ah, 2002).
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Cytoplasm
COOH
Histidine-rich Region
Figure 1.1. Schematic representation of a CDF transporter.
The putative structure comprises six transmembrane domains, intracellular amino 
and carboxyl termini, and a histidine rich, potential metal binding domain. Adapted 
from Colvin et al (2003).
ZnT-1 was the first CDF family member identified, maintaining intracellular Zn^^ 
concentrations ([Zn^f i) of baby hamster kidney cells between 150-300pM via Zn^  ^
exportation (Palmiter and Findley, 1995). Following ischaemia, ZnT-1 mRNA 
expression was shown to increase in CAl pyramidal neurons. These cells are 
vulnerable to ischaemic injury and demonstrate elevated intracellular Zn^^ 
concentrations ([Zn^^Ji) in response to ischaemic insult. The increase in ZnT-1 
mRNA following ischaemia suggests that Zn“  ^accumulation induces ZnT-1 
expression. This then promotes Zn“' extrusion to limit cellular injury through 
excessive [Zn“ ]^i (Tsuda et al., 1997). ZnT-1 mRNA expression also increased 
following exposure of HeLa cells to non-toxic exogenous Zn“' concentrations, and
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following dietary zinc supplementation in the rat intestine, again probably to promote 
Zn^^ extrusion (McMahon and Cousins, 1998; Devergnas et ah, 2004). As mentioned 
above, MTF-1 may regulate ZnT-1 expression via binding to MRE in the ZnT-1 
promoter (Langmade et ah, 2000).
Subsequent studies revealed the identity of further ZnT-type transporters in various 
tissues: ZnT-2 was found on endosomal vesicles of kidney, intestine and testis 
(Palmiter et ah, 1996a), ZnT-3 was identified in the testis, but more importantly on 
the membrane of mossy fibre synaptic vesicles in the brain, possibly participating in 
Zn^^ accumulation (see section 1.1.6.2) (Palmiter et ah, 1996b; Wenzel et ah, 1997; 
Cole et ah, 1999), ZnT-4 showed high levels in the brain, and in mammary glands, 
possibly involved in Zn^^ loading into milk (Cousins and McMahon, 2000), ZnT-5 
expression was particularly abundant in intracellular non-lysozymal compartments of 
pancreatic p-cells, but it may also co-operatively participate in Zn^^ influx from the 
apical enterocyte membrane with hZIP4 (described below) (Cragg et ah, 2002; Kambe 
et ah, 2002), and ZnT- 6  is suggested to transport cytoplasmic Zn^^ into the trans 
Golgi Network (TGN) and vesicular compartments in brain, kidney and lung (Huang 
et ah, 2002) similar to ZnT-7 (Kirschke and Huang, 2003). Most recently, ZnT- 8  and 
ZnT-10 have been identified via in silico analysis, with ZnT- 8  expression in the 
pancreas, and ZnT-10 showing foetal liver and brain expression. Data on ZnT-9 
awaits publication (Seve et ah, 2004).
1.1.5.2 ZIP transporters
As mentioned above, ZIP transporters are required for cytosolic Zn^^ influx. They 
belong to the SLC39A gene family (Taylor and Nicholson, 2003). Zinc-regulated
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influx transporters (ZRT) were initially characterised in yeast following identification 
of both high and low affinity Zn^^-specific uptake mechanisms, which responded to 
zinc status via a proposed metalloregulatory protein (Zhao and Eide, 1996a, b; Zhao 
and Eide, 1997). Elucidation of further family members lead to the determination of 
the ZIP transporter family. The predicted structure of ZIP transporters comprises 
eight transmembrane domains with extracytoplasmic amino and carboxyl termini, and 
a histidine rich putative metal binding domain (figure 1.2) (Rogers et al., 2000).
NK
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Figure 1.2. Schematic representation of a ZIP transporter.
The putative structure comprises eight transmembrane domains, extracellular amino 
and carboxyl termini, and an intracellular histidine rich, potential metal binding 
domain. Adaptedfrom Colvin et al (2003).
ZIP transporters can be regulated by extracellular Zn“' concentrations. For example, 
mZip4 (mouse Zip4) mRNA expression increased following zinc deprivation, but 
decreased in the presence of excess zinc (Dufner-Beattie et al., 2003b). Post-
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translational modification of ZIP transporters may also occur via changes to 
transporter localisation. For example mZipl and mZip3 are located at the intracellular 
organelles when extracellular Zn^^ concentrations are normal. They are abundant on 
the plasma membrane in zinc deficient media though through decreased endocytosis 
(Wang et al., 2004b). Endocytosis of mZip5 however, is not regulated by zinc status 
(Wang et al., 2004a). Increasing extracellular Zn^^ concentration enhances Zn^^ 
influx through ZIP transporters, but divalent cations including Cu^\ Fe^^ and Cd^ ,^ 
but not Ca^^ nor Mg^^, may inhibit influx (Gaither and Eide, 2001a). Zn^^ influx via 
ZIP transporters is also proposed to be concentration-, temperature- and time- 
dependent (Gaither and Eide, 2001a; Taylor et al., 2003; Wang et al., 2004a).
ZIP transporters are fiirther divided into four subfamilies; ZIP subfamily I; ZIP 
subfamily II; the Gufa subfamily; and the LIV-1 subfamily of ZIP transporters, LZT. 
LZT transporters are located on the plasma membrane and are proposed to mediate 
Zn^^ influx, exemplified by hZIP4 (human ZIP4) and LIV-1 (ZIP6 ) (Taylor et al., 
2003; Taylor and Nicholson, 2003). Significantly, a mutation in the hZIP4 gene 
sequence is proposed to account for the defective zinc absorption seen in 
Acrodermatitis enteropathica (Wang et al., 2002). LIV-1 and hZIPl mRNA 
expression also occurs in the brain (Gaither and Eide, 2001a; Taylor et al., 2003; 
Taylor and Nicholson, 2003). Recently, a novel LZT protein, HKE4 (ZIP7), has been 
identified on intracellular membranes including the endoplasmic reticulum, 
participating in Zn^^ redistribution from intracellular organelles to maintain 
intracellular Zn^^ concentrations (Taylor et al., 2004). ZIPS (BIGM103), another LZT 
transporter, is found on lysosomes and endosomes of the pancreas (Begum et al.,
2 0 0 2 ) .
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Co-ordinated regulation of ZIP transporters to increase intracellular Zn^^ levels, and 
CDF transporters to decrease intracellular Zn^^ levels is therefore probably essential. 
for Zn^^ homeostasis. Accordingly, a recent microarray analysis in human THP-1 
mononuclear cells demonstrated decreased ZnT-1 gene expression but enhanced ZIP2 
gene expression in response to zinc depletion, possibly to promote Zn^^ uptake over 
extrusion (Cousins et al., 2003).
1.1.6 The Zn^^-containing neuron
1.1.6.1 Hippocampal Zn^^-containing circuitry
Zn^^-containing neurons are a significant feature of the hippocampal circuitry. The 
origins of Zn^^-containing neuronal boutons were elucidated through the formation of 
silver-enhanced zinc-selenium precipitates following intraperitoneal injection of 
Na2Se0 3  into the rat. Following retrograde transport, the somata of Zn^^-containing 
neurons were visualised, demonstrating that Zn^^-containing neurons provide dense 
innervation in the telencephalon including the hippocampal formation (Slomianka et 
al., 1990). Four individual groups of hippocampal Zn^^-containing neurons have been 
identified; dentate granule neurons, CAl pyramidal neurons, CA3 pyramidal neurons 
and prosubicular neurons (Frederickson and Danscher, 1990). The mossy fibre 
boutons of the dentate granule cells contain the highest concentrations of Zn^^ in the 
CNS (Frederickson, 1989; Choi andKoh, 1998).
Figure 1.3 illustrates the major Zn^^-containing hippocampal pathways. The 
entorhinal cortex innervates the dentate granule cells via the perforant pathway, which 
in turn innervates the hippocampal CA3 region via mossy fibre axons (Bliss and 
Collingridge, 1993). The CA3 pyramidal neurons project to either the ipsilateral or
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contralateral CAl pyramidal neurons via Schaffer colaterals or commissural fibres 
respectively (Bliss and Collingridge, 1993). This trisynaptic circuit is proposed to be 
Zm-containing (Frederickson, 1989). The subsequent CAl projection to the 
subiculum is also supposed to be zinc-containing (Frederickson, 1989).
^^T^yramidal
Granule
i
Figure 1.3. Simplified illustration of a rat hippocampal slice.
The major excitatory pathways are represented; the entorhinal cortex (EC) to the 
granule cells and the CA3 subfield via the perforant pathway (PP); the granule cells 
o f the dentate gyrus (DC) to the CA3 via the mossy fibres (MF); the CA3 to either the 
ipsilateral or contralateral CAl via the Schaffer collaterals (SC) or commissural 
jibres (Com) respectively. The inhibitory pathways have been omitted. Adapted from  
Bliss and Collingridge (1993).
The dentate granule cells form typical mossy synapses with the CA3 pyramidal 
neurons and the hilar mossy cells. However, the mossy fibres also send fllopodal 
projections and small en passant synaptic varicosities to GABAergic (y-aminobutyric 
acid) intemeurons in the hilar and CA3 regions thus providing distinct terminals 
particular to this cell type (Acsady et al., 1998). Inhibitory GABAergic cells receive
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ten-fold greater granule cell innervation than the excitatory CA3 pyramidal neurons 
(Acsady et ah, 1998). The overall outcome of the entorhinal-granule cell network on 
the CA3 pyramidal neurons is therefore probably suppressive (Bragin et ah, 1995).
1.1.6.2 and the synaptic vesicle
In the mammalian CNS, Zn^^ is reportedly sequestered and co-released with L- 
glutamate from glutamatergic synaptic vesicles of hippocampal and other forebrain 
neurons (Frederickson, 1989). Recently, it has been suggested that mossy fibres may 
also release GABA in addition to glutamate and Zn^^ (Romo-Parra et ah, 2003). In 
the spinal cord, the co-occurrence of both ZnT-3 and Zn^^ has been demonstrated in 
synaptic vesicles of both inhibitory GABAergic neuron terminals (Danscher et ah, 
2001; Wang et ah, 2001b; Wang et ah, 2001a), and glycinergic neuron terminals 
(Wang et ah, 2001a).
The presence of ZnT-3 on the synaptic vesicle membrane, and localisation in regions 
rich in histochemically reactive Zn^^ including glutamatergic neurons of the 
hippocampus, implies a role for vesicular Zn^^ loading as mentioned earlier (Palmiter 
et ah, 1996b; Wenzel et ah, 1997; Cole et ah, 1999; Cole et ah, 2000). Indeed, ZnT-3 
gene knockout mice demonstrate an absence of histochemically reactive Zn^^ in their 
synaptic vesicles, whereas mice with one functional ZnT-3 allele show an 
intermediate level of Zn^^ compared to wildtype. Additionally, the hippocampal and 
cortical zinc content is reduced by 20% in ZnT-3 knockout mice, with the remaining 
80% tightly sequestered for example within proteins (Cole et ah, 1999).
Recently it has been demonstrated that a chloride channel, CIC-3, co-localises to the
synaptic vesicle with ZnT-3 in hippocampal mossy fibre terminals. Both proteins are
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sorted into the vesicles via AP-3 dependent adaptor-based mechanisms (Salazar et al., 
2004). Indeed, mocha mice, which have a disrupted AP-3 complex, demonstrate 
reduced ZnT-3 expression and Zn^^ staining in the hippocampal mossy fibres 
(Kantheti et al., 1998). Enhanced CIC- 3  expression in wildtype mice increased Zn^^ 
influx into synaptic vesicles, demonstrating a facilitatory action of CIC-3  on ZnT-3 
function (Salazar et al., 2004). CIC-3 is required for vesicle acidification and 
therefore regulates neurotransmitter and Zn^^ accumulation (Stobrawa et al., 2001; 
Salazar et al., 2004).
Concentrations of chelatable Zn^  ^in the synaptic vesicles have been estimated at 
1.4mM (Frederickson, 1989; Frederickson et al., 2000), which suggests that the . 
synaptic vesicle is likely to provide a significant source of extracellular Zn^^. It is 
suggested that Zn^^ accumulation within synaptic vesicles occurs during vesicular 
maturation and passage to the axonal bouton, since Zn^^ staining is not seen in 
synaptic vesicles of the soma or Golgi apparatus but begins to become apparent along 
the axon (Frederickson and Danscher, 1990). It has also been shown that not all 
synaptic vesicles within the bouton demonstrate Zn^^ staining (Perez-Clausell and 
Danscher, 1985).
1.1.6.3 Role o f Zti^ in the Zn^^-containing neuron
The physiological function of Zn^^ in Zn^^-containing neurons remains to be fully 
elucidated. Its co-localisation with L-glutamate implies a role in modulating 
glutamate receptor evoked responses (discussed in section 1 .2 .2 ), or simply the 
storage or cycling of glutamate in and out of the vesicle (Frederickson et al., 2000). 
Zn^^ release from Zn^^-containing neurons occurs in a Ca^^-dependent and
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tetrodotoxin- (blocks Na^-dependent action potentials) sensitive manner, similar to 
neurotransmitter release (Li et al., 2001b).
Non-neuronal cells including salivary granular convoluted tubule (GCT) cells 
(Frederickson et al., 1987) exhibit similar Zn^^ staining within their secretory storage 
granules to that seen in synaptic vesicles. In GCT cells, Zn^^ is necessary to stabilize 
the 7S-nerve growth factor subunits (7S-NGF) (Pattison and Dunn, 1976). 
Additionally, Zn^^ is co-released with the storage compound during secretion. The 
participation of Zn^^ in secretory compound stabilisation and storage suggests that 
Zn^^ may perform a similar function in neuronal cells (Frederickson, 1989).
Although unlikely to stabilise glutamate itself (not all glutamatergic neurons are also 
Zn^^-containing neurons), Zn^^ may enhance glutamate storage within the synaptic 
vesicle although there is currently little evidence supporting this (Frederickson et al., 
2000).
Zn^^ cycling by Zn^^-containing neurons however, is likely to be an essential process. 
Its controlled uptake by postsynaptic neurons is necessary to avoid excessive 
intracellular Zn^^ levels. Zn^^ reuptake by presynaptic neurons may also occur by 
ZIP-like proteins to replenish the synaptic vesicles whilst removing excess synaptic 
Zn^^ (Frederickson et al., 2000; Colvin et al., 2003). Zn^^ cycling has been shown by 
Howell and colleagues, who established the presence of an energy-dependent (via 
electrical stimulation), and Ca^^-dependent, Zn^^ uptake and release mechanism in 
mossy fibre neuropil and dentate granule cells (Howell et al., 1984).
The fact that Zn^^ co-localises with glutamate only within a specific subset of 
glutamatergic neurons suggests that Zn^^ is not required for normal glutamatergic 
neuronal activity. However, since Zn^^-containing neurons predominate in the
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cortical-limbic-cortical associational circuitry this suggests that may play a role 
in cortical cognitive-mnemonic function (Frederickson and Moncrieff, 1994). Indeed, 
Zn^^ has been shown to be associated with the process of long-term potentiation 
(LTP) at the mossy fibre-CA3 pyramidal neuron synapse which may participate in 
cognitive-mnemonic function as detailed below (Lu et al., 2000; Li et al., 2001b).
1.1.6.4 Long-term potentiation (LTP)
LTP is a long-lasting form of synaptic plasticity and a cellular process supposedly 
required for the mechanism of learning and memory (Bliss and Collingridge, 1993).
It has been proposed that LTP may either be a pre- or postsynaptic event, or both 
(Lauri et al., 2003). Recent evidence suggests that presynaptic Ca^^-permeable 
kainate receptors, in particular the GluR5-containing subtype (see section 1.2.2.2), 
may participate in LTP induction at the mossy fibre-CA3 synapse (Lauri et al., 2003; 
More et al., 2004; Bortolotto et al., 2005).
As will be described below (section 1.2.2.2), kainate receptors containing unedited 
GluR5 or GluR6  subunits display Ca^^ permeability. Lauri et al (2003) revealed 
inhibition of mossy fibre LTP induction with either the Ca^^-permeable receptor 
channel blocker, PhTX (Philanthotoxin-433 tris-trifluoracetate), or the GluR5 subunit 
antagonist, LY382884, following dentate granule cell electrical stimulation or kainate 
application to hippocampal slices (Lauri et al., 2003). Similarly, a novel and potent 
GluR5-containing kainate receptor channel blocker, UBP296, also attenuated mossy 
fibre LTP induction (More et al., 2004). In addition, inhibition of Ca^^-induced Ca^^ 
release from intracellular stores using ryanodine, reversibly blocked LTP induction.
A hypothesis for LTP induction was therefore proposed whereby presynaptic Ca^^
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influx via GluR5-containing Ca^^-permeable kainate receptor-gated channels induced 
Ca^^ release from intracellular stores, which then mediated LTP induction (Lauri et 
ah, 2003; Bortolotto et ah, 2005). As will be described below (section 1.2.2.2), Zn^^ 
may gain neuronal entry via Ca^^-permeable kainate receptor-gated channels, and may 
therefore contribute to the mechanism of LTP induction.
Evidence exists supporting the participation of Zn^^ release during physiological 
activity in LTP induction in the CA3 hippocampal subfield (Weiss et ah, 1989; Li et 
ah, 2001a). As mentioned above, mossy fibres rich in Zn^^-containing synaptic 
vesicles form synapses with CA3 pyramidal neurons (Frederickson and Danscher, 
1990). As will be discussed later (section 1.2.2), glutamate receptors including the 
NMDA (A-methyl-D-aspartate), AMP A (a-amino -3 -hydroxy-5 -methyl-4- 
isoxazolepropionic acid) and kainate subclasses of glutamate receptor present a route 
of neuronal Zn^^ influx, and responses through these receptors may be modulated by 
Zn^^ (Smart et ah, 1994). NMDA receptors are sparse in the CA3 region and Zn^^ 
inhibits EPSPs (excitatory postsynaptic potentials) mediated through these receptors 
(Vogt et ah, 2000) therefore LTP is probably mediated via non-NMDA receptors in 
this pathway (Monaghan et ah, 1983; Benke et ah, 1993) (although see Vogt et al 
(2000)). Indeed, Zn^^ potentiates CA3 pyramidal neuron AMP A currents (see section 
1.2.2). Increased excitatory firing at the mossy fibre-CA3 synapse would act to 
facilitate LTP (Lin et ah, 2001).
Zn^^ release from mossy fibre synapses and influx into CA3 pyramidal neurons is 
frequency dependent and can induce LTP (Li et ah, 2001b). Accordingly, during high 
frequency electrical stimulation of rat hippocampal slices, Ca#EDTA (lOmM) blocked 
NMDA-independent LTP activation without affecting its maintenance (Lu et ah.
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2000; Li et al., 2001a). Exogenous Zn^^ application (50-100p,M) in the absence of 
electrical stimulation induced prolonged EPSPs, which were not achieved by 
glutamate addition alone. However, increasing glutamate concentrations facilitated 
the speed of Zn^^-mediated EPSP induction. Zn^^ influx and the presence of 
glutamate (possibly to facilitate Zn^^ entry) were therefore prerequisites for LTP 
induction (Li et al., 2001a).
Furthermore, Lu et al (2000) demonstrated that a reduction of bouton Zn^^ via chronic 
dietary Zn^^ deficiency or Zn^^ chelation with dithizone attenuated the induction but 
not the maintenance of mossy fibre-CA3 LTP. LTP could be restored by either zinc 
supplementation or the addition of exogenous Zn^^ immediately following application 
of the Zn^^ chelator (Lu et al., 2000). This further supports the role of endogenous 
Zn^^ in LTP induction at the mossy fibre-CA3 synapse (Lu et al., 2000).
Synaptic Zn^^ is however, unlikely to participate in neurotransmission under basal 
conditions. This is evidenced by the inability to detect significant synaptic Zn^^ 
increases using the Zn^^-specific probe, FluoZin-3, during electrically stimulated 
synaptic firing (Kay, 2003), the insensitivity of basal synaptic transmission to 
Ca#EDTA or chronic dietary zinc deficiency (Lu et al., 2000; Li et al., 2001a), and the 
fact that only mossy fibre LTP is impaired in rats lacking bouton Zn^^ (Lu et al., 
2000). However, Zn^^ may perform regulatory functions during normal synaptic 
activity according to its modulatory action at various receptors and channels 
(discussed in section 1.2.2) (Li et al., 2001a). Furthermore, entry into postsynaptic 
neurons, unlike conventional neurotransmitters, suggests that Zn^^ may additionally 
participate as a second messenger, for example via actions on PKC (Chou et al., 2004) 
and ERKl/2 (Li et a l, 2001a; Li et a l, 2001b).
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1. 2 The Pathological role of
1.2.1 Excitotoxicity
As mentioned earlier (section 1.1), excessive glutamate receptor activation during 
ischaemic insult is an established mechanism involved in neuronal death (Choi et al., 
1987; Ross et al., 1995). Glutamate released following presynaptic neuronal 
depolarisation binds predominantly to NMDA receptors, but also to AMPA receptors, 
triggering an initial influx of extracellular Ca^^, Na^ and Cl" ions and induces plasma 
membrane depolarisation and characteristic neuronal swelling. Secondary to this is 
the influx of Ca^^ through NMDA receptors and also voltage-sensitive Ca^^ channels 
(VSCC) opened following depolarisation, and the release of Ca^^ from intracellular 
stores. The considerable increase in cytosolic Ca^^ initiates a cell death cascade and 
results in delayed neurodegeneration. This process is known as ‘excitotoxicity’ 
(Atlante et al., 2001; Olney, 2003). It has been suggested that antagonism of 
glutamate action at the relevant receptors may be neuroprotective following ischaemic 
insult. For example, the AMPA receptor antagonist NBQX (2,3-Dihydroxy-6 -nitro-7- 
sulfamoylbenzo(/)quinoxaline) protects thalamic reticular neurons when administered 
after global ischaemia (Ross et al., 1995).
1.2.2 Mechanisms of influx and receptor/channel modulation
The co-storage of Zn^^ with glutamate suggests that it may act at glutamate receptors 
(Yin et al., 2002) and therefore also contribute to the induction of neuronal death as 
detailed below (section 1.2.5) (Koh et al., 1996). Mapping the location of the NMDA 
and AMPA subclasses of glutamate receptor in the hippocampus and cerebral cortex 
coincides with the distribution of Zn^^-containing boutons (Cotman et al., 1987). It
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has been suggested therefore that NMDA receptors or AMPA receptors may provide a 
mechanism for Zn^^ influx. Zn^^ may also play an important role in modulating 
excitotoxicity via direct interactions with ionotropic glutamate receptors and VSCC, 
but also via actions on the responses elicited through these receptors. Smart et al 
(1994) provide an extensive review of the effects of Zn^^ at various receptor and 
channel types, but the main actions are summarized below.
1.2.2.1 NMDA receptor-gated channels
Using neuronal culture it has been established that divalent cations including Zn^^ 
may enter cells directly via Ca^^-permeable channels gated by NMDA receptors 
following glutamate- or NMDA-mediated activation (Christine and Choi, 1990; Sensi 
et al., 1997; Cheng and Reynolds, 1998). This is evidenced by the inhibitory effects 
of the NMDA antagonists, MK-801 and D-(-)-2-amino-5-phosphonopentanoic acid 
(D-AP5), on intracellular Zn^^ increases, and the partial sensitivity to a non-specific 
Ca^^ channel inhibitor, gadolinium (Gd^^ (Koh and Choi, 1994; Sensi et al., 1997; 
Cheng and Reynolds, 1998). Zn^^ influx through NMDA receptor-gated channels 
may also occur independently of agonist-mediated activation (Koh and Choi, 1994).
Both Ca^  ^and Zn^^ might compete for the same route of cellular entry, since reducing 
extracellular Ca^^ enhanced Zn^^ neurotoxicity, whereas increasing extracellular Ca^^ 
reduced Zn^^ toxicity (Koh and Choi, 1994). Moreover, activation of NMDA 
receptors in the absence of extracellular Na^ and Ca^^ to limit excitotoxicity further 
enhanced Zn^^ neurotoxicity (Koh and Choi, 1994).
Zn^^ can block responses through NMDA receptors at micromolar concentrations 
(Peters et al., 1987; Westbrook and Mayer, 1987; Christine and Choi, 1990;
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Rassendren et al., 1990; Chen et al., 1997; Traynelis et al., 1998), although 
potentiation of responses through particular NMDA receptor splice variants by 
submicromolar Zn^^ concentrations has also been demonstrated (Hollmann et al., 
1993). Christine and Choi (1990) demonstrated a voltage-sensitive fast-flicker block 
of NMDA receptor-gated channels by Zn^^, which allowed Zn^^ permeation following 
removal of the block. Using recombinant NMDA receptors in oocytes, Zn^^ was also 
shown to attenuate both low affinity voltage-dependent and high affinity voltage- 
independent components of NMDA receptor responses (Williams, 1996). The 
blockade of high affinity voltage-independent NMD A-mediated responses by synaptic 
Zn^^ may be necessary under conditions of neuronal overexcitation (Frederickson and 
Moncrieff, 1994; Dominguez et al., 2003). For example, Zn^^ (500|iiM) was 
protective against neurotoxic NMDA insults (Peters et al., 1987).
In cerebellar granule cells, Zn^^ induced a dose-dependent block of NMD A-mediated 
neurotransmitter release (Westergaard et al., 1995). The extracellular Zn^^ chelators, 
citrate and ethylenediaminetetraacetic acid (EDTA) attenuated this block 
(Westergaard et al., 1995). Zn^^ also inhibited NMDA receptors at the mossy fibre- 
granule cell synapse of the recurrent mossy fibre pathway, involved in epileptiform 
activity (Molnar and Nadler, 2001). The subsequent Zn^^-induced reduction of 
dentate granule cell excitability may be protective against seizure activity (Molnar and 
Nadler, 2001). Indeed, Zn^^ chelation with membrane-permeable sodium 
diethyldithiocarbamate (DEDTC) during a normally sub-convulsive kainate exposure 
induced seizure and neuronal death in the hilus, CAl and CA3 regions. This was 
attenuated by MK-801 pre-treatment, suggesting that synaptic Zn^^ participates in 
limiting NMD A-mediated excitation and associated death. However, Zn^^ chelation
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under normal conditions had neither pro-convulsive nor cell damaging effects 
(Dominguez et ah, 2003).
1.2.2,2 -permeable AMPA and/or kainate receptor-gated channels
The majority of AMPA and/or kainate receptors gate Ca^^-impermeable channels 
(Weiss et ah, 2000). However, an alternative site of Zn^^ entry may be through Ca^^- 
permeable AMPA and/or kainate receptor-gated channels although these are relatively 
rare, occurring on approximately 16% of total hippocampal neurons (Yin et ah, 1999). 
AMPA receptors comprise a tetramer of four subunits; GluRl-4 (Weiss and Sensi, 
2000). As will be described in section 1.2.7.1, AMPA receptor-gated channels are 
impermeable to Ca^^ due to the presence of an edited version of the GluR2 subunit. 
Approximately 99% of GluR2 subunit mRNA is edited at the Q/R site, whereby a 
glutamine codon is substituted for arginine. The arginine residue confers Ca^^ 
impermeability (Dingledine et ah, 1999; Kew and Kemp, 2005).
Kainate receptors similarly comprise tetrameric assemblies of the subunits GluR5-7 
and KAl-2 (Dingledine et ah, 1999). Like the AMPA receptor GluR2 subunit, GluR5 
and GluR6  subunit mRNA is edited at the Q/R site. This again confers Ca^^ 
impermeability (Sommer et ah, 1991). However, the Q/R editing is less complete in 
the GluR5 (30-55%) and GluR6  (70-90%) subunits compared to GluR2. Therefore 
Ca^^-permeable kainate receptor-gated channels probably show greater abundance 
than Ca^^-permeable AMPA receptor-gated channels (Bernard et ah, 1999). Indeed, 
GluR5 and GluR6  subunit expression has been demonstrated in the mossy fibre-CA3 
region both pre- and postsynaptically (Contractor et ah, 2000; Lauri et ah, 2003; 
Lerma, 2003; More et ah, 2004). Furthermore, evidence supports the presence of
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GluR5- and GluR6 -containing heteromeric receptors at presynaptic terminals of CAl 
intemeurons, participating in the modulation of GABA release (Christensen et ah, 
2004).
As mentioned earlier (section 1.1.6.4), presynaptic GluR5-containing kainate 
receptors may play a significant role in LTP induction by virtue of their Ca^^ 
permeability. Thus PhTX, a Ca^^-permeable receptor antagonist, blocked synaptic 
facilitation in the CA3 region following electrical stimulation of the dentate granule 
cells, or exposure to kainate. Similar effects were seen following exposure of 
hippocampal slices to the GluR5 subunit antagonist, LY382884 (Lauri et ah, 2003). 
Moreover, a more selective GluR5 subunit antagonist, UBP296, suppressed mossy 
fibre Ca^^ influx (More et ah, 2004). The evidence presented supporting the 
occurrence of Ca^^-permeable kainate receptors at the mossy fibre-CA3 synapse, in 
particular GluR5-containing receptors, suggests that they may provide a significant 
endogenous route of Zn^^ influx although this has yet to be examined.
In general, Ca^^-permeable AMPA and/or kainate receptor-gated channels display the 
highest permeability to exogenous Zn^^ of all channels and are localised on 
postsynaptic membranes of cell types particularly vulnerable to Zn^^-induced 
degeneration, adjacent to sites of presynaptic Zn^^ release (Sensi et ah, 1999). 
Moreover, lower Zn^^ concentrations are required to mediate selective death via these 
receptors than are required when entry is via other routes, suggesting that Zn^^ entry is 
more likely through Ca^^-permeable AMPA and/or kainate receptor-gated channels 
(Weiss et ah, 1993; Yin et ah, 1998). They may therefore provide a significant 
pathological route of Zn^^ influx.
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Kainate-induced Co  ^uptake is a method used to identify neurons expressing Ca^^- 
permeable AMPA and/or kainate receptor-gated channels (Pruss et ah, 1991; Yin and 
Weiss, 1995). Kainate-induced Zn^^ uptake mediates Zn^^ accumulation in a similar 
specific subpopulation of neurons, which was not achieved during NMDA or K^ 
exposure (Sensi et ah, 1997; Yin et ah, 1998). Accordingly, kainate and 300pM Zn^^ 
exposure in the absence of extracellular Na^ to block VSCC activation, induced 
neuronal death and Zn^^ accumulation restricted to the specific subset of neurons 
stained by Co^^ and the histochemical Zn^^ stain, TSQ (6 -methoxy-8 -p-toluene 
sulphonamide quinoline) (Yin and Weiss, 1995; Yin et ah, 1998).
In support of a route o f Zn^^ influx through Ca^^-permeable AMPA and/or kainate 
receptor-gated channels, Zn^^ accumulation and neuronal death were only partially 
attenuated by Gd^^ and unaffected with MK-801 following kainate-induced 
depolarisation or ischaemic insult (Sheline et ah, 2002; Yin et ah, 2002). Entry 
through Ca^^-permeable AMPA and/or kainate receptor-gated channels as opposed to 
NMDA receptor-gated Ca^^ channels is further evidenced by selective 
neurodegeneration post-ischaemic insult. This selective death coincides with the 
specific pattern of Ca^^ permeable AMPA and/or kainate receptor-gated channel 
expression, whereas NMDA receptor expression is more generalised and therefore if 
death were elicited via these receptors the pattern of death would be more widespread 
(Weiss and Sensi, 2000).
Ca^^-permeable AMPA and/or kainate receptor-gated channels show high levels of 
expression on GABAergic intemeurons (Yin et ah, 1998) and in the presence of 
extracellular Zn^^, kainate induces an inward Zn^^ current in these neurons (Jia et ah, 
2 0 0 2 ). Ca^^ and Zn^^ however, do not appear to compete for entry through these
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channels (Jia et al., 2002). Although Ca^^-permeable AMPA and/or kainate receptor- 
gated channels have not been specifically demonstrated on pyramidal neurons, the 
Ca^^-permeable AMPA and/or kainate receptor-gated channel inhibitor, 1-naphthyl 
acetyl spermine (NAS), inhibited Zn^^ accumulation in CAl and CA3 pyramidal 
neurons following ischaemic injury (Yin et al., 2002). However, Toth et al (1998; 
2000) suggested that CA3 pyramidal neurons may only contain Ca^^-impermeable 
AMPA and/or kainate receptors, owing to an insensitivity to PhTX).
Zn^^ has demonstrated voltage-independent potentiation of AMPA receptor-mediated 
responses at micromolar concentrations (Peters et al., 1987; Westbrook and Mayer, 
1987; Rassendren et al., 1990; Lin et al., 2001). As mentioned above, most Ca^^- 
permeable AMPA and/or kainate receptor-gated channels in the brain are found on 
GABAergic intemeurons (Jia et al., 2002). Indeed, single GABAergic intemeurons 
may form both Ca^^-permeable and Ca^^-impermeable AMPA and/or kainate 
receptor-gated channel synapses with the mossy fibres (Toth and McBain, 1998; Toth 
et al., 2000). GABA is the main inhibitory neurotransmitter in the brain. GABA 
induces neuronal hyperpolarisation by either eliciting an increase in CT conductance 
through C r channels of the GABAa receptor complex (Lyden and Wahlgren, 2000), 
or enhancing neuronal efflux following action on the GABAb receptor (Misgeld et 
al., 1995). This can inhibit excitatory neurotransmitter release including glutamate 
(Lyden and Wahlgren, 2000). Significantly, perfusion of Zn^^ onto the CA3 
hippocampal region induced the release of GABA and subsequently decreased 
glutamate release. This effect was attenuated by Zn^^ chelation with Ca.EDTA, or 
the AMPA/kainate receptor antagonist, NBQX, but not with antagonists of NMDA 
receptors (MK-801) or VSCC (verapamil) (Takeda et al., 2004). In an in vivo model 
of zinc deficiency, a specific reduction in vesicular Zn^^ was observed without
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perturbation of total hippocampal Zn  ^concentration. K^- or kainate-induced 
depolarisation of the CA3 region in zinc-deficient rats enhanced glutamate release, 
but attenuated GABA release (Takeda et al., 2003b; Takeda et al., 2003a).
These observations suggest that Zn^^ may attenuate presynaptic glutamate release and 
glutamate-mediated responses in the CA3 region through potentiation of 
AMPA/kainate receptors on GABAergic intemeurons and stimulated GABA release 
(Takeda et al., 2004). Accordingly, zinc-deficient rats demonstrate enhanced 
susceptibility to kainate-induced seizure, corroborating the increased excitability seen 
following enhanced glutamate release in the absence of vesicular zinc (Takeda et al., 
2003b). The effects on excitation and inhibition may therefore have important 
consequences during processes such as the development of LTP, by Zn^^-mediated 
inhibition of glutamate release (Takeda et al., 2004).
It should be noted however, that both exogenous and endogenous Zn^^-mediated 
inhibition of AMPA receptor responses has also been demonstrated in retinal 
horizontal intemeurons (Zhang et al., 2002). Furthermore, at very high concentrations 
Zn^^ was shown to inhibit AMPA/kainate responses possibly through interaction with 
the channel sulphydryl groups (Rassendren et al., 1990). Therefore the effects of Zn^^ 
at the AMPA/kainate receptor may not be ubiquitous.
1.2.23 Voltage-sensitive Ca^  ^channels (VSCC)
VSCC including L- and T-type Ca^^ channels (Atar et al., 1995), provide another 
potential mechanism for Zn^^ influx following neuronal depolarisation induced by 
AMPA and/or kainate receptor activation (Weiss et a l, 2000). Indeed, evidence
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suggests that VSCC may be the primary route of entry (Sensi et ah, 1997; Cheng 
and Reynolds, 1998). For example, K’^ -induced depolarisation enhanced both 
intracellular Zn^^ accumulation and subsequent neuronal toxicity, which was 
attenuated by increasing extracellular Ca^^, or Gd^^ addition (Weiss et ah, 1993; Sensi 
et ah, 1997; Sheline et ah, 2002; Sheline et ah, 2004). Zn^^-induced death was also 
attenuated following an increase in extracellular Ca^^ levels (10-20mM), 
demonstrating direct competition for entry sites between the two ions (Weiss et ah, 
19%%.
In contrast with neurons, depolarisation of non-reactive astrocytes in the presence of 
Zn^^ attenuated glial cell death (Sheline et ah, 2004). This is probably because 
neurons possess both L-type Ca^^ channels and T-type Ca^^ channels, whereas non­
reactive astrocytes lack L-type Ca^^ channels (Westenbroek et ah, 1998). T-type Ca^^ 
channels are low voltage activated channels and are inactivated upon depolarisation 
thus preventing Zn^^ influx and accumulation. L-type Ca^^ channels are however, 
high voltage activated channels and activate upon depolarisation to allow significant 
Zn^^ influx and neuronal toxicity (Sheline et ah, 2004).
In support of Zn^^ entry through L-type Ca^^ channels, the L-type Ca^^ channel 
antagonists nimodipine and amlodipine attenuated Zn^^-induced mitochondrial 
dysfunction in cultured rat cerebellar granule cells (Manev et ah, 1997). Nimodipine 
also reduced Zn^^-induced cell death under depolarising conditions in PC 12 cells and 
murine neocortical cell cultures, suggesting that Zn^^ influx again occurred through L- 
type Ca^^ channels. In contrast, opening the channels with Bay K8644 enhanced cell 
death (Kim et ah, 2000; Sheline et ah, 2002). In murine cortical neurons, an inward 
voltage-gated Zn^^ current was observed under non-depolarising conditions in the
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presence of extracellular Zn This current was sensitive to both and 
nimodipine and slightly sensitive to co-conotoxin suggesting mediation by 
predominantly L-type but also partially N-type VSCC. Under depolarising 
conditions, this Zn^^ current was associated with Zn^^ influx and was blocked by 
nimodipine (Kerchner et al., 2000).
In cortical astrocytic culture Zn^^ (400pM) exposure was sufficient to activate T-type 
Ca^^ channels (Sheline et al., 2004). Mibeffadil attenuated astrocytic death under 
these conditions attributed to decreased [Zn^^Ji (Sheline et ah, 2004). In the 
corresponding neuronal cells however, mibeffadil only partially attenuated the [Zn^^]i 
increase and subsequent death, suggesting that little neuronal Zn^^ entry occurs 
through T-type Ca^^ channels (Sheline et ah, 2004). In a hippocampal slice model, 
CayS.l and Cay3.2 T-type Ca^^ channels were localised to the CAl, CA3 and dentate 
gyrus. Antagonism of these channels by mibeffadil following oxygen-glucose 
deprivation attenuated subsequent neurodegeneration (Nikonenko et ah, 2005). 
However, the effects of Zn^^ entry via T-type Ca^^ channels in hippocampal neurons 
remain to be elucidated.
Zn^^ may induce an inhibitory block of responses through VSCC. In clonal rat 
pancreatic P-cells, Zn^^ antagonised both high voltage-activated Ca^  ^currents and 
more significantly, low voltage-activated Ca^^ currents (Bloc et ah, 2000). In isolated 
rat CAl hippocampal neurons, Zn^^ inhibited current through T-type Ca^^ channels at 
micromolar concentrations (Takahashi and Akaike, 1991). Similarly, Zn^^ attenuated 
Ca^^ current through T-type Cay3.2 channels of the dentate gyrus, CAl and CA3 
(Nikonenko et ah, 2005). Furthermore, in murine cortical neurons Zn^^(300pM) was 
also shown to reduce the high voltage-activated Ca^^ current by approximately 60%
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(Kerchner et al., 2000). Inhibition of VSCC-mediated responses by Zn^^ may 
therefore be important to reduce neuronal excitability by attenuating Ca^^ influx.
L2,2,4 Na^ /Ca^ '^  exchanger
A further potential route of Zn^^ entry may be reverse operation of the Na^/Ca^^ 
exchanger (Sensi et al., 1997). Loading neurons with intracellular Na^ followed by 
depletion of extracellular Na^ in the presence of Zn^^ induced a steady increase in 
[Zn^^ji (Sensi et ah, 1997). [Zn^^Ji increases were attenuated following addition of 
KB-R7943, an antagonist of the reverse operation of the NaVCa^^ exchanger, or 
benzamil-amiloride which blocks NaVCa^^ exchange (Sensi et ah, 1997; Cheng and 
Reynolds, 1998). However, the blockade of [Zn^^Ji increase was not complete with 
[Na^]i depletion, or significantly affected in the presence of normal extracellular Na^, 
indicative of a mechanism similar to but independent from NaVCa^^ exchange which 
may mediate these effects. Regardless, the [Zn^^ji increases observed via this process 
occurred relatively slowly, suggesting that this may not be an important mechanism of 
Zn^^ influx (Cheng and Reynolds, 1998).
1.2.2.5 andKATP channels
Zn^^ has also been shown to elicit effects through ATP-sensitive K ^  channels ( K a t p ) .  
During a moderately depolarising stimulus, Zn^^ was demonstrated to activate 
presynaptic K a t p  which reduce glutamate release from mossy fibre synaptosomes by 
hyperpolarising the resting membrane potential (Bloc et ah, 2000; Bancila et ah, 
2004). Indeed, Zn^^ reduced presynaptic Ca^^ signals and therefore Zn^^ release from 
presynaptic terminals following strong tetanic stimulation of the mossy fibre pathway.
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This may be through reduced Ca^^ influx either by direct inhibition of presynaptic 
VSCC (as described above) or indirectly by KATP-mediated hyperpolarisation (Quinta- 
Ferreira and Matias, 2005). The abundance of K a t p  channels on mossy fibre granule 
cells suggests that Zn^^ regulates glutamate release to avoid postsynaptic 
excitotoxicity (Quinta-Ferreira and Matias, 2005).
1.2.2.6 GAB A receptors
Zn^^ inhibits responses through GABAa receptors lacking y subunits at micromolar 
concentrations (Westbrook and Mayer, 1987; Legendre and Westbrook, 1991; 
Harrison and Gibbons, 1994). However, the majority of GABAa receptors in the 
brain probably contain the y subunit therefore the contribution of Zn^^-mediated 
inhibition is likely to be minimal (Harrison and Gibbons, 1994). The presence of Zn^^ 
in GABAergic synaptic terminals of the spinal cord however, suggests that Zn^^ may 
have an important postsynaptic regulatory action on G ABA receptors in this region 
(Mocchegiani et al., 2005).
Zn^^ influx may therefore occur via various routes allowing modulation of receptor 
and channel function as summarised in table 1 .1 .
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RECEPTOR/
CHANNEL ENTRY MECHANISM
POSTSYNAPTIC
RESPONSE
NMDA
• Permeation following 
fast flicker block
• Inhibition of NMDA 
responses
• Potentiation of certain 
splice variants
VSCC
• L-type 
Ca^^channels
• T-type 
Ca^^channels
• Direct entry • Inhibits high voltage 
activated Ca^^ current
• Predominantly 
astrocytic entry
• Inhibits Ca^^ current 
through T-type Ca^^ 
channels
AMPA/Kainate
• Direct permeation only 
via Ca ^-permeable 
receptor-gated 
channels
• Potentiation of AMP A 
responses
GABAa —
• Inhibits GABAa 
lacking y subunits
Na+/Ca^+
exchanger
• Reverse operation of 
exchanger
—
K a t p  Channels —
• Activates channels 
inducing
hyperpolarisation
Table 1.1. Summary of influx mechanisms and postsynaptic responses.
Predominantly Zn^^ reduces glutamate-mediated excitability as evidenced by the fact 
that presynaptic glutamate release is attenuated by the Zn^^-induced release of GAB A 
from inhibitory intemeurons (Takeda et a l, 2004), the activation of presynaptic K a t p
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channels (Quinta-Ferreira and Matias, 2005), and the inhibition of VSCC (Kerchner et 
al., 2000; Nikonenko et al., 2005). Zn^^ antagonism of NMDA receptors, and VSCC 
also limits the glutamate-mediated responses through these channels (Peters et al., 
1987; Westergaard et al., 1995; Kerchner et al., 2000; Nikonenko et al., 2005). 
Conversely, excessive Zn^^ release may alternatively potentiate glutamate-mediated 
excitotoxicity via inhibition of glutamate reuptake by the glial excitatory amino acid 
transporter 1 (EAATl) (Vandenberg et al., 1998), and also via direct potentiation of 
the AMPA/kainate receptor mediated response on glutamatergic neurons (Peters et al., 
1987). Therefore Zn^^ may elicit different actions on different cell types in the 
regulation of glutamate excitotoxicity.
1.2.3 Zinc efflux
Although several mechanisms mediating Zn^^ influx have been described, fewer 
studies focus on the precise mechanisms of neuronal Zn^^ efflux. As mentioned 
earlier (section 1.1.5), ZnT-1 may mediate cellular Zn^^ extrusion. A further 
mechanism, a reversible H^Zn^^ exchanger, has additionally been proposed to 
participate in Zn^^ efflux (Colvin, 1998; Colvin et al., 2000). However, the size of the 
electrochemical H^ gradient is probably insufficient to actively maintain the steep 
intracellular/extracellular Zn^^ gradient observed, and the affinity of the antiporter for 
intracellular Zn^^ is probably too low for physiological relevance (Colvin et al., 2000; 
Ohana et a l, 2004).
Recently, another Zn^^ efflux mechanism, a NaVZn^^ exchanger, has been elucidated 
which participates in maintaining transmembrane Zn^^ gradients. This activity is 
different to and not mediated by the NaVCa^^ exchanger, and does not require ATP.
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The exchanger utilises the Na^ electrochemical gradient to catalyse intracellular Zn^^ 
removal against a 500-fold transmembrane gradient. It could therefore prevent toxic 
Zn^^ accumulation and also possibly operate under normal synaptic function such as 
LTP regulation (Ohana et al., 2004).
1.2.4 Zn^^-mediated neuroprotection
Until relatively recently, due to the redox inert nature of Zn^^ a non-toxic role was 
favoured compared to a toxic one. In support of this view, extracellular Zn^^ 
concentrations in excess of lOOpM may be protective against apoptosis in certain non­
neuronal cells. For example, thymocytes can withstand exposure to 5mM zinc 
(Cohen and Duke, 1984). There is also evidence to suggest that Zn^^ may be 
neuroprotective during ischaemia. Indeed, Zn^^ (IpM) addition to organotypic 
hippocampal slices during ischaemic insult significantly increased CA3/CA2 subfield 
cell viability, a function attributed to reduced glutamate release following activation 
of presynaptic K a t p  channels (Bancila et ah, 2004). This group additionally 
demonstrated that Zn^^ chelation with Ca.EDTA (500pM) enhanced cell death 
(Bancila et ah, 2004). This may however, be the result o f Ca.EDTA stripping and 
sequestering Zn^^ from important intracellular binding sites such as transcription 
factors and metalloproteins and inhibiting its re-uptake (Frederickson et ah, 2002b). 
This phenomenon is also demonstrated by the toxic effects of the membrane 
permeable high affinity Zn^^ chelator, N,N,N’,N’-tetrakis (2-pyridyImethyl) 
ethylenediamine (TPEN) in the absence of exogenous Zn^^ (Canzoniero et ah, 2003).
Exogenous Zn^^ has also been shown to protect neurons against NMDA- and kainate- 
induced excitotoxicity (Peters et ah, 1987; Dominguez et ah, 2003), whereas
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endogenous Zn^^ chelation from synaptic vesicles reduces the threshold for kainate- 
induced seizures (Dominguez et al., 2003). Conversely, in an in vivo model, 
intracellular chelation of endogenous Zn^^ with TPEN or DEDTC during kainate 
administration failed to affect seizure-induced neuronal death, whereas TPEN 
protected cells against Zn^^-induced toxicity (Lees et al., 1998). This suggests that 
endogenous Zn^^ may not participate in modulating the effects of kainate-induced 
seizure (Lees et ah, 1998).
Devergnas et al (2004) demonstrated a biphasic effect of exogenous Zn^^ on HeLa 
cells, whereby up to 125pM Zn^^ enhanced cell viability but 154pM Zn^^ induced 
substantial cell death. Furthermore, Frederickon and Moncrieff (1994) also 
demonstrated low Zn^^ concentrations were anticonvulsive and neuroprotective, 
whereas high Zn^^ concentrations enhanced seizure and neurodegeneration. 
Therefore the Zn^^ concentration may dictate either a neuroprotective or 
neurodegenerative role (see chapter 3).
1.2.5 Zn^^-induced death
Substantial evidence exists supporting a role for Zn^^-induced neuronal injury 
following ischaemic insult including stroke, mechanical head trauma and epilepsy 
(Choi and Koh, 1998; Suh et ah, 2000b). One of the initial examples of Zn^^-induced 
toxicity in the CNS was observed following 24hr exposure of dorsal root ganglion 
cells to ImM ZnS0 4 . As a result, disruption to neurotubule and neurofilament 
assemblies occurred accompanied by some neurodegeneration (Gaskin et ah, 1978). 
Many groups have since examined the effects of Zn^^ exposure in a 
pathophysiologically relevant range. For example, Choi et al (1988) observed that
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15min exposure of cultured murine cortical neurons to 300-600pM Zn^^ induced 
morphological changes, ensued by death if exposure duration was extended (Choi et 
ah, 1988). Similarly Koh and Choi (1994) demonstrated widespread death 
specifically of neurons in mixed murine cortical cultures following acute Zn^^ 
exposure (300-1000pM Zn^^; 15min) (Koh and Choi, 1994).
A role for Zn^^-induced death following cerebral ischaemia was initially proposed by 
Tonder et al (1990), who revealed enhanced Zn^^ concentrations in degenerating CA3 
or hilar neurons concomitant with a reduction of mossy fibre Zn^^ after global 
ischaemia (Tonder et ah, 1990). A delayed increase in Zn^^ (up to 72hr) was apparent 
in susceptible CAl pyramidal neurons following global ischaemia, but prior to cell 
death (Park et ah, 2000; Calderone et ah, 2004).
The degeneration of rat hippocampal neurons and glia in vivo following injection of 
ZnCh was shown to be attenuated by the co-addition of TPEN, implying that Zn^^ 
influx and accumulation occurs prior to death (Cuajungco and Lees, 1996). 
Accordingly, addition of TPEN or the low affinity Zn^^ chelator, l-hydroxypyridine-2- 
thione (pyrithione), to murine mixed cortical cultures following Zn^^ exposure 
attenuated [Zn^^ji increase and neuronal death (Canzoniero et ah, 2003).
Using a hippocampal slice model, Ca^^-dependent Zn^^ release was observed fi*om 
dentate granule cells following electrical stimulation (Howell et ah, 1984). Moreover, 
Zn^^ release from mossy fibres was achieved following high frequency perforant 
pathway stimulation or K^-induced depolarisation in a rat microdialysis model 
(Aniksztejn et ah, 1987). In a further hippocampal slice model, kainate- or K^- 
induced depolarisation mediated similar Ca^^-dependent Zn^^ release conceivably 
reaching local extracellular concentrations of 300pM (Assaf and Chung, 1984).
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Endogenous Zn^^ release in the CA3 region was however blocked following specific 
ablation of the granule neurons and their mossy fibres (Aniksztejn et al., 1987).
Addition of 300pM Zn^^ to cortical cultures in the presence of kainate or KCl (but not 
NMDA) induced >400nM [Zn^^ji assessed by Newport Green fluorescence, and 
widespread neuronal death 24hr post-insult suggesting that Ca^^-permeable AMPA 
and/or kainate receptor gated channels or VSCC are the main sites of Zn^^ entry 
(Canzoniero et al., 1999). In agreement, exposure to Zn^^ in the presence of AMPA 
or kainate, potentiated neuronal necrosis (Kim et al., 1999a). Canzoniero et al (1999) 
demonstrated a dose-dependent correlation between [Zn^ "^ ]i and neuronal death 
following exogenous Zn^^ application under depolarising conditions. Intracellular 
Zn^^ concentrations in excess of 250-300nM were required for substantial 
neurodegeneration (Canzoniero et al., 1999).
It is worth noting that different Zn^^ fluorescent probes may yield conflicting data 
regarding Zn^^ concentrations under different conditions. This may be the result of 
several factors, for example, interference from contaminating cations such as the 
sensitivity of mag-fura-2 to Mg^^ and Ca^^ (Cheng and Reynolds, 1998), inadequate 
neuronal loading with V-(6-methoxy-8-quinolyl)-/>-carboxybenzoylsulphonamide 
(TEL) or Zinquin (Sensi et al., 1997), and dependence on intracellular dye 
concentration (Dineley et al., 2002). Therefore data presented regarding Zn^^ 
concentrations should be considered as estimated values only and treated with 
caution.
Recently, an intriguing finding has demonstrated neuronal Zn^^ accumulation 
following target loss, presenting a further pathological role for Zn^^ in an unrelated 
disease paradigm. Specific ablation of the rat primary visual cortex, the cortical target
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of lateral geniculate nucleus (LGN) neurons, via kainate injection removed trophic 
support to LGN neurons. Zn^^ accumulation was detected in LGN neurons ensued by 
active caspase 3 immunoreactivity. The LGN does not contain presynaptic Zn^^- 
containing boutons and therefore the source of Zn^^ is probably intracellular Zn^^- 
binding proteins as discussed below (see also chapter 4) (Land and Aizenman, 2005). 
This suggests that intracellular Zn^^ accumulation may be a ubiquitous feature of 
‘normal’ neuronal cell death.
1.2.6 Synaptic translocation
There is considerable evidence suggesting that Zn^^ translocation from presynaptic to 
postsynaptic neurons, and resultant accumulation is responsible for inducing death 
following ischaemic insult. Indeed, Koh et al (1996) confirmed Zn^^ accumulation in 
the somata of degenerating postsynaptic neurons (specifically in the hippocampal 
hilus and CAl region) and its depletion from presynaptic neurons (dentate granule 
neurons of the hilus and CA3 region) following transient forebrain ischaemia using 
Zn^^ staining in rat brains (Koh et al., 1996). Zn^^ translocation and accumulation 
correlated with the neurons undergoing degeneration. Addition of Ca.EDTA 
prevented Zn^^ influx and thus protected both murine cultured cortical neurons, and 
hilar or CAl pyramidal neurons in vivo against Zn^^-induced cell death (Koh et al.,
1996). A similar demonstration of Zn^^ translocation also has been obtained in a rat 
model of mechanical head trauma (Suh et al., 2000b). The delay prior to 
neurodegeneration following ischaemic insult can be explained by the requirement for 
Zn^^ translocation, influx and accumulation to sufficiently high levels to induce 
neurotoxicity (Koh et ah, 1996).
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staining studies revealed the presence of Zn^^ within the presynaptic bouton, in 
the synaptic cleft (Schroder, 1979) in synaptic vesicles and on the outer surface of the 
presynaptic membrane (Friedman and Price, 1984), demonstrating that Zn^^ had been 
exocytosed (Frederickson, 1989). Additionally, reduced bouton Zn^^ staining is seen 
following brain damage concomitant with an increase in staining outside the bouton 
(Frederickson, 1989) and within degenerating neurons (Perez-Clausell et al., 1989). 
During focal brain ischaemia induced by middle cerebral artery occlusion, the density 
of Zn^^-positive neuronal terminals in the neocortex, the dorsolateral striatum and the 
ventrobasal thalamic nucleus is significantly reduced attributed to vesicular Zn^^ 
release (Sorensen et al., 1998).
Conflicting evidence demonstrates sustained accumulation of Zn^  ^in postsynaptic 
CAl and CA3 neurons of ZnT-3 knockout mice following kainate-induced seizure. 
These mice lack vesicular Zn^^, suggesting that the accumulating Zn^^ does not 
originate in the synaptic vesicle. However, administration of the extracellular Zn^^ 
chelator, Ca.EDTA, during seizure reduced both Zn^^ accumulation and 
neurodegeneration implying that Zn^^ still derives from an extracellular source (Lee et 
al., 2000). An alternative hypothesis for the origin of the extracellular Zn^^ suggests 
that Zn^^ may be released from intracellular stores such as metallothioneins under 
ischaemic conditions (see chapter 4), and pumped into the extracellular space via 
ZnT-1 where it could then proceed to enter postsynaptic neurons (Palmiter and 
Findley, 1995; Lee et al., 2000). Accordingly, application of the membrane 
permeable oxidative agent, 2, 2’-dithiodipyridine (DTDP), to murine cortical cultures 
induced toxic [Zn^^Ji attributed to the oxidation of metallothioneins and subsequent 
release of bound Zn^^ by catalytic disulphide exchange (see chapter 4) (Aizenman et 
al., 2000).
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Arguing against synaptic Zn^^ translocation, Kay (2003) demonstrated that despite 
synaptic Zn^^ release following K^-induced depolarisation, the levels detected (~ 
24nM) were significantly less than those proposed by other groups (Assaf and 
Chung, 1984; Howell et ah, 1984). Furthermore, following depolarisation the highest 
increases in extracellular Zn^^ were observed around the CAl region, which does not 
correlate with regions rich in Timm’s histochemical stain i.e. the mossy fibre 
terminals. It was proposed that Zn^^ might associate with molecules in the 
extracellular space following extrusion, before slow re-uptake (Kay, 2003). Indeed, 
residual Zn^^ was also observed extracellular to the Timm’s stainable regions without 
presynaptic stimulation (Kay, 2003). However, ZnT-3 null mice did not show a 
depolarisation-induced increase in extracellular Zn^^ fluorescence, suggesting that 
Zn^^ is released from synaptic vesicles (Kay, 2003).
Significantly, the observations of Kay (2003) were based in a hippocampal slice 
model. Suh et al (2000a) have suggested that the process of slice preparation and the 
low temperatures required for brain slice study allows for loss of up to 75% synaptic 
Zn^^. Therefore caution is warranted when interpreting data regarding endogenous 
Zn^^ release from hippocampal slice preparations (Suh et al., 2000a).
1.2.6.1 MT-III, ZnT-3 and synaptic Zii^ translocation
Synaptic Zn^^ translocation may only participate in mediating Zn^^-induced 
cytotoxicity in selective brain regions, and MT-III may play a significant role in 
regulating differential neuronal vulnerability. In the hippocampal CA3, where 
synaptic Zn^^ translocation from mossy fibre inputs contributes to significant Zn^^ 
accumulation, ZnT-3/MT-III double knockout mice demonstrate enhanced
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susceptibility to kainate-induced seizure, Zn^^ accumulation and CA3 neuronal death 
similar to ZnT-3 single knockout mice (Cole et ah, 2000; Lee et ah, 2003). As 
mentioned earlier, enhanced vulnerability of ZnT-3 knockout mice to kainate-induced 
seizure corroborates the suggestion that Zn^^ normally acts to decrease hippocampal 
excitability (Cole et ah, 2000). MT-III single knockout mice show enhanced seizure 
activity and neuronal damage compared to wildtype (Erickson et ah, 1997; Lee et ah, 
2003), but not ZnT-3/MT-III double knockout mice (Cole et ah, 2000).
This suggests that ZnT-3 and MT-III may participate in the same pathways (Cole et 
ah, 2000). MT-III may be required for Zn^^ removal from the synaptic cleft and 
recycling to the synaptic vesicle in the CA3 (as described in section 1.1.3.2), thus 
protecting the neuron from Zn^^ toxicity (Erickson et ah, 1997). In the absence of 
MT-III, synaptic Zn^^ is therefore toxic as it cannot be recycled. However, in the 
absence of vesicular zinc the actions of MT-III are irrelevant (Cole et ah, 2000).
In the CAl region, ZnT-3 gene knockout mice also show significant CAl pyramidal 
neuronal damage compared to wildtype following kainate-induced seizure (Cole et ah, 
2000). ZnT-3/MT-III double knockout mice however, show substantially reduced 
CAl neuronal damage compared to ZnT-3 single knockout mice (Cole et ah, 2000; 
Lee et ah, 2003). This suggests that MT-III is required to promote Zn^^ toxicity in the 
C A l. Furthermore, MT-III knockout mice show reduced Zn^^ accumulation and 
neuronal death in the CAl, dentate gyrus and the thalamus following kainate-induced 
seizure or addition of an NO donor (sodium nitroprusside) compared to wildtype mice 
(Lee et ah, 2003). Significantly, the thalamus does not contain synaptic Zn^^ (Cole et 
ah, 1999), but does contain MT-III suggesting the source of Zn^^ in this region 
following kainate-induced seizure is MT-III (Lee et ah, 2003). This model therefore
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favours cytotoxic release from MT-III, potentially via thiol oxidation (see 
chapter 4), in the CAl rather than the synaptic vesicle in response to ischaemic stimuli 
(Lee et al., 2003).
In summary therefore, MT-III sequesters and potentially recycles Zn^^ in the CA3 to 
reduce seizure susceptibility, whereas MT-III releases Zn^^ in the CAl to enhance 
seizure susceptibility (Cole et al., 2000; Lee et al., 2003).
1.2.6.2 Alternative sources
Evidence presented thus far suggests that the synaptic vesicle may not be the sole 
source of cytotoxic Zn^^. As discussed earlier, Zn^^-stained neurons appear following 
kainate-induced seizure in the absence of vesicular Zn^^ (ZnT-3 knockout mice) (Lee 
et al., 2000). Infusion of a NO donor to the cerebellar cortex also induces Zn^^- 
positive Purkinje neurons, in the absence of presynaptic Zn^^ (Frederickson et al., 
2002a). Furthermore, target ablation induced Zn^^ accumulation in LGN neurons 
despite the absence of Zn^^-containing boutons in the LGN (Land and Aizenman, 
2005). It has recently been proposed that there are three potential sources of cytotoxic 
Zn^^ origin. These include the synaptic vesicle (described above), oxidative 
mobilisation from Zn^^-containing metalloproteins, and mitochondrial pools (see 
chapter 4) (Frederickson et al., 2004).
1.2.7 Differential neuronal susceptibility
Neurons differ in their vulnerability to death induced following transient global 
ischaemia. Particularly susceptible neurons appear in the hippocampal CAl
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pyramidal layer, the striatum and the cerebellum (Choi and Koh, 1998). Following 
epileptic seizure however, GABAergic intemeurons of the CA3 subfield strata oriens 
and lucidum have enhanced vulnerability correlating with high Zn^^ accumulation, 
compared to the CA3 pyramidal neurons which accumulate moderate [Zn^^Ji and 
survive (Cote et al., 2005).
Neuroprotection in the pyramidal neurons is attributed to the stimulation of Akt 
phosphorylation by low [Zn^^Ji (Cote et al., 2005). Phosphorylated Akt subsequently 
phosphorylates and deactivates proapoptotic Bcl-2 associated protein, BAD, limiting 
downstream caspase 3 activation therefore cell death (see chapter 3). Significantly, 
depletion of [Zn^^Ji with a zinc-deficient diet enhanced Akt phosphorylation and 
intemeuron viability, whereas chelation of Zn^^ in pyramidal neurons induced 
massive cell death (Cote et al., 2005). Therefore the interplay of various Zn^^- 
regulated mechanisms is both cell and concentration specific. The protection of CA3 
pyramidal neurons by Zn^^ may be important during intense synaptic activity 
associated with learning and memory via LTP (Cote et al., 2005). It is also postulated 
that differential expression of Ca^^-permeable AMPA and /or kainate receptors 
underlies the differences in susceptibility of intemeurons (see below) (Toth and 
McBain, 1998; Toth et al., 2000).
Differential susceptibility may also exist between neurons and glia in the same brain 
regions. For example, in mixed cortical cultures, astrocytes are more resistant to 
enhanced extracellular Zn^^ than neurons (Sheline et al., 2000; Sheline et al., 2004). 
Depolarisation induced by extracellular K^ and energy failure during ischaemic injury 
may mediate astrocytic protection, evidenced by enhanced viability following 
exogenous KCl application in the presence of Zn^^. However, the same conditions
47
augment neuronal Zn^^ vulnerability. Astrocytes thus require a greater [Zn^^ji prior to 
apoptotic death compared to neurons which die via necrosis under the same insult 
(Sheline et al., 2004).
1.2.7.1 The GluR2 hypothesis
As mentioned above, differential expression of Ca^^-permeable AMPA and/or kainate 
receptors may specify neuronal susceptibility to Zn^^-induced death following 
ischaemia (Toth and McBain, 1998; Toth et al., 2000). The Ca^^-permeable AMPA 
receptor-gated channel comprises a combination of subunits; GluRl, GluR2, GluR3 
and GluR4 (or GluRA-D) (Weiss and Sensi, 2000). Enhanced Ca^^ permeability of 
Ca^^-permeable AMPA receptor-gated channels is dependent on the formation of 
heteromers lacking the GluR2 /GluRB subunit (figure 1.4) (Hollmann et al., 1991).
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GluR1 GluR2 GluR1 GluR3
Na+Ca2+
COOH COOHCOOH COOH
Ca2+-impermeable Ca2+-permeable
Figure 1.4. GluR2 subunit expression determines Ca^-permeability of the 
AMPA receptor.
(A) AMPA receptor channels comprising GliiRl subunits are Ca~ -impermeable due 
to the presence o f an arginine residue (R) instead o f glutamine (Q) at the Q/R site.
(B) AMPA receptors lacking the GluR2 subunit are Ca^^-permeable. Adapted from  
Pellegrini-Giampietro et al (1997).
Studies on rat and gerbil hippocampal CAl pyramidal neurons have demonstrated a 
selective downregulation of GluR2 AMPA subunit mRNA and protein expression 
following transient global ischaemia but prior to neurodegeneration (Pellegrini- 
Giampietro et al., 1992; Gorter et al., 1997). As a result, increased expression of 
Ca^ -permeable AMPA receptor-gated channels enhances Ca  ^ and Zn^' neuronal 
entry and accumulation, and therefore promotes degeneration of cells specifically 
expressing these channels (Pellegrini-Giampietro et al., 1992; Gorter et al., 1997).
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This observation is known as the ‘GluR2 hypothesis’ (Pellegrini-Giampietro et al.,
1997).
The importance of the GluR2 subunit in determining selective neuronal injury was 
revealed following the administration of antisense oligodeoxynucleotides directed 
against the GluR2 mRNA in rats. In this model, CAl and CA3 pyramidal neuron 
specific death was observed even in the absence of ischaemic insult (Oguro et al., 
1999). Further experiments demonstrated that expression of Ca^^-impermeable 
AMPA receptors containing GluR2(R) in CAl pyramidal neurons was capable of 
rescuing against ischaemic death. However, expression of Ca^^-permeable AMPA 
receptors containing GluR2(Q) in normally non-susceptible granule cells induced 
selective death following ischaemia (Liu et al., 2004a). Recently, it has been 
suggested that Zn^^ may also functionally regulate neuronal susceptibility to injury 
during ischaemic insult. Intraventricular Ca.EDTA addition immediately prior to 
ischaemic insult attenuated Zn^^-mediated downregulation of GluR2 mRNA and 
protein expression in CAl hippocampal pyramidal cells, thus preventing Ca^^- 
permeable AMPA and/or kainate receptor-gated channel expression and cell death 
(Calderone et al., 2004).
In CAl hippocampal neurons, the delay between ischaemic insult and increased Ca^^ 
permeable AMPA receptor-gated channel expression may explain the interval 
observed between Zn^^ influx and neurodegeneration (Pellegrini-Giampietro et al., 
1992). However, sufficiently intense Zn^^ insults may permit neuronal injury through 
pre-existing Ca^^ permeable AMPA and/or kainate receptor-gated channels prior to 
their selective upregulation resulting in earlier injury (Yin et al., 2002).
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To establish the mechanism of GluR2 subunit repression, the GluR2 gene sequence 
was examined. Analysis of the promoter region of the GluR2 subunit revealed a 
functional repressor element-1 (RE-l)-like silencer (neuron-restrictive silencer 
element) (Myers et al., 1998). The zinc finger-containing gene silencing transcription 
factor, neuron-restrictive element-1 silencing transcription factor (REST), is proposed 
to participate in GluR2 subunit repression through binding to this element (Myers et 
al., 1998; Huang et al., 1999; Calderone et al., 2003). Following co-repressor 
complex formation with Sin3 A and coREST, REST recruits histone deacetylase to 
specific gene promoter regions. These genes are then silenced via deacetylation of 
core histone proteins associated with the promoter (Huang et al., 1999; Balias et al., 
2001).
Under non-pathological conditions, REST is associated with a downregulation of 
GluR2 in non-neuronal cells (Myers et al., 1998; Huang et al., 1999). However, 
REST mRNA upregulation and protein expression, and subsequent GluR2 gene 
suppression occurs specifically in the vulnerable CAl pyramidal neurons following 
global ischaemia (Calderone et al., 2003). Antisense REST mRNA 
oligodeoxynucleotides attenuated CAl death by inhibiting REST protein expression 
and therefore GluR2 promoter suppression (Calderone et al., 2003). Therefore 
derepression of REST following ischaemic insult, suppresses GluR2 subunit 
expression and therefore enhances Ca^^ permeable AMPA and/or kainate receptor- 
gated channel expression.
REST activation may be regulated by a Ca^^-dependent cAMP response element 
binding protein, CREB. It is suggested that CREB binds to CRE (Ca^^ regulatory 
element) sequences in the brain-derived neurotrophic factor (BDNF) promoter to
51
enhance BDNF expression (Tabuchi et ah, 2002). BDNF may subsequently inhibit 
REST and attenuate GluR2 subunit repression (Brene et al., 2000). Activation of 
CREB transcription following ischemic insult and GluR2 subunit downregulation 
however, ameliorates CAl pyramidal neuron viability by rescuing GluR2 gene 
expression via BDNF-mediated REST repression thus inhibiting AMPA receptor Ca^  ^
permeability (Liu et al., 2004a).
1,2.7.2 TheP75^^^ death-cascade
A further mechanism that may regulate neuronal vulnerability following cytotoxic 
Zn^^ insult and ischaemia involves the P75^^^ death cascade. Nerve growth factor 
(NGF) can promote both pro- and anti-apoptotic signals in cells. NGF binds to TrkA 
tyrosine kinase receptor and can interact with P75^^^, a low affinity neurotrophin 
receptor and TNF family member to potentiate cell growth and survival (Hempstead 
et al., 1991). In the absence of TrkA however, NGF mediates a neurotoxic function 
via high affinity binding to P75^^^ (Frade et al., 1996; Allington et al., 2001). The 
P75NTR-associated death executor, NADE, binds to the death-domains of P75^^^ in an 
NGF-dependent manner to induce downstream apoptosis via its pro-apoptotic domain 
(Mukai et al., 2000; Mukai et al., 2002). Furthermore, inhibition of the interaction of 
P7 ^ntr NADE prevented neuronal apoptosis, suggesting this association is 
important for cell death progression (Park et al., 2000).
Enhanced P75^^^ expression occurs in vulnerable neurons following seizure, possibly 
to promote apoptosis of these cells (Roux et al., 1999). Zn^^ (lOOpM) has been 
shown to inhibit both the binding of NGF to P75^^^ in embryonic chick neural retinal 
cells (which lack TrkA), and downstream apoptosis (Allington et al., 2001).
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Conversely, Zn^^ exposure in cortical cultures induced P75^^^, NADE and NGF 
expression, an effect not replicated following NMDA, ionomycin (Ca^^ ionophore), 
nor F1202 exposure. P75^^^ and NADE induction following transient global 
ischaemia also correlated with the delayed Zn^^ increase in CAl pyramidal neurons 
and neuronal apoptosis (Park et al., 2000; Calderone et al., 2004). Zinc chelation 
however, inhibited both P75^^^ and NADE induction (Park et al., 2000). Despite the 
fact that direct interaction of NGF binding to P75^^^ was not demonstrated in these 
experiments, Zn^^ is unlikely to have an inhibitory effect as seen in chick retinal cells 
(Allington et al., 2001). This is evidenced by the induction of NGF by Zn^^ exposure, 
and potentiation of apoptosis revealed in the presence of both exogenous Zn^^ and 
NGF (Park et al., 2000). These data suggest that P75^^^, NADE and NGF expression 
may also be important to determining neuronal vulnerability following Zn^^-induced 
and ischaemic insult.
It should be noted that overall susceptibility to Zn^^-induced degeneration will 
therefore be dependent on a number of factors including presence of Zn^^ entry 
mechanisms, Zn^^ homeostatic mechanisms and various cell death pathway 
mechanisms such as expression of the immediate early transcription factor, Egr-1 
(discussed in section 1.2.9) (Park and Koh, 1999). Additionally, the delay following 
Zn^^-translocation and ensuing neurodegeneration suggests the interplay of other 
mechanisms (Choi and Koh, 1998).
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1.2.8 Ischaemic preconditioning
It is possible to protect neurons from ischaemic insults via a process known as 
ischaemic preconditioning. Here, brief subtoxic ischaemic exposure induces 
protective mechanisms in vulnerable neurons to limit further damage induced by 
subsequent ischaemic insult (Kitagawa et al., 1991). Oxygen-glucose deprivation 
induced an increase in [Zn^^ji and [Ca^^Ji in CAl neurons of hippocampal slices, 
which were attenuated if preceded by a period of ischaemic preconditioning 
(Miyawaki et al., 2004). It should be noted that hippocampal [Ca^^]i increases are 
non-specific following ischaemia; increases are seen in the CAl, CA3 and dentate 
gyrus following oxygen-glucose deprivation, whereas only [Zn^^i increases in the 
CAl (Miyawaki et al., 2004). This implies that ischaemic tolerance is mediated by 
reduced [Zn^^Ji accumulation following preconditioning (Miyawaki et al., 2004).
Preconditioning prior to global ischaemia failed to inhibit subsequent caspase 9 and 
caspase 3 activation. However, activation of the downstream targets, caspase- 
activated DNase (CAD) and P75^^^ were attenuated. Moreover, mitochondrial 
release of the antiapoptotic molecule, cIAP (inhibitor of apoptosis), occurred in the 
absence of the proapoptotic compounds cytochrome c and Smac/DIABLO (second 
mitochondria-derived activator of caspases/direct inhibitor of apoptosis protein- 
binding protein with low PI) (see chapter 3) (Tanaka et al., 2004). This suggests that 
apoptotic mechanisms initiated by global ischaemia were arrested by preconditioning 
potentially by maintaining mitochondrial membrane integrity (Tanaka et a l, 2004). 
Furthermore, ischaemic preconditioning prevented REST induction and therefore 
GluR2 subunit downregulation following subsequent ischaemic insult (Calderone et 
a l, 2003).
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As an alternative to preconditioning, prolonged mild post-ischaemic hypothermia can 
also mediate significant CAl neuroprotection. Indeed, reducing gerbil body 
temperature for two days post-ischaemic insult significantly attenuated the specific 
GluR2 mRNA downregulation in this region (Colboume et al., 2003). Therefore 
mechanisms for both pre- and post-ischaemia mediated-protection have been 
identified to limit subsequent neuronal death.
1.2.9 Zn^^-regulated gene expression
Zn^^-toxicity has been associated with the activation of specific genes. For example, 
expression of the immediate early transcription factor, Egr-1, in murine cortical 
cultures was significantly induced following acute Zn^^ exposure, attributed to 
neuronal Zn^^ influx. This effect was dependent on Erk 1/2 (extracellular signal- 
regulated kinase) activation. These data suggest that Egr-1 may be an important 
component of Zn^^-induced death (Park and Koh, 1999). Furthermore, oxidative Zn^^ 
release following DTDP treatment (see chapter 4) induced the activation of the 
mitogen-activated protein kinase (MAPK) family member, p38, prior to apoptotic 
death (McLaughlin et al., 2001). Oxidative stress and Zn^^-mediated p38 
upregulation enhanced both the current through delayed rectifier potassium channels 
(K^ efflux), and subsequent caspase 9 and 3 activation and apoptosis (McLaughlin et 
al., 2001). Zn^^ chelation with TPEN however, prevented p38 induction and the 
downstream cascades (McLaughlin et al., 2001).
Significantly, Zn^^ depletion has also been shown to inhibit DNA binding of the 
transcription factor, NF-kB (nuclear factor kappa-B) (Oteiza et al., 2000; Ho and 
Ames, 2002). NF-kB is required to upregulate processes involved in immune and
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inflammatory responses (DiDonato et al., 1995). Therefore Zn^^ is necessary to 
mediate these effects.
1.2.10 The cytotoxic model
As has been described in this chapter, presynaptic Zn^^ release may elicit many 
downstream effects depending on its mechanism of action at various postsynaptic 
membrane receptors and channels, and subsequent intracellular effects following 
influx. Figure 1.5. summarises the mechanisms detailed herein.
56
MT
Glu
•  •
ZnT-1NMDA ; 
Receptor Al Ca-A/K
Na'
EGR-1 PKC
ZIPCyto-c
Necrosis
Figure 1.5. Potential mechanisms of Zn^  ^release, uptake and downstream 
targets.
Zn is co-stored with glutamate in synaptic vesicles o f  Zn^^-containing neurons (1) 
prior to co-release from the presynaptic neuron following depolarisation (2). 
inhibits the NMDA receptor channel on the postsynaptic neuron (3). Routes ofZn^'^ 
entry include Ca^ -permeable AMPA and/or kainate channels (4), VSCCs (5), the 
Na -Ca^ exchanger (6), and the ZIP transporter (7). Both the Na -Ca~ 
exchanger/Na -Zrf exchanger (6) and ZnT-1 (8) also promote Zn ' efflux. 
Metallothioneins (MT) (9) can sequester, store and release intracellular Zn to 
maintain Zn homeostasis. Zn^^ can act on the mitochondria (10) to promote ROS 
generation and necrotic cell death (chapter 4), or possible cytochrome c release and 
apoptotic cell death (chapter 3) (11). Alternative mechanisms o f ZT^-induced 
toxicity include the activation o f PKC leading to ROS-mediated death, or Egr-1 
induction resulting in cell death. Adapted from Weiss et al (2000).
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1.3 Thesis research aims
There is substantial evidence implicating a role for Zn^^ in mediating neuronal death 
following ischaemic insults. Zn^^ has been shown to induce neurodegeneration 
independently of glutamate, suggesting that during ischaemia they may exert their 
toxic effects via separate mechanisms. However, the mechanisms involved in Zn^^- 
induced cytotoxicity remain currently unresolved. Hippocampal neurons are 
recognised as being particularly susceptible to both ischaemic and Zn^^ insults, 
therefore the hippocampal neuronal cell line, HT-22, has been employed in this study. 
The aims of this thesis are to:
1. Establish whether HT-22 cells provide a suitable model to examine the effects 
of Zn^^-induced toxicity.
2. Identify the mechanisms of Zn^^ influx.
3. Determine whether death is apoptotic or necrotic.
4. Elucidate the contribution of mitochondria and ROS to the cytotoxic 
mechanism.
5. Evaluate a potential role of energy inhibition in Zn^^-induced death.
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CHAPTER 2 
ZINC-INDUCED HT-22 CELL INJURY
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2.1 -induced neuronal death
As detailed in chapter 1, Zn^^ may play a significant role in mediating neuronal death 
following ischaemic insult (Choi and Koh, 1998; Suh et ah, 2000b). Indeed, owing to 
its high concentration in synaptic vesicles of mossy fibre terminals (Choi and Koh,
1998), post-ischaemia Zn^^-induced injury is frequently observed in the CAl and 
CA3 hippocampal subfields (Tonder et ah, 1990; Koh et ah, 1996; Park et ah, 2000; 
Calderone et ah, 2004). Mossy fibre Zn^^ release has been observed following 
electrical stimulation of either the perforant pathway (Aniksztejn et ah, 1987) or 
dentate granule neurons directly (Howell et ah, 1984). Moreover, both kainate and 
K^-induced depolarisation have also induced Zn^^ release (Assaf and Chung, 1984; 
Aniksztejn et ah, 1987). Under these conditions, local extracellular concentrations 
may attain 300pM (Assaf and Chung, 1984), although substantially lower 
concentrations (~ 24nM) have also been reported (Kay, 2003).
Zn^^ influx and accumulation is a requisite for postsynaptic neuronal injury following 
ischaemic insult (Koh et ah, 1996; Suh et ah, 2000b). Both extracellular (Ca#EDTA) 
and intracellular (TPEN) Zn^^ chelation were shown to attenuate Zn^^ accumulation 
and subsequent neurodegeneration (Cuajungco and Lees, 1996; Koh et ah, 1996; Lee 
et ah, 2000; Canzoniero et ah, 2003). Possibly the most significant endogenous route 
of toxic Zn^^ influx is the Ca^^-permeable AMPA and/or kainate receptor-gated 
channel owing to its high Zn^^ permeability and selective expression on the cell 
membranes of vulnerable postsynaptic neurons (Sensi et ah, 1999). Other potential 
Zn^^ entry mechanisms include NMDA receptor-gated channels (Christine and Choi, 
1990; Sensi et ah, 1997; Cheng and Reynolds, 1998), VSCC including L-type and T- 
type Ca^^ channels (Weiss et ah, 1993; Sensi et ah, 1997; Kim et ah, 2000; Sheline et
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al., 2002; Sheline et al., 2004) and reverse operation of the NaVCa^^ exchanger (Sensi 
et ah, 1997; Cheng and Reynolds, 1998). Furthermore, although less well 
characterised, Zn^^ uptake may also occur via ZIP transporters (Gaither and Eide, 
2001a; Taylor et ah, 2003; Taylor and Nicholson, 2003).
2.1.1 HT-22 cells
HT-22 cells are a murine hippocampal neuronal cell line immortalised by 
temperature-sensitive SV-40 T antigen, subcloned from the HT-4 cell line through its 
sensitivity to glutamate. HT-22 cells have been shown to lack ionotropic glutamate 
receptors owing to their insensitivity to up to lOmM NMDA, AMPA and kainate, and 
the inability to detect these receptors via PCR and Northern blot analysis. HT-22 cells 
were insensitive to the selective metabotropic glutamate receptor agonist, 1- 
aminocyclopentane-1,3 dicarboxylic acid (ACPD). The glutamate receptor 
antagonists, D-AP5 and MK-801, were also unable to inhibit glutamate-mediated 
death. Furthermore, HT-22 cells were unable to synthesize adrenaline, noradrenaline, 
DOPA or dopamine (Maher and Davis, 1996).
Most frequently HT-22 cells are employed as a model investigating the effects of 
oxidative glutamate toxicity via inhibition of cystine uptake (see chapter 4) (Maher 
and Davis, 1996; Ishige et ah, 2001; Choi et ah, 2002). Their lack of ionotropic 
glutamate receptors is a significant characteristic, enabling examination of the effects 
of glutamate independently from potentially masking responses through these 
receptors.
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2.2 Chapter 2 research aims
Hippocampal neurons are vulnerable to Zn^^-induced injury following ischaemic 
insult, and cytotoxicity requires both Zn^^ influx and accumulation. HT-22 cells are a 
hippocampal neuronal cell line lacking ionotropic glutamate receptors, making them 
an ideal model with which to study Zn^^-induced toxicity without any ‘cross-talk’ 
from glutamate pathways.
The aims of the present study are to:
1. Determine whether HT-22 cells are vulnerable to Zn^^ insults at 
concentrations reportedly attained during ischaemia.
2. Establish whether Zn^^ influx and accumulation occurs in HT-22 cells.
3. Elucidate potential routes of Zn^^ uptake.
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2.3 Methods
2.3.1 Reagents 
Cell Culture
Dulbecco’s Modified Eagle Medium (DMEM) and foetal bovine serum (ECS) were 
purchased from Invitrogen (Paisley, UK). Phosphate buffered saline (PBS) was 
bought from 0 X 0 ID Ltd (Hants,UK). All other cell culture reagents were obtained 
from Sigma-Aldrich (Dorset, UK). All plastic cultureware was purchased from 
NUNC (Roskilde, Denmark).
Cytotoxicity assays
Dimethylsulphoxide (DMSO) and NaCl were purchased from Fisher Scientific UK 
(Leicestershire, UK) and glycine was bought from BDH (Dorset, UK). N-2- 
hydroxyethylpiperazine-N’-2-ethanesulfonic acid (HEPES) (assay stock lOmM in 
milliQ water) was obtained from Calbiochem (Nottingham, UK) and the lactate 
dehydrogenase release kit was purchased from Roche (Mannheim, Germany). ZnS0 4  
(99.5% purity minimum) was bought from Hopkin and Williams (Essex, UK), and 
absolute alcohol (100%) was purchased from Hayman Ltd (Essex, UK). Mibefradil 
dihydrochloride (lOmM stock in lOmM HEPES pH 7.4) was kindly donated by Dr C. 
Sheline (Washington University School of Medicine, St. Louis, Missouri, USA). All 
other reagents were purchased from Sigma-Aldrich (Dorset, UK) and coverslips were 
obtained from BDH (Dorset, UK).
Zinc uptake assays
FluoZin-3-AM (51 nmol stock in 100% DMSO) was obtained from Molecular Probes 
(Leiden, The Netherlands) and F-127 protein grade detergent was purchased from
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Calbiochem (Nottingham, UK). D-glucose, KCl and NaHCOs, were obtained from 
Fisher Scientific UK (Leicestershire, UK) and MgS0 4 *7 H2 0 , CaClz (IM  solution) and 
Pyruvate.Na were purchased from BDH (Dorset, UK). Coverslips were bought from 
BDH (Dorset, UK).
2.3.2 Cell culture
HT-22 cells (immortalised murine hippocampal cell line derived from HT-4 cells) 
were obtained from Dr P. Maher (The Scripps Research Institute, La Jolla, CA, USA) 
and maintained in DMEM (supplemented with 10% FCS, 50 units ml'^ penicillin/ 
50pg ml'^ streptomycin and 2mM L-glutamine) in a humidified atmosphere (5% CO2 , 
37°C). Cells were routinely passaged via trypsinisation (0.5mg ml'^ porcine trypsin / 
0.2mg ml'^ EDTA).
2.3.3 Cytotoxicity assays
2.3.3.1 MTT reduction assay
Cells were seeded into 96 well microtitre plates (5x10^ cells well'*) in DMEM/10% 
FCS medium, and following a 24hr recovery, were exposed to the test agents for up to 
24hr, with 6 replicate wells/treatment. For all experiments, all test compound 
dilutions were prepared in lOmM HEPES. Cell viability was determined 
spectrophotometrically via 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide thiazol blue (MTT) reduction to a coloured formazan product via 
mitochondrial dehydrogenases, as described previously (Hansen et al., 1989). In 
brief, 15 pi 5mg/ml MTT was added to individual wells and plates incubated at 
31°d 5% CO2 for 4hr. The MTT-containing medium was removed and formazan
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crystals were solubilised with 129pl DMSO + 21pl Sorensen’s glycine buffer (O.IM 
glycine, O.IM NaCl, pH 10.5). Plates were shaken at 200rpm (15min) and absorbance 
then read at 540nm (Labsystems Multiskan RC, Labsystems; GENESIS v.3.05). 
Results are expressed as a percentage mean (+S.E.M.) of untreated cell MTT 
reduction.
2.33.2 Lactate dehydrogenase (LDH) release assay
HT-22 cells were seeded into 24 well plates (8 x 10^  cells welT^) in DMEM/10% FCS 
and incubated overnight (37°C, 5% CO2). Medium was replaced with DMEM/2% 
FCS and cells were exposed to the experimental treatments for up to 24hr. For all 
experiments, all test compound dilutions were prepared in lOmM HEPES. Where 
appropriate, cells were pre-incubated with TPEN Ihr prior to cytotoxic exposure. 
Lactate dehydrogenase (LDH) release, corresponding to cell lysis, was subsequently 
assessed according to Koh and Choi (1987) as per the manufacturer’s instructions 
(Roche, Mannheim, Germany). Briefly, 120pl medium was centrifuged (13,000 x g, 
3min), and lOOpl of the cytotoxicity reaction mixture was applied to lOOpl 
supernatant. Following a 30min incubation (room temperature), the absorbance was 
read at 490nm (Labsystems Multiskan RC, Labsystems; GENESIS v.3.05). Total 
cell lysis was determined via the addition of Triton X-100 (0.1% v/v). Data are 
expressed as the percentage maximal LDH release for each treatment (mean +S.E.M.).
2.3.3.3 Propidium iodide and fluorescein diacetate dual staining
HT-22 cell viability was also analysed by confocal microscopy (Zeiss 510 META
confocal microscope) using a dual staining technique with propidium iodide (PI) and
65
fluorescein diacetate (FDA) as described by Jones and Senft (1985). PI enters and 
intercalates with the DNA of cells with disrupted cell membranes emitting a red 
fluorescence. In contrast, FDA accumulates in the cytosol of intact cells and emits a 
green fluorescence, thus enabling clear distinction between viable and compromised 
cells. Cells were seeded onto 13mm diameter ethanol-sterilised coverslips in 24 well 
plates (1.5 X 10"^  cells ml'^) in DMEM/10%FCS medium and allowed a 24hr recovery 
at 37°C/ 5% CO2/ 95% humidified atmosphere. Medium was replaced with 
DMEM/2%FCS medium immediately before cytotoxic treatment (prepared in lOmM 
HEPES) for 6 or 24hr. The addition of 50pl lOOmM HEPES (pH7.4) allowed 
stabilisation of pH prior to imaging. The dual PI/FDA containing solution was 
prepared under reduced light levels (final concentrations in PBS; PI 20p.g m l'\  FDA 
60pg ml" )^. Medium was removed and cells then incubated at room temperature for 
5min with 300pl PI/FDA solution. Fluorescence was then examined using 488nm 
Argon and 543nm He-Ne laser lines and analysed with Zeiss multitracking software 
(Carl Zeiss Laser Scanning Microscope LSM 510 Version 3.2 SP2, Carl Zeiss Ltd).
2.3.4 Zinc uptake assays
2.3.4.1 FluoZin-3 single cell imaging
Dynamic changes in intracellular Zn^^ levels ([Zn^^ji) can be monitored directly using 
the recently developed, high affinity Zn^^ selective fluorophore, FluoZin-3 AM. This 
probe is cell permeable, but following de-esterification is maintained intracellularly as 
FluoZin-3 (Gee et al., 2002). Cells were seeded onto 32mm diameter ethanol- 
sterilised coverslips (2.5 x 10"^  cells welf^) in 6 well plates (DMEM/10% FCS media) 
and then incubated at 37°C for 3 days in vitro. Following medium removal, cells were
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washed once with 2ml well'^ buffer (composition mM: NaCl 137; KCl 5; 
MgS0 4 *7 H2 0  1, NaHCOg 3; HEPES 20; CaCh 1.8; Glucose 25; Pyruvate.Na 1; pH 
7.35) and under reduced light levels, loaded for 30min (37°C) with FluoZin-3 AM 
(final concentration in buffer; 12.5pM FluoZin-3-AM / 0.2% F-127). Cells were then 
washed twice with 2ml welf^ buffer, and incubated with 2ml well"  ^buffer for a 
further 30min at 37°C. Cells were mounted in a perfusion open-closed (POC) 
chamber and then viewed under a Zeiss 135 TV inverted epifluorescence microscope 
(450-490nm lOOW Xe lamp with neutral density filter fitted, bandwidth 515-565nm) 
and dynamic fluorescence recorded (510-550nm) using a Dage RC300 CCD/video 
intensifier linked to MCID v4 analysis system. Imaging was performed at 37°C, with 
a 5min baseline acquisition (average = Fo) performed prior to addition of experimental 
treatment (prepared in buffer). Data represent the mean (+S.E.M.) F/Fo FIuoZin-3 
fluorescence (indicative of [Zn^^Ji).
23.4.2 FluoZin-3 microtitre plate assay
HT-22 cells were seeded into black 96 well microtitre plates (Nunclon, SLS, 
Nottingham, UK) (5 xlO'' cells well ') in DMEM/10% FCS (3VC, 5% CO2, 95% 
humidity) and incubated overnight. Medium was aspirated and cells washed once 
with 170pl buffer well"  ^ (composition as per section 2.3.4.1). All subsequent stages 
were performed under limited light conditions. lOOpl well"  ^FluoZin-3 AM/F-127 
solution (final concentration in buffer; 12.5pM FluoZin-3-AM / 0.2% F-127) was 
added to each well and plates incubated at 37°C for 30min. Cells were washed twice 
with 150pl weir^ buffer, before 150pl well"  ^buffer was added and the plates 
incubated for a further 30min to permit de-esterification. Cells were washed once
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with 150pl weir^ buffer prior to exposure to the experimental treatments (prepared in 
buffer) for up to Ihr. Fluorescence was measured on a fluorescence plate reader 
(Spectra Max Gemini XS, Molecular Devices; SOFTmax® PRO v. 4.0; excitation 
485nm, emission 525nm). Results are presented as the mean (+S.E.M.) FluoZin-3 
fluorescence.
2.3.5 Statistical analyses
A one-way analysis of variance (ANOVA), or a two-way ANOVA was performed 
with either a Dunnett’s or Tukey-Kramer multiple comparisons post test where 
appropriate (GraphPad InStat v.3.05). P<0.05 was considered statistically significant.
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2.4 Results
2.4.1 Zn^Mnduced cytotoxicity
To verify whether HT-22 cells were susceptible to pathophysiologically-reported 
concentrations of extracellular Zn^^, cells were incubated with increasing 
concentrations of ZnS0 4  over 24hr. Fig. 2.1A illustrates concentration-dependent 
Zn^^-induced cytotoxicity, with 150pM-lmM ZnS0 4  significantly decreasing MTT 
reduction (EC50 = 119pM ± l.lpM , n>4) (confirmed by LDH release assay; data not 
shown), and a narrow susceptibility threshold (i.e. no significant death with lOOpM 
ZnS0 4 ). In contrast, 24hr incubation with ImM Na2S0 4  had no significant effect on 
MTT reduction (Fig. 5.3B). During ischaemia, cytotoxic extracellular Zn^^ 
concentrations may attain 300pM following release from mossy fibres (Assaf and 
Chung, 1984). Since a near-complete loss of HT-22 cell MTT reduction was 
demonstrated following 200pM ZnS0 4  insults, this concentration was utilised as a 
cytotoxic dose for all further experimental work in order to model ischaemic injury.
Time-dependent cytotoxic Zn^^ effects were directly examined via the continuous 
exposure of HT-22 cells to HEPES (final concentration ImM; vehicle control) or 
200pM ZnS0 4  over 24hr and LDH release was monitored. Significant LDH release 
occurred after 6hr with 200pM ZnS0 4 , with enhanced release at 24hr (Fig. 2.1B). 
Accordingly, propidium iodide/fluorescein diacetate (PI/FDA) dual cell staining 
confirmed Pl-positive nuclei (indicative of cell lysis) following 6hr ZnS0 4  exposure 
(Fig. 2.1CÜ) and 100% Pl-positive nuclei at 24hr (Fig. 2.1 Civ), whereas HEPES- 
treated time-matched control cells maintained membrane integrity with their cytosol 
retaining FDA (Fig. 2.1 Ci and Fig. 2.1Ciii).
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Figure 2.1A. Dose-response curve of ZnS0 4  cytotoxicity.
HT-22 cells were continuously exposed to the indicated ZnSÛ4 concentrations over 
24hr and cell viability was estimated via the MTT reduction assay as described in 
Methods. Data are expressed as the mean (± S.E.M.) o f at least four independent 
experiments. ** = P<0.01 ZnS0 4  concentration versus untreated cells (data not 
shown) by one-way Analysis o f Variance (ANOVA) followed by a Dunnett’s post hoc 
test.
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Figure 2.IB. Time eourse of -indueed cytotoxicity.
Cells were continuously exposed to either HEPES (final concentration ImM; vehicle 
control) or 200pM  Zri over 24hr and cell death was estimated via LDH efflux as 
described in Methods. Data are expressed as a percentage o f total cellular LDH  
release fo r  each treatment, determined via the final addition o f Triton X-100 (0.1% 
v/v). Data represent the mean (± S.E.M.) o f  four independent experiments. ** = 
P<0.01 and *** = P<0.001 versus HEPES control via two-way ANOVA, followed by 
Tukey Kramer multiple comparisons post hoc test.
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Figure 2.1 C. Cell viability imaging following ZnS0 4  exposure.
HT-22 cells were either incubated with Im M  HEPES for 6hr (i) or 24hr (Hi), or with 
200pM ZnS0 4  fo r 6hr (it) or 24hr (iv) prior to the addition o f the PI/FDA dual stain. 
Images were obtained from random fields o f view using confocal microscopy as 
detailed in Methods.
72
2.4.2 entry mechanisms
2.4.2.1 influx and accumulation
The Zn^^-selective intracellular fluorescent probe, FluoZin-3 AM, was utilised to 
confirm Zn^^ entry into HT-22 cells (Gee et ah, 2002). A 200pM ZnS0 4  cytotoxic 
insult induced a rapid increase in FluoZin-3 fluorescence (indicative of [Zn^^Ji 
loading) when compared to the ZnS0 4  vehicle, HEPES (final concentration ImM) 
(Fig. 2.2^ and Fig. 2.25).
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Figure 2.2. exposure induces a rapid and sustained increase in FIuoZin-3
fluorescence.
HT-22 cells were preloaded with 12.5pMFhioZin 3-AMprior to 60min continuous 
exposure to either ImM  HEPES or 200pM ZnSOi. (A) Fluorescence was determined 
via single cell imaging as detailed in Methods. Data are expressed as the mean 
(±S.E.M.) F/F0 fluorescence o f at least 12 individual cells. (B) Changes in cell 
population fluorescence (indicative of[Zn~ ]i) were determined via a microtitre plate- 
based assay protocol as described in Methods. Data represent mean (±S.E.M.) o f  six 
experiments. * =  P<0.05, ** = P<0.01 and *** = P<0.001 indicate difference
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versus HEPES time-matched control (two-way ANOVA and Tukey Kramer multiple 
comparisons post hoc test).
2.4.2.2 chelation limits cytotoxicity
It has been suggested previously that influx is required to induce neuronal death 
(Cuajungco and Lees, 1996; Koh et ah, 1996; Lee et ah, 2000). Fig. 2.3 demonstrates 
that the presence of either the membrane impermeant Zn^^ chelator, Ca#EDTA 
(0.5mM or ImM; standard effective concentrations), or the membrane permeable Zn^^ 
chelator, N,N,N’,N’-tetrakis (2-pyridylmethyl) ethylenediamine (TPEN) (200pM; 
standard effective concentration), completely blocked the LDH release induced by 6hr 
200pM ZnS0 4 . In the absence of Zn^\ neither compound nor 0.1% ethanol vehicle 
(EtOH) significantly influenced LDH release. Earlier studies have also suggested that 
cellular depolarisation may enhance Zn^^ influx and therefore cytotoxicity (Assaf and 
Chung, 1984; Kim et ah, 2000). However, 50mM KCl (standard effective 
concentration) failed to significantly enhance 200pM Zn^^-induced LDH release and 
failed to significantly influence LDH release in the absence of Zn^ .^
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Figure 2.3. Zn^  ^chelation prevents cell death.
HT-22 cells were exposed to 200pM  ZnS0 4  fo r  6 hr in the presence or absence o f  
0.5mMor 7wMCa»EDTA, 200pM TPEN (Ihrpreinciibation), or 50mMKCl. Cell 
death was determined via LDH efflux as detailed in Methods. Data are expressed as 
a percentage o f total cell lysis fo r each treatment determined via the final addition o f  
Triton X-100 (0.1% v/v). Data represent the mean (± S.E.M.) o f at least four 
independent experiments. ** = P<0.01 versus 200pM ZnSO 4 via one-way ANOVA 
and Dunnett ’s post hoc test.
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2,4,23 influx does not occur via L- or T-typc channels
Previous experiments suggest that Zn^^may enter neurons via voltage-activated Ca^  ^
channels (Hollmann et ah, 1991; Manev et ah, 1997; Yin et ah, 2002). To elucidate 
whether HT-22 cells exhibit a similar entry mechanism, cells were incubated with 
200pM ZnS0 4  for 24hr with either the selective L-type Ca^^-channel antagonist, 
nimodipine (lOpM; standard effective concentration) (Fig. 2.4^4) or the selective T- 
type Ca^^-channel antagonist, mibefradil (lOpM; standard effective concentration) 
(Fig. 2.45) (Manev et ah, 1997; Kim et ah, 2000; Sheline et ah, 2004). However, 
neither lOpM nimodipine (Fig. 2.4^4) nor lOpM mibefradil (Fig. 2.45) significantly 
influenced 200pM Zn^^-induced cytotoxicity. Additionally, neither lOpM 
nimodipine, its vehicle, 0.02% EtOH (Fig. 2.4^), nor lOpM mibefradil alone (Fig. 
2.45) significantly affected cell viability.
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Figure 2.4. Neither the L-type Ca^-channel blocker nimodipine, nor the T- 
type Ca^-channel blocker mibefradil, significantly limit Zn^-induced death.
HT-22 cells were exposed for 24hr to 200pM ZnS0 4  in the presence or absence o f
lOpMnimodipine (A) or lOpMmibefradil (B). Cell viability was estimated via the
MTT reduction assay (outlined in Methods). Data represent mean (±S.E.M.) o f  four
experiments. *** = P<0.001 signifies difference from HEPES control by one-way
ANOVA followed by a Dunnett’s post hoc test.
78
2.5 Discussion
The aim of the present study was to determine whether HT-22 cells were vulnerable 
to Zn^^ cytotoxic insults in a pathophysiologically relevant range and to examine 
potential mechanisms of Zn^^ influx and accumulation.
Initial experiments demonstrated time- and dose-dependency of Zn^^-induced HT-22 
cytotoxicity. ZnS0 4  was utilised as a source of Zn^^; Na2 S0 4  had no significant effect 
on cell viability (see section 5.4.1 Results), controlling against a possible toxic role of 
S0 4 ‘^ ions. Zn^^ induced HT-22 cell death in a concentration-dependent manner over 
24hr. Whilst lOOpM Zn^^ had no significant effect on cell viability, concentrations in 
excess of ISOpM induced almost complete death (EC50 = 119pM). Thus there was a 
narrow threshold for susceptibility. Similarly, Choi et al (1988) established a steep 
concentration-dependent relationship in mixed cortical cell cultures, with 2 0 0 pM Zn^^ 
having little toxic effect but 250pM Zn^^ inducing widespread death.
This suggests the presence of Zn^^ homeostatic mechanisms in HT-22 cells to 
critically regulate [Zn^^i and avoid toxicity. Metallothioneins, in particular MT-III, 
may provide an important Zn^^ buffer under these conditions (Weiss et al., 2000). 
Indeed, MT-III knockout mice demonstrated enhanced vulnerability to kainate- 
induced seizure attributed to an inability to sequester intracellular Zn^^ effectively 
thus permitting toxic Zn^^ accumulation (Erickson et al., 1997; Lee et al., 2003). 
Metallothioneins co-ordinate seven Zn^^ ions (Hasler et al., 2000). Saturation of these 
proteins by high intracellular Zn^^ would overwhelm the buffering eapability, 
allowing rapid accumulation of excessive Zn^^ and consequently death, as implied by 
the narrow threshold.
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Further potential homeostatic mechanisms include regulation of Zn^^ influx and 
efflux. For example, upregulation of ZnT-1 expression mediated by Zn^^-activated 
MTF-1 to promote Zn^^ extrusion (Tsuda et al., 1997; Langmade et al., 2000), and 
downregulation of ZIP transporters to reduce Zn^^ influx (Dufner-Beattie et ah, 
2003b). Additionally, redistribution of ZIP transporters may occur from the plasma 
membrane to intracellular compartments via increased endocytosis (Wang et al., 
2004b). These mechanisms however, require transcriptional activity or post- 
translational modifications and are possibly less relevant under conditions of acute 
toxic Zn^^ exposure as modelled here.
Assaf and Chung (1984) estimated that during ischaemic insult, local synaptic Zn^^ 
concentrations attaining 300pM may be achieved, although it should be noted that 
significantly lower concentrations (~24nM) were demonstrated following -induced 
depolarisation in a similar model (Kay, 2003). According to the former study, the 
data obtained here reveal that HT-22 cells were susceptible to Zn^^ insults in an 
appropriate range. Significant death was achieved following 6hr exposure to 200pM 
Zn^ .^ Accordingly, 300-600pM Zn^^ induced significant neuronal death following 
15min exposure in mixed cortical cultures (Choi et ah, 1988; Koh and Choi, 1994).
Presynaptic Zn^^ translocation and subsequent accumulation in postsynaptic neurons 
is believed to be essential for Zn^^-induced toxicity following ischaemic insult 
(Tonder et ah, 1990; Koh et ah, 1996; Suh et ah, 2000b). In addition to the vesicular 
Zn^^ release mechanism, a recent study using ZnT-3 knockout mice suggested that 
Zn^^ released following oxidation of intracellular metalloproteins may be exported 
extracellularly and contribute to the elevated synaptic Zn^^ levels (Aizenman et ah, 
2000; Lee et ah, 2000). Regardless of the synaptic Zn^^ origin, previous studies
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demonstrated that inhibition of Zn  ^influx with the extracellular Zn^^ chelator, 
Ca#EDTA (Koh et al., 1996; Lee et al., 2000), or prevention of Zn^^ accumulation 
with the membrane permeant chelator, TPEN (Cuajungco and Lees, 1996; Canzoniero 
et al., 2003), limited neuronal death. Indeed, in the HT-22 paradigm both Ca#EDTA 
and TPEN significantly attenuated Zn^^-induced death, suggesting that Zn^^ influx 
and accumulation mediates Zn^^ toxicity. This was verified in HT-22 cells via the 
high affinity Zn^^-selective probe, FluoZin-3. Significant fluorescence was achieved 
following 30min Zn^^ exposure. This demonstrates that Zn^^ gained rapid entry and 
accumulated in HT-22 cells, supporting the speed at which Zn^^ elicits its toxic effects 
in this model.
HT-22 cells lack ionotropic glutamate receptors (Maher and Davis, 1996). Zn^^ entry 
can therefore only occur via Zn^^ permeable channels such as VSCC or the Na^/Ca^^ 
exchanger (Weiss et al., 1993; Sensi et al., 1997; Sheline et al., 2002), or via a Zn^^ 
transporter such as a ZIP family member (Taylor and Nicholson, 2003). VSCC are 
implicated as the predominant route of Zn^^ entry during Zn^^-induced death (Sensi et 
al., 1997; Cheng and Reynolds, 1998). K^-induced depolarisation in the presence of 
exogenous Zn^^ has been shown to induce Zn^^ accumulation and widespread 
neuronal death, which was sensitive to the non-specific VSCC blocker, Gd^^ (Weiss 
et al., 1993; Sensi et al., 1997; Sheline et al., 2002; Sheline et al., 2004).
There are two classes of Ca^^ channels; high voltage activated (L-type) and low 
voltage activated (T-type). L-type Ca^^ channels are activated following 
depolarisation, whereas T-type Ca^^ channels are inactivated (Sheline et al., 2004).
The L-type Ca^^ channel blocker, nimodipine (InM), was shown to attenuate death of 
cerebellar granule neurons following BOmin Zn^^ exposure (BOOpM) (Manev et al..
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1997), and similarly in PC 12 cells and murine neocortical cultures following Zn^^ 
exposure under depolarising conditions (Kim et al., 2000; Sheline et al., 2002). Death 
was associated with an inward nimodipine- and Gd^^-sensitive voltage-gated Zn^^ 
current, corresponding to Zn^^ influx through L-type Ca^^ channels (Kerchner et al., 
2000).
Sheline et al (2004) determined that the T-type Ca^^ channel antagonist, mibefradil, 
prevented Zn^^-induced astrocytic cell death by attenuating Zn^^ influx. However, 
only partial protection was obtained in the neuronal equivalents under the same 
conditions (Sheline et al., 2002). In an ischaemic model of oxygen-glucose 
deprivation, mibefradil significantly attenuated neuronal death. However, Zn^^ 
addition was neuroprotective in this model by significantly blocking Ca^^ current 
through the T-type Ca^^ channels (Nikonenko et al., 2005).
In this study, neither nimodipine nor mibefradil attenuated Zn^^-induced HT-22 death 
following 24hr exposure. Likewise, depolarisation with 50mM KCl, a concentration 
previously shown to promote Zn^^ entry through VSCC in cortical neurons (Sensi et 
al., 1997), did not enhance Zn^^-induced toxicity over 6 hr. This implies that the route 
of HT-22 cell Zn^^ entry is not via VSCC, in particular L- or T-type Ca^^ channels.
The data obtained to date suggest that a Zn^^ transporter(s) is the most likely 
candidate for Zn^^ influx, potentially the ZIP family of plasma membrane Zn^^ 
transporters (Gaither and Eide, 2001a; Dufher-Beattie et al., 2003a; Taylor and 
Nicholson, 2003). It has been proposed that the divalent cations Cu^^, Fe^^ and Cd^^ 
may impede Zn^^ influx through ZIP transporters (Gaither and Eide, 2001a). These 
inhibitory cations could therefore be utilised to examine whether ZIP transporters 
present a mechanism of Zn^^ entry in HT-22 cells. Furthermore, the occurrence of
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ZIP transporters may be also be determined with the use of RNAi to downregulate the 
expression of putative ZIP transporter mRNA.
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CHAPTER 3 
ZINC-INDUCED DEATH: 
APOPTOSIS VERSUS NECROSIS
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3.1  Apoptosis versus necrosis
A cell can die by two different mechanisms, necrosis or apoptosis. Necrosis is a 
pathological form of death, triggered by an external stimulus often under conditions of 
energy depletion, and inflammation fi*equently follows cell lysis (Artal-Sanz and 
Tavemarakis, 2005). Apoptosis is a physiological type of death elicited in response to 
specific stimuli such as growth factor deprivation, DNA damage or cell cycle 
dysfunction (Shen and White, 2001). Apoptosis is executed by a specific and ordered 
series of cellular events without cell lysis and requires ATP (for review see Martin et 
al (1998b)). Characteristics of necrosis and apoptosis are indicated in table 3.1.
85
APOPTOSIS NECROSIS
Pattern of cell 
death
• Individual cells • Groups of cells
Cell size • Shrinkage
• Fragmentation
• Swelling
Plasma membrane • Continuity maintained
• Blebbing
• Extracellular 
phosphatidylserine 
presentation
• Early lysis
Mitochondria • Enhanced membrane 
permeability
• Contents released into 
cytoplasm e.g. 
cytochrome c; Apafl
• Structurally intact
• Swelling
• Disordered 
structure
Organelle shape • Contracted • Swelling
• Disruption
Nuclei • Condensed,
fragmented chromatin
• Membrane 
disruption
DNA degradation • Fragmented 
intemucleosomal 
cleavage
• Diffuse and random
Cell degradation • Formation of 
apoptotic bodies
• Phagocytosis
• No inflammation
• Inflammation
• Macrophage 
invasion
Pathway stimulus • Developmental 
programme
• Endogenous signals 
e.g. growth factor 
deprivation
• Intercellular signals 
e.g. Fas ligand
• Disease process
• Disease process
Cellular processes • Programmed cascade 
of reactions
• Activation of caspases
• Requires ATP for new 
RNA transcription 
and protein synthesis
• Energy independent
• ATP depletion
Table 3.1. Characteristic features associated with apoptosis and necrosis.
Adapted from Gerschenson and Rotello (1992), Martin et al (1998b), and Fink and 
Cookson (2005).
86
3.1.1 Cysteine proteases
3.1.1.1 Caspases
Caspases, cysteine-dependent aspartate-directed proteases, are key enzymes of the 
apoptotic cascade, 14 of which are currently known (Love, 2003). They contain a 
catalytic cysteinyl residue and cleave on the carboxyl side of predominantly aspartate 
residues (the Pi position of the substrate) of specific tetrapeptide sequences (residues 
labelled P4-P3-P2-P1 respectively). Specific caspases have a preference for particular 
amino acids in the P4 position, allowing distinction of three sub-families according to 
substrate recognition (Thomberry et al., 1997). The interleukin-1 (3-converting 
enzyme (ICE) subfamily, including caspases 1, 4 and 5, recognise large hydrophobic 
residues at P4 for example tyrosine or tryptophan, the caspase 3 subfamily (caspases 2, 
3 and 7) recognise P4 aspartate, and the caspase 6  subfamily (caspases 6 , 8  and 9) 
prefer branched hydrophobic residues, for example valine (Thomberry et al., 1997).
Caspases are synthesised as inactive single chain zymogens. Activity results from 
self-association of two zymogens followed by proteolytic cleavage to yield a 
tetrameric enzyme with two active sites (see table 3.2). Zymogen processing requires 
initial cleavage between the large and small subunits, and then separation of the N- 
terminal pro-domain from the large subunit. All cleavages occur after the aspartate 
residue (Thomberry et al., 1997; Shen and White, 2001).
Apoptotic caspases fall into two broad categories; initiator caspases and effector
caspases. Initiator caspases (caspases 1 ,2 ,4 , 5, 8 , 9 and 10) have large N-terminal
pro-domains (>90 amino acid residues) and are activated following recmitment by
adaptor proteins to death-receptor complexes (Boldin et al., 1996; Muzio et al., 1996)
or the apoptosome (described below), and proximity-mediated autocatalytic activation
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following self-aggregation (Li et al., 1997; Zou et al., 1997; Cain et al., 1999). 
Effector caspases (caspases 3, 6 and 7) have short pro-domains (20-30 amino acid 
residues) and are activated through proteolytic cleavage mediated by upstream 
initiator caspases. The effector caspases are required for downstream cellular 
destruction (see table 3.2) (Shen and White, 2001). It has recently been proposed that 
initiator caspase (described below) activation is dependent on zymogen monomer 
dimerization at the activating complex, and cleavage may simply release the active 
caspase to the cytosol (Boatright and Salvesen, 2003). Conversely, effector caspases 
(see below) exist as inactive dimers and just require proteolytic cleavage for activity 
(Boatright and Salvesen, 2003).
3.1.1.2 Caspase cascades
There are two separate pathways of caspase activation; the death-receptor-mediated 
extrinsic pathway, and the mitochondrial-mediated intrinsic pathway. The pathways 
are not exclusive, with interplay frequently observed. Several reviews describe these 
cascades in detail (See Eamshaw et al (1999), Yuan and Yankner (2000), and 
Zimmermann et al (2001)), but they are summarised here (see also figure 3.1.).
Extrinsic Pathway Intrinsic Pathway
Chemicals
FasR
DNA damaging agents
Cathepsins 
Calpain
Cytochrome cActive 
caspase-8I
ATP^o Cytochrome c
Procaspase-3
Apaf-1 
Procaspase-9
Nuclear 
DNA 
degradation
Apoptosome
Smac/DIABLO
Active
■ 3 ^ 1
Substrates
Cleaved substrates
I
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Figure 3.1. Extrinsic and intrinsic pathways of apoptosis.
Ligation o f death receptors initiates the extrinsic apoptotic pathway via activation o f  
caspase 8 and caspase 3. The intrinsic pathway is initiatedfollowing the action o f  
damaging environmental stimidi on the mitochondria. This induces the release o f  
apoptogenic proteins and activation o f caspase 9. The extrinsic pathway may interact 
with the intrinsic pathway following cleavage and mitochondrial translocation o f  
tBid. Adapted from van Loo et al (2002).
In the extrinsic pathway, ligation of Fas or TNF (tumour-necrosis factor) to the 
respective death receptor recruits the appropriate adaptor molecule and procaspase 8 
to the death-inducing signal complex (DISC) (Boldin et al., 1996; Muzio et a l, 1996; 
Martin et a l, 1998a). Oligomerisation of procaspase 8 and subsequent activation
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(Martin et al., 1998a) may elicit two effects; activation of downstream effector 
caspases including caspase 3, mediating DNA and cellular degradation (Sun et al.,
1999); cleavage of the proapoptotic Bcl-2 (B-cell lymphoma) family member Bid, to a 
truncated form (tBid) which translocates to the mitochondria, releasing mitochondrial 
factors including cytochrome c, Smac/DIABLO and AIF in the presence of other 
proapoptotic factors, Bak and Bax (Li et ah, 1998; Sun et ah, 1999; Du et ah, 2000; 
Verhagen et ah, 2000; van Loo et ah, 2002). Both processes lead to the activation of 
downstream caspases and cellular degradation (see table 3.2).
In the intrinsic pathway, environmental stimuli (including chemicals and pH changes) 
induce Bax translocation and oligomerisation at the mitochondria (Cartron et ah, 
2004), inducing cytochrome c release. Apaf-1 (apoptosis protease activating factor-1) 
interacts with cytochrome c and dATP, inducing a conformational change and Apaf-1 
oligomerisation. Apaf-1 then recruits procaspase 9 molecules to form the apoptosome 
protein complex, providing a suitable environment for procaspase 9 processing (Li et 
ah, 1997; Zou et ah, 1997; Cain et ah, 1999). Caspase 9 may then cleave caspase 3, 
also found in the apoptosome (Slee et ah, 1999; Bratton et ah, 2001). Importantly, 
caspase 3 activation can mediate a proteolytic cascade of procaspase 2, 6, 8 and 10 
activation to drive the apoptotic signal (Slee et ah, 1999). Downstream caspase 8 
activation may then cleave Bid to upregulate cytochrome c release from the 
mitochondria and augment the apoptotic cascade (Ganju and Eastman, 2002).
3.1.1.3 Calpains
Calpains are Ca^^-dependent cysteine proteases, assuming a potential role during
ischaemia (Blomgren et ah, 1995; Neumar et ah, 1996). Calpain isoforms p (I) and m
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(II) are ubiquitously expressed and activated in vitro by micro- and millimolar 
concentrations of Ca^^ respectively (Suzuki and Sorimachi, 1998). Calpains comprise 
two subunits, an 80kDa catalytic subunit and a 28kDa regulatory subunit. Calpains 
undergo Ca^^-dependent autolysis via the removal of specific N-terminal amino acids, 
which induces proteolytic activity (see table 3.2.) (Goll et al., 1992).
Caspases may activate calpains via proteolytic degradation of the endogenous calpain 
inhibitory molecule, calpastatin (Wang, 2000; Neumar et al., 2003). It has been 
proposed that calpains are required for plasma membrane disruption and secondary 
necrosis (see section 3.1.3) following caspase-mediated calpastatin degradation and 
late [Ca^^]i overload (Neumar et al., 2003). Conversely, calpains may either activate 
(Yamashima, 2000; Blomgren et al., 2001), or inhibit caspase activity (Bizat et al., 
2003; Neumar et al., 2003; Volbracht et al., 2005), suggesting that calpains may have 
important regulatory consequences on apoptotic cascades.
Calpain-mediated caspase inhibition could attenuate apoptosis in favour of necrosis, 
as may be observed following acute ischaemic insult and rapid [Ca^^Ji elevations (Dux 
et al., 1987; Neumar et al., 2003). However, milder insults without rapid [Ca^^Ji 
overload may be insufficient to activate calpains, allowing execution of caspase- 
mediated apoptosis (Neumar et al., 2003). p,-Calpain-mediated caspase 9 and caspase 
3 inactivation has been implicated in a rat striatal neuronal model of Huntingdon’s 
disease (Bizat et al., 2003). Conversely, m-calpain-induced caspase 3 activation has 
been demonstrated following hypoxia/ischaemia in vivo and in vitro, facilitating 
further caspase-dependent cleavage and downstream apoptosis (Blomgren et al.,
2001). This suggests that [Ca^^ji not only regulates which calpain isoform is 
activated, but may also determine whether caspases are inhibited or activated.
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Caspases and calpains share many common substrates (see table 3.2), and caspase 
inhibitors for example zVAD-fmk (Z-Val-Ala-DL-Asp-fluoromethylketone), may 
also prevent calpain activity (Waterhouse et al., 1998). Calpain activity has 
additionally been implicated in apoptosis via Bid and Bcl-2 cleavage and subsequent 
activation of the intrinsic apoptotic pathway (Gil-Parrado et al., 2002; Sedarous et al., 
2003). Furthermore, calpains may also participate in caspase-independent apoptosis 
(Volbracht et al., 2005). For example, following ischaemia-reperfusion p-calpain 
mediated Bid cleavage to a proapoptotic fragment, inducing mitochondrial 
dysfunction and cytochrome c release ensued by apoptosis but without caspase 
activation (Chen et al., 2001; Chen et al., 2002a).
Following massive Ca^^ increases as can occur during excitotoxicity and ischaemia, 
unregulated excessive calpain activation may occur suggesting the participation of 
calpains in necrotic death (see figure 3.2) (Gil-Parrado et al., 2002; Artal-Sanz and 
Tavemarakis, 2005). For example, during oxygen-glucose deprivation in rat optic 
nerves, calpains were shown to induce neurofilament cleavage (Stys and Jiang, 2002). 
Furthermore, during ischaemic injury, calpains mediated the cleavage of the NaVCa^^ 
exchanger, which could then participate in deleterious Ca^^ accumulation. These 
effects were inhibited by calpastatin overexpression or expression of a calpain- 
resistant NaVCa^^ exchanger isoform (Bano et al., 2005). During ischaemia- 
reperfusion, calpain-mediated calpastatin cleavage has also been suggested in the 
hippocampus to further augment the calpain cascade (Saido et al., 1997). Moreover, 
p-calpain activation has specifically been demonstrated at the lysosomal membranes 
in the CAl region following global ischaemia (Yamashima et al., 1996). This implies 
that dysregulated p-calpain activity elicited lysosomal rupture, releasing both
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degradatory hydrolytic enzymes and cathepsins (see figure 3.2) (Yamashima et al., 
2003).
3.1.1.4 Cathepsins
Cathepsins are lysosomal proteolytic enzymes of the papain cysteine protease 
superfamily (Turk et al., 2001). They are categorised into 2 classes; aspartyl 
(cathepsin D) and cysteine (cathepsin B, H and L) (Yamashima, 2004). These 
enzymes participate in the non-specific degradation of intracellular components 
during both apoptosis and necrosis (see figure 3.2.) (Yamashima, 2004). Similar to 
other cysteine proteases, the inactive precursors require proteolytic processing, which 
occurs at an acidic pH (see table 3.2.) (Chapman et al., 1997). Calpains may 
contribute to cathepsin activation following ischaemic insult by lysosomal rupture as 
mentioned above (Yamashima et al., 2003). Cathepsins have also been shown to 
activate caspase 3 (see figure 3.2.) (Ishisaka et al., 1999).
There is some evidence suggesting the participation of cathepsins during ischaemic 
injury. In a model of focal cerebral ischaemia and reperfusion, increased abundance 
and activity of cathepsin B was seen in vulnerable neurons (Seyffied et al., 1997). 
Specific inhibition of cathepsins B and L afforded significant in vivo protection 
against neuronal damage (Seyffied et al., 2001). Following kainate-induced 
excitotoxicity, increased expression of cathepsin D was also observed in vulnerable 
neurons and glia undergoing degeneration, for example in the pyramidal layer of CAl 
and CA3 (Hetman et al., 1995). This suggests that cathepsins may mediate 
downstream degradatory processes during cell death.
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PROTEASE
FAMILY
ACTIVATION
MECHANISM SUBSTRATES
CASPASE
• Proteolytic processing; 
Autoproteolysis or 
proteolysis by other 
proteases (caspases, 
calpains, cathepsins)
• Cytoskeletal proteins
• Signal transduction 
proteins
• Plasma membrane 
Ca^^ pump
• Calpastatin
• Polyglutamine- 
containing proteins
CALPAIN
.  Autoproteolysis (Ca^^ 
-dependent)
• Membrane 
translocation
• Cytoskeletal proteins
• Nuclear proteins
• Signal transduction 
proteins (NF-kB)
• Receptor ion channels
• Caspases
• Apoptotic regulatory 
factors
• Polyglutamine- 
containing proteins
CATHEPSIN
• Acidic pH
• Proteolytic processing 
by other lysosomal 
enzymes
• Non-specific cleavage
• Proinfiammatory 
caspases
Table 3.2. Med lanisms of activation and downstream targets of caspase-,
calpain- and cathepsin-mediated degradation.
Adapted from Artal-Sanz and Tavemarakis (2005)
3.1.2 Mechanisms regulating apoptosis
Apoptosis requires the ordered execution of specific cellular processes, therefore 
regulatory mechanisms are essential to maintain control of the apoptotic program (see 
figure 3.1.). The presence of pro-apoptotic and anti-apoptotic members of the Bcl-2 
family is necessary for regulation of mitochondrial cytochrome c release. 
Redistribution of Bax from the cytosol to the mitochondria, described above, 
participates in a pro-apoptotic role. Homodimer formation of pro-apoptotic members
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on mitochondrial membranes induces cytochrome c release (Ganju and Eastman,
2002). However, heterodimer formation with anti-apoptotic members, such as Bcl-2 
and B c1-Xl found on the outer mitochondrial membrane, may inhibit cytochrome c 
release (Yin et al., 1994; Farrow and Brown, 1996). The mechanism of cytochrome c 
release by pro-apoptotic members is currently unresolved. Proposed mechanisms 
include opening of the mitochondrial permeability transition pore (mPTP) (Shimizu et 
ah, 1999) (see chapter 4), formation of membrane spanning channels (Eskes et ah,
2000), or direct rupture of the outer mitochondrial membrane (Hengartner, 2000).
Other apoptosis regulatory molecules include the Zn^^-containing inhibitor of 
apoptosis (lAP) family o f proteins (for review see Shi (2002)). These proteins contain 
N-terminal baculovirus lAP repeat (BIR) motifs allowing interaction with and 
inhibition of mature caspases (Deveraux et ah, 1997; Roy et ah, 1997). cIAPl, cIAP2 
and XIAP are found in the apoptosome and can bind to and inhibit both caspase 3 and 
caspase 7, and also procaspase 9 (Deveraux et ah, 1997; Roy et ah, 1997; Bratton et 
ah, 2001), although inhibition may be overcome by a strong pro-apoptotic stimulus 
(van Loo et ah, 2002). Additionally, Smac/DIABLO released from the mitochondria 
accompanying cytochrome c can also inhibit XIAP and other lAPS, allowing 
apoptosis to proceed (Du et ah, 2000; Verhagen et ah, 2000).
3.1.3 Ischaemic cell death
Following ischaemia, several factors determine the type of cell death elicited
(Nicotera et ah, 1999), including the intensity of the insult (Bonfoco et ah, 1995) and
cellular ATP status (Eguchi et ah, 1997). ATP status is likely to be a key regulatory
factor since ATP depletion following caspase 3 activation may promote necrotic death
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(Eguchi et al., 1997). Similarly, inhibition of apoptosis may also stimulate the drive 
into necrosis (Lemaire et al., 1998). Necrosis evoked following initial apoptosis is 
coined secondary necrosis (Hirsch et al., 1998). Therefore, it is possible that both 
apoptosis and necrosis share common initiation events (Yamashima, 2000).
Ca^^ load may also be a significant determinant of apoptotic or necrotic cascades. For 
example, Ca^^ depletion reduced both mitochondrial Ca^^ load (by Ca^^ efflux) and 
the mitochondrial membrane potential (A\j/m), followed by cytochrome c release, 
caspase activation and apoptosis. Significantly, high extracellular Ca^^ induced 
necrosis through rapidly increased mitochondrial Ca^^ load and reduced A\|/m (Zhu et 
al., 2000). Similarly, Zn^^ load may also participate in determining apoptosis or 
necrosis. Loading human leukaemia HL-60 cells with Zn^^ (25pM) in the presence of 
the Zn^^ ionophore, pyrithione, induced apoptosis mediated by p38 MAPK and 
successive caspase activation. However, an acute (50-100pM) Zn^^ load induced 
dose-dependent necrotic death (Kondoh et al., 2002; Kondoh et al., 2005).
Following ischaemia, simultaneous apoptosis and necrosis has been reported in 
neuronal cells (Gwag et al., 1995). Furthermore, it has been demonstrated that 
following ischaemic insult, neurons at the foci of the trauma undergo necrosis, 
whereas neurons at the periphery undergo apoptosis (Charriaut-Marlangue et al.,
1996). Changes in apoptotic regulatory mechanisms during ischaemia may act to 
promote apoptosis in certain neuronal types, which may account for these 
observations. For example, upregulation of Bax with a concomitant decrease in Bcl-2 
and B c1-X l has been specifically observed in the CAl, but not the CA3 or dentate 
gyrus, following global ischaemia (MacManus and Linnik, 1997).
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A novel form of death following ischaemia has also been postulated, coined 
paratopsis (Sperandio et ah, 2000). This is a mode of programmed cell death 
morphologically distinct from apoptosis, insensitive to caspase inhibition or B c1-X l 
expression, that shows alternative PARP cleavage to that obtained during necrosis, 
and is independent of Apaf-1, but involves an alternatively processed version of 
caspase 9 (Sperandio et ah, 2000). A typical feature of this type of death is the 
formation of vacuoles in the cytoplasm, as is observed during kainate-induced 
neuronal death (Sperandio et ah, 2000).
As mentioned in section 3.1.1, there may be considerable interplay between the 
various cysteine proteases during the execution of cell death. Figure 3.2. illustrates 
some of the interactions that may occur following ischaemic insult and Ca^^ overload.
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Figure 3.2. Schematic illustration of the ischaemic cell death pathways.
Following ischaemia, increased intracellular [Ca~ ]  may induce both apoptotic death 
via mitochondrial-directed caspase activation, or necrosis via calpain and cathepsin 
activation. Considerable cross-talk between the pathways directs the mode o f  death 
elicited. Taken from Yamashima (2000).
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3.1.4 Zn^^-induced death
3.1.4.1 as an apoptotic inhibitor
Several lines of evidence suggest that Zn^^ is more likely to induce necrotic death 
over apoptosis. Primarily, Zn^^ is proposed to participate as an apoptotic inhibitor in 
certain systems. The initial evidence for this was demonstrated by Zn^^-induced 
inhibition of a Ca^^/Mg^^-dependent DNA endonuclease involved in DNA 
fragmentation during apoptotic cellular disassembly (Cohen and Duke, 1984; McCabe 
et al., 1993; Sunderman, 1995). Since then, Zn^^ has been shown to inhibit many 
apoptotic processes including caspases.
Zn^^-mediated inhibition of poly(ADP-ribose) polymerase (PARP) proteolysis in 
Molt-4 cells was demonstrated following apoptotic etoposide (intrinsic pathway) 
exposure (Perry et al., 1997). PARP is a DNA repair enzyme (see chapters 4 and 5) 
that is deactivated by caspase-mediated cleavage during the apoptotic cascade 
(Kaufmann et al., 1993). Further investigation with recombinant caspase 3 and 
isolated PARP demonstrated that Zn^^ inhibited caspase 3 with an IC50 o f 0.1|liM 
(Perry et al., 1997). Other groups have subsequently shown Zn^^-mediated inhibition 
of recombinant caspase 3 (Maret et al., 1999; Wei et al., 2004).
Examination of the effect of Zn^^ on other caspases revealed that when expressed in 
Escherichia coli, caspase 6 was completely inactivated by lOOpM Zn^^, whereas 
caspase 3 was inhibited at >lmM  (Stennicke and Salvesen, 1997). Additionally, both 
caspase 7 and caspase 8 were inhibited by submicromolar Zn^^ concentrations 
(Stennicke and Salvesen, 1997). Direct caspase inhibition may be achieved through 
Zn^^ binding to the catalytic cysteine in the active site (Truong-Tran et al., 2001).
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Moreover, inhibited procaspase 3 processing and therefore caspase 3 activation 
in both ML-1 myeloid leukaemia and HeLa cells (Lambert et ah, 2001).
In isolated cytosols, Zn^^ exposure attenuated caspase activity induced following the 
addition of cytochrome c (Truong-Tran et al., 2000; Wei et al., 2004). Interestingly, 
Wei et al (2004) demonstrated that Zn^^-mediated inhibition of recombinant caspases 
required ten-fold higher concentrations of Zn^^ than in isolated cytosol stimulated 
with cytochrome c. This suggests that Zn^^ may inhibit targets upstream of caspase 
activation in addition to direct effect on the caspases themselves (Wei et al., 2004). 
Accordingly, Zn^^ (300pM) was shown to inhibit the intrinsic apoptotic cell death 
pathway in Jurkat T-lymphocytes and ML-1 myeloid leukaemia cells by antagonising 
Bak and Bax activation, thus preventing cytochrome c release, caspase 3 activation, 
and DNA degradation (Ganju and Eastman, 2003).
In the extrinsic pathway mediated by Fas or TNF, high Zn^^ (3mM) concentrations 
were required to inhibit caspase 3 activation and DNA fragmentation, but without 
inhibition of tBid, Bak or Bax or cytochrome c release, suggesting that Zn^^ acts 
downstream of mitochondria in this pathway (Ganju and Eastman, 2003). It has been 
suggested however, that Zn^^ mediates caspase -8 and -3 inhibition in ethanol-induced 
liver cell apoptosis indirectly by preventing Fas ligand expression, therefore inhibiting 
the downstream cascades (Lambert et al., 2003). In HeLa cells conversely, caspase 3 
activation by TNF a or etoposide (intrinsic death pathway) was only partially inhibited 
by Zn^^, and caspase -8 and -9 activation were unaffected, although apoptosis was 
inhibited (Chimienti et al., 2001b). This suggests that Zn^^-mediated inhibition of 
apoptosis may be both cell and insult specific.
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In a rat renal cell model of ischaemia, Zn^^ (lOpM) inhibited caspase activation and 
apoptosis by partially attenuating Bax translocation and cytochrome c release 
following ATP depletion (Wei et ah, 2004). Under these conditions, Zn^^ was thus 
protective. Increasing the Zn^^ concentration to 100}iM however, induced necrotic 
death (Wei et ah, 2004). Intriguingly, in C6 rat glioma cells Zn^^ (10-50pM) was 
shown to protect cells against cadmium-induced apoptosis, whereas TPEN-mediated 
Zn^^ chelation induced apoptosis (Watjen et ah, 2002).
As would be expected in its role as an apoptotic inhibitor, Zn^^ depletion has also 
been associated with enhanced caspase activation and apoptosis (Chimienti et ah, 
2001b). In HeLa cells, intracellular Zn^^ chelation by TPEN induced caspase -3, -8 
and less significantly -9 activation, and subsequent PARP cleavage (Chimienti et ah, 
2001b). Additionally, Zn^^ depletion in 3T3 cells was demonstrated to limit activity 
of the PKC-a isoform associated with cell proliferation, whilst inducing proteolytic 
cleavage of PKC-5 to a catalytic pro-apoptotic 40kDa fragment which enhances 
caspase 3 activation and subsequent cell death (Chou et ah, 2004).
3.1.4.2 -induced apoptosis
Zvi^ has conversely been associated with the induction of apoptosis. For example, as 
described in chapter 1, Zn^^ accumulation following LGN neuron target ablation 
occurred specifically in LGN neurons prior to caspase 3 activation, suggesting a role 
for Zn^^ in caspase activation and therefore in apoptosis (Land and Aizenman, 2005). 
Similarly, Zn^^ accumulation in CAl hippocampal pyramidal cells following 
ischaemic insult induced mitochondrial release of cytochrome c and Smac/DIABLO
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with subsequent caspase 3 activation and DNA fragmentation (Calderone et ah,
2004). In a prostate epithelial cell model, Zn^^ induced a downregulation of Bcl-2 
protein expression to drive apoptotic death (Untergasser et ah, 2000). Additionally, in 
isolated mitochondria, Zn^^ mediated the release of apoptogenic factors, cytochrome 
c, Smac/DIABLO and AIF (Jiang et ah, 2001). This suggests that Zn^^ may 
participate in both inducing and inhibiting apoptosis under different conditions.
3.1.4.3 -induced death: Apoptosis versus necrosis
The type of cell death elicited following Zn^^ exposure varies among different cell 
types and with the intensity and duration of the insult. For example in PC 12 cells,
200p-M ZnCb induced apoptotic death, prevented by addition of the caspase inhibitor, 
benzyloxycarbonyl-Val-Ala-ASP-CH2F (Z-VAD), whereas ImM ZnClz induced 
necrosis (Kim et ah, 2000). Similarly, exposure of murine hippocampal or cortical 
neurons to Zn^^ concentrations above 50pM induced necrotic death accompanied by 
random DNA fragmentation and cellular and organellar swelling, which was 
insensitive to Z-VAD, zVAD-fmk or the protein synthesis inhibitor, cycloheximide 
(Lobner et ah, 1997; Kim et ah, 1999a). Reducing exposure intensity to 10-30pM 
Zn^^ for 12-24 hours however, induced an apoptotic type death with intemucleosomal 
DNA fragmentation, cell shrinkage, and chromatin condensation, which was reversed 
by ZVAD (Lobner et ah, 1997). Furthermore, Zn^^-induced toxicity elicited apoptosis 
in C6 rat glioma cells at 150-200pM, which became necrotic >200pM (Watjen et ah,
2002). This phenomenon is not restricted to Zn^^-induced death however. Indeed, 
mild exposure to NMDA or peroxynitrite (ONOO ) in cortical cell cultures induced 
apoptotic death, whereas intense exposure induced necrosis (Bonfoco et ah, 1995).
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3.2 Chapter 3 research aims
There is much controversy surrounding the role of Zn^^ in ischaemic injury. Under 
certain conditions Zn^^ may be protective by inhibiting apoptotic processes including 
caspases. However, Zn^^ has also been shown to induce apoptosis and at higher 
concentrations, necrosis.
The aims of the present study are to:
1. Determine whether increased Zn^^ concentrations induce apoptosis in 
hippocampal HT-22 neurons.
2. Examine the effects of pathophysiologically relevant Zn^^ concentrations on 
caspase activation.
3. Elucidate whether caspases mediate Zn^^-induced death.
103
3.3 Methods
3.3.1 Reagents 
Cell culture
As described in section 2.3.1 Methods.
Bisbenzimide H  33342 staining
Hoechst 33342 (stock Img/ml in PBS) and formaldehyde were purchased from 
Sigma-Aldrich (Dorset, UK) and Vectashield with 4',6'-diamidino-2-phenylindole 
hydrochloride (DAPI) was bought from Vector (CA, USA). Coverslips and 
microscope slides were obtained from BDH (Dorset, UK). Other reagents were 
obtained as above, or in section 2.3.1 Methods.
Cytotoxicity assays
Z-Val-Ala-DL-Asp-fluoromethylketone (zVAD-fmk) (50mM stock in 100% DMSG) 
was obtained from Bachem (Merseyside, UK) and staurosporine (ImM stock in 100% 
DMSG) was purchased from Alexis Biochemicals (Nottingham, UK). Other reagents 
were obtained as per section 2.3.1 Methods.
Active caspase 3 detection
The phycoerythrin-conjugated monoclonal anti-active caspase-3 antibody apoptosis 
kit was obtained from BD PharMingen (CA, USA). All other reagents were obtained 
as above, or in section 2.3.1 Methods.
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3.3.2 Cell culture
As detailed in section 2.3.2 Methods.
3.3.3 Bisbenzimide H 33342 staining
Nuclear morphology was assessed according to Jones et al (1998) using the DNA 
intercalating dye, Hoechst 33342 (Crissman and Steinkamp, 1987). HT-22 cells were 
seeded (1x10^ cell well'^) onto 13mm diameter ethanol-sterilised coverslips in 
DMEM/10% PCS in 6 well plates and incubated at 37°C in a humidified atmosphere 
overnight. Medium was replaced with DMEM/2% ECS immediately prior to 
exposure to cytotoxic treatment (prepared in lOmM HEPES) for up to 24hr. Cells 
were washed once with 2ml well'^ PBS following medium removal, before fixing with 
2ml weir^ 2% (v/v) formaldehyde for 30min (4°C). The formaldehyde was removed 
prior to washing cells twice with 2ml well'^ PBS. Cells were then incubated at room 
temperature with 2ml welT^ PBS containing 2pg ml'^ Hoechst 33342 stain (stock Img 
mT  ^ in PBS) for 5min. The Hoechst stain was removed and cells washed once with 
2ml weir^ PBS. Coverslips were then mounted on microscope slides in 2pi 
DAPIWectashield, and cells examined under UV excitation with a Zeiss 135 TV 
inverted epifluorescence microscope (excitation 365nm and emission 420nm; lOOW 
Xe lamp with neutral density filter fitted).
3.3.4 Cytotoxicity assays
All compound dilutions were prepared in lOmM HEPES. Cells were pre-incubated 
with zVAD-fmk 30min prior to cytotoxic treatment.
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3.3.4.1LDH release assay 
As detailed in section 2.3.3.2 Methods.
3.3.5 Active caspase 3 detection
Cells were seeded at a density of 5 x 10  ^cells well'^ in 25cm^ tissue culture flasks in 
DMEM/10% ECS. Medium was replaced with DMEM/2% PCS after 24hr and cells 
were exposed to the experimental treatments (prepared in lOmM HEPES) for up to 
24hr. Caspase 3 activation was determined via flow cytometric analysis using a 
phycoerythrin-conjugated monoclonal anti-active caspase-3 antibody apoptosis kit 
according to the manufacturer’s instructions (BD PharMingen, CA, USA). Medium 
was removed from flasks, cells were washed twice with ice-cold PBS (washes were 
retained) and following trypsinisation, cells were added to the relevant samples. 
Samples were then centrifuged (1500 x g, 3min) and the pellet resuspended in 0.5ml 
cytofix/cytoperm™ solution (BD PharMingen) and incubated on ice for 20min. 
Following centrifugation (1500 x g, 3min), the supernatant was removed and the 
pellet washed twice in 0.5ml Perm/wash™ buffer (BD PharMingen). 120pi 
Perm/wash™ alone or with the addition of PE-conjugated monoclonal rabbit anti­
active caspase-3 antibody was then added to the relevant samples and flasks incubated 
at room temperature for 25min. The cells were centrifuged (1500 x g, 3min) and the 
pellet resuspended in 0.5ml Perm/wash™ buffer. Samples were analysed using a 
Coulter Epics XL flow cytometer (Beckman Coulter; Expo32 ADC Cytometry List 
Mode Data Acquisition and Analysis software; excitation 488nm and emission 
575nm), where cells were sorted into either non-fluorescent (B gated) or fluorescent 
(M2 gated) groups. Data represent the mean (+S.E.M.) percentage of M2 gated cells 
expressing active caspase 3.
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3.3.6 Statistical analyses
Either an unpaired Student’s t-test, or a one-way ANOVA was performed with a 
Dunnett’s or Tukey-Kramer multiple comparisons post test where appropriate 
(GraphPad InStat v.3.05). P<0.05 was considered statistically significant.
107
3.4 Results
3.4.1 induces abnormal chromatin condensation
There is conflicting evidence as to whether neuronal death is via apoptosis or necrosis 
following Zn^^ exposure in various cell types examined, with the intensity of the 
insult often determining the type of death executed (Kim et al., 1999b; Kim et al., 
2000). Changes to HT-22 cell nuclear morphology were therefore examined over 
24hr with 200pM ZnS0 4  exposure using the Hoechst 33342 nuclear stain. Fig. 3.3 
demonstrates normal nuclear morphology following 24hr exposure to HEPES (ImM), 
whereas chromatin was highly condensed (bright punctate nuclei) following 24hr 
staurosporine (STS) (IpM) exposure. There is some initial condensation apparent in 
some nuclei following Ihr ZnS0 4  exposure versus 24hr HEPES treatment. Following 
3hr ZnS0 4  exposure though, nuclei became partially condensed and with some degree 
of fragmentation. Most striking was the appearance of nuclear blebbing, a 
phenomenon also observed in rat thymocyte nuclei triggered to undergo apoptosis by 
dexamethasone (G.E.N. Kass, personal communication). By 6hr, staining was 
weaker, and the dye became apparent in the surrounding medium. Little staining 
remained by 24hr exposure, a likely post mortem effect of Hoechst 33342 binding to 
fragments of cellular debris.
1 0 8
IpM Staurosporine 24hr
•  ,  •  
m #
200pM ZnSCL 3hr
m m
200uM Z11SO4 24hr
Figure 3.3. Zn^  ^induces abnormal nuclear morphology.
HT-22 cells were incubated with 1 piM staurosporine (STS) (24hr) or 200pM ZnSÛ4 
over 24hr. Nuclei were stained using 2fig ml'^ Hoechst 33342 dye, and images were 
captured from random fields of view (magnification X 400) using epifluorescence 
microscopy as described in Methods.
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3.4.2 zVAD-fmk does not limit Zn^^-induced toxicity
The appearance of partial chromatin condensation along with the presence of some 
nuclear fragmentation with Hoechst 33342 suggested that the role of caspases in the 
Zn^^-induced HT-22 cell death mechanism should be investigated. This was 
examined with the use of the pan-caspase inhibitor, zVAD-fmk (Garcia-Calvo et al.,
1998). Cells were incubated with the indicated treatments for 6hr or 24hr in the 
presence or absence of lOOpM zVAD-frnk (standard effective concentration) (Fig. 
3.4v4 and B). Both 6hr and 24hr exposure to 200pM ZnS0 4  alone induced significant 
LDH release (indicative of cell death), but this effect was not significantly reversed by 
lOOpM zVAD-fmk (confirmed by MTT assay; data not shown). In contrast, 
staurosporine (STS) (IpM), a known apoptotic inducer, also induced significant levels 
of LDH release at 24hr which were significantly inhibited by lOOpM zVAD-fmk (Fig. 
3AB) (confirmed by MTT assay; data not shown). When tested alone, 0.3% DMSO 
(vehicle for IpM STS and lOOpM zVAD-fmk) had no significant effect on LDH 
release versus HEPES (Fig. 3.45), and 0.2% DMSO (vehicle for lOOpM zVAD-frnk) 
had no significant effect on LDH release in the presence of 200pM ZnS0 4  (Fig. 3.4^4).
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Figure 3.4. The broad-spectrum caspase inhibitor zVAD-fmk fails to 
significantly inhibit Zn^-induced toxicity.
HT-22 cells were exposed to 200pMZnS0 4  fo r  6hr (A) or 200pMZnS0 4  or IpM STS  
fo r  24hr (B) in the presence or absence o f lOOpMzVAD-fmk (30min preincnbation). 
Cell death was determined via LDH efflux into the culture medium as detailed in 
Methods. Data correspond to the mean (±S.E.M.) o f four independent experiments.
* = P<0.05, ** = P<0.01 and *** = P<0.001 signifies difference from Im M  HEPES 
control (one-way ANOVA and Tukey-Kramer multiple comparisons post hoc test).
# = P<0.05 signifies difference from IpM  STS (unpaired Student’s t-test).
I l l
3.4.3 exposure fails to induce caspase 3 activation
Since cell death following Zn^^ exposure was not reversed in the presence of zVAD- 
fmk, the unlikely activation of the major effector caspase, caspase 3, following 
200pM ZnS0 4  treatment was confirmed further by a monoclonal anti-active caspase 3 
antibody and flow cytometry. Cells were gated according to phycoerythrin (PE) 
fluorescence levels. Therefore M2-gated cells were fluorescent (indicative of caspase 
3 activation) whereas B-gated cells were non-fluorescent (indicative of no caspase 3 
activation). Untreated and 24hr HEPES (ImM) treated cells demonstrated no 
difference in the level of M2-gated cells compared to unstained cells (non-PE treated) 
(Fig. 3.5C). 200pM ZnSÛ4 failed to induce significant levels of M2-gated cells at 3hr 
(Fig. 3.5/4), 6hr or 24hr (Fig. 3.55 and Fig. 3.5C) versus HEPES (ImM). Fig. 3.55 
and Fig. 3.5C demonstrate that lOOpM ZnS0 4  also failed to induce an increase in M2- 
gated cells at 6hr or 24hr. The positive control STS (IpM) however, induced 
significant levels of M2-gated cells at 24hr (Fig. 3.55 and Fig. 3.5Q  but not at 3hr 
(Fig. 3.5/4). The STS (IpM) vehicle, 0.1% DMSO, also had no effect on inducing an 
increase in M2-gated cells at 24hr (Fig. 3.55).
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Figure 3.5. does not induce significant caspase 3 activation.
HT-22 cells were incubated with 200pM  ZnSO 4 or IpM  STS fo r  3 hr (A), or with 
lOOpM or 200pM ZnS04, or IpM  STS for 6hr or 24hr (B, C). Caspase 3 activation 
was determined via flow  cytometry (described in Methods). (A, B) Data represent the 
mean (±S.E.M.) o f at least four independent experiments. ** = P<0.01 indicates 
difference from HEPES control (ImM) by one-way ANOVA followed by a Dunnett’s 
post hoc test. (C) Data are expressed as representative individual raw trace results. 
Cells were gated according to fluorescence levels, assuming approximately 
autofluorescence in untreated cells. M2-gated cells represent fluorescent cells with 
active caspase 3, whereas B-gated cells are non-fluorescent (inactive caspase 3).
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3.5 Discussion
As was presented at the outset of the chapter, there is controversy regarding the mode 
of death following both ischaemic insult and exogenous Zn^^ exposure. Cross talk 
may occur between different cell death mechanisms, including caspases, calpains and 
cathepsins, further complicating identification of the death process. This section 
aimed to determine whether Zn^^-induced HT-22 cell death was apoptotic or necrotic.
HT-22 cells are unlikely to die via apoptotic cell death following toxic Zn^^ exposure. 
Preliminary experiments examining nuclear morphology assessed by Hoechst staining 
at Ihr, 3hr, 6hr and 24hr demonstrated that although Zn^^ induced partial chromatin 
condensation, fragmentation was only apparent following 3hr exposure. It therefore 
appeared that Zn^^ induced initial chromatin condensation, which subsequently 
decondensed at later time points. Accordingly, staurosporine induced a compact 
chromatin conformation and pyknotic nuclei indicative of apoptotic morphology. 
Morphological data therefore suggest that Zn^^-induced death is via a non-apoptotic 
mechanism in HT-22 cells.
Investigation of the potential involvement of caspases in the cell death mechanism 
demonstrated that in contrast with the positive apoptotic inducer, staurosporine, the 
pan-caspase inhibitor, zVAD-fmk, failed to prevent Zn^^-induced death at either 6hr 
or 24hr. This implies that a mechanism independent of caspase activation is 
employed during Zn^^-induced death. In support of these findings, zVAD-fmk has 
previously been shown to inhibit death induced by 24hr staurosporine insult in mixed 
cortical cultures (Lobner, 2000). zVAD-fmk may however, also inhibit calpain 
activity (Waterhouse et al., 1998). Calpain activation has been implicated in both 
apoptosis (Blomgren et al., 2001) and necrosis (Neumar et al., 2003). Furthermore,
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calpains may mediate caspase-independent apoptosis as is observed in an ischaemia- 
repertnsion model (Chen et al., 2001; Chen et al., 2002a). The inability of zVAD-fmk 
to protect against Zn^^-induced HT-22 cell toxicity suggests that death is therefore 
independent of caspases and possibly also calpains.
Zn^^ seems to play a conflicting role in the activation of caspases. As discussed 
earlier, Zn^^ inhibited both recombinant caspase 3, 6, 7 and 8 (Perry et al., 1997; 
Stennicke and Salvesen, 1997), and caspases activated following cytochrome c- 
mediated stimulation of isolated cytosols (Truong-Tran et al., 2000; Wei et al., 2004). 
Zn^^ may also mediate inhibition at earlier stages of apoptosis, including prevention 
of Bak and Bax activation (Ganju and Eastman, 2003), and attenuation of Fas ligand 
expression (Lambert et al., 2003). Conversely, Zn^^-mediated caspase activation has 
been demonstrated during Zn^^ toxicity in a neuronal target loss model (Land and 
Aizenman, 2005) and following hippocampal ischaemic insult (Calderone et al.,
2004).
The potential role for Zn^^-directed caspase activation in HT-22 cells was examined 
by direct assessment of active caspase 3 levels. Caspase 3 is a major effector caspase 
activated during apoptosis, mediating a proteolytic cascade of downstream caspase 
activation and cellular disassembly (Liu et al., 1997; Slee et al., 1999; Samejima et al., 
2001; Shen and White, 2001). In accordance with the lack of zVAD-fmk protection, 
Zn^^ exposure did not induce caspase 3 activation at 3hr, 6hr or 24hr. The absence of 
active caspase 3 detection at any of the time points investigated supports the fact that 
HT-22 cells do not execute a caspase-mediated death mechanism following Zn^^ 
exposure. Again, staurosporine was employed as a positive control, demonstrating
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significant levels of caspase 3 activation following 24hr exposure, thus supporting its 
utilisation as an apoptotic inducer.
The inability to detect caspase 3 activation may not be surprising considering the 
proposed role for Zn^^ as an apoptotic antagonist as mentioned above. It has been 
suggested that inhibition of apoptosis may drive necrosis (Lemaire et al., 1998), 
therefore necrotic death might result from Zn^^-induced caspase inhibition in the HT- 
22 cell toxic paradigm. This could be determined through examination of the mode of 
death elicited following subtoxic Zn^^ treatment during exposure to a known apoptotic 
inducer, for example staurosporine or etoposide.
ATP is another key determinant of the cell death mechanism since apoptosis requires 
sustained energy levels for execution of the apoptotic program whereas necrosis does 
not (Kass et al., 1996; Shen and White, 2001; Artal-Sanz and Tavemarakis, 2005). 
Furthermore, ATP depletion may induce necrosis following initiation of apoptosis 
(Eguchi et al., 1997). In the HT-22 cell model, the acute toxic Zn^^ exposure utilised 
may therefore trigger necrosis either following commencement of apoptosis 
(secondary necrosis; (Hirsch et al., 1998)) or independent of apoptosis in response to 
rapid depletion of ATP levels. Examination of ATP levels during Zn^^-induced HT- 
22 cell death will permit elucidation of this hypothesis.
The specific cell death pathway executed following toxic Zn^^ exposure is a 
disputable issue. Certain groups have demonstrated that neurons die via necrosis 
when exposed to high Zn^^ concentrations, but via apoptosis when exposed to lower 
concentrations (Lobner et al., 1997; Kim et al., 2000). Zn^^ exposure may however, 
induce both apoptotic and necrotic features simultaneously as revealed in murine 
cortical cultures (Kim et al., 1999b). Similar observations of concurrent apoptosis and
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necrosis have also been described following ischaemic neuronal injury (Gwag et ah, 
1995). However, ischaemic insults have also demonstrated necrotic cell death at the 
injury focus, but apoptosis at the periphery (Charriaut-Marlangue et al., 1996). This 
suggests that the insult intensity determines the mechanism of death in both ischaemic 
and Zn^^ cytotoxic paradigms.
More recently, a novel form of ischaemic cell death coined paratopsis has been 
described. Paratopsis is distinct from apoptosis and necrosis owing to its insensitivity 
to apoptotic inhibitors including caspase inhibition, the occurrence of novel PARP 
cleavage fragment, and generation of a distinctly processed form of caspase 9 
(Sperandio et al., 2000). Vacuolated cytoplasm is a morphological characteristic of 
this mode of death (Sperandio et al., 2000).
The evidence presented here implies that Zn^^ mediated caspase-independent HT-22 
cell death. Although zVAD-frnk could potentially attenuate calpain participation in 
the Zn^^-induced death mechanism (Waterhouse et al., 1998), the role of calpains and 
cathepsins have not specifically been addressed. Both calpains and cathepsins have 
been implicated in ischaemic injury (Hetman et al., 1995; Saido et al., 1997; Seyfried 
et al., 2001; Yamashima et al., 2003; Bano et al., 2005), therefore it will be necessary 
to elucidate their involvement in Zn^^-induced death. The potential execution of 
‘paratoptic’ cell death should also be examined, owing to the insensitivity of Zn^^- 
induced HT-22 cell death to caspase inhibitors, as was also demonstrated in this mode 
of death. This could be achieved with the use of antibody probes raised against the 
alternatively processed forms of PARP or caspase 9 which are specific to paratoptic 
death. Additionally, the cells could be examined morphologically for the presence of 
vacuolated cytoplasm.
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CHAPTER 4 
THE ROLE OF MITOCHONDRIA IN 
ZINC-INDUCED HT-22 CELL DEATH
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4.1 Mitochondria
It has been demonstrated that Zn^^ induces significant HT-22 cell death. However, 
based on both morphological and biochemical data, there is no evidence supporting a 
role of apoptosis in Zn^^-induced cytotoxicity. This suggests that death is potentially 
necrotic. It is proposed that the mitochondrial permeability transition pore (mPTP) 
plays a significant role in the induction of apoptotic and necrotic cell death (Lemasters 
et al., 1998; Lemasters, 1999; Kim et al., 2003b). The mPTP comprises three 
components; a voltage-dependent anion channel (VDAC), the adenine nucleotide 
translocase, and cyclophilin-D (CyPD), and forms a pore between the inner and outer 
mitochondrial membranes (Crompton, 1999).
Opening of the mPTP in response to stimuli including oxidative stress and ischaemic 
injury initiates mitochondrial permeability transition (MPT) (Kim et al., 2003b). 
Correspondingly, following mPTP opening, the inner mitochondrial membrane 
becomes permeable to solutes of up to l.SkDa, resulting in mitochondrial 
depolarisation, uncoupling of oxidative phosphorylation and matrix swelling 
(Lemasters et al., 1998; Kim et al., 2003b). Rapid ATP depletion may subsequently 
result in necrotic cell death (Lemasters, 1999; Kim et al., 2003b). However, 
maintenance of ATP levels through sustained glycolysis (Lemasters et al., 1998; Kim 
et al., 2003b), in addition to the release of apoptogenic compounds including 
cytochrome c and AIF following rupture of the outer mitochondrial membrane 
induced by mitochondrial swelling, allows apoptotic cell death (Crompton, 1999; 
Lemasters, 1999). As described previously (chapter 3) though, ATP depletion 
following initiation of apoptosis may induce the switch to secondary necrosis (Hirsch
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et al., 1998). ATP levels are thus integral to the mode of cell death elicited following 
MPT (Lemasters, 1999; Kim et al., 2003b).
The lack of evidence supporting the role of apoptosis in Zn^^-induced HT-22 cell 
death suggests that the mitochondria may be an important site of Zn^^-induced 
cytotoxicity and necrotic cell death. The aim of this study was therefore to examine 
the involvement of the mitochondria and downstream cellular oxidative stress in the 
Zn^^ cytotoxic mechanism.
4.1.1 and mitochondria
4.1.1.1 Mitochondrial uptake
Mitochondria may be vital to buffering intracellular Zn^^ concentrations. Indeed, in 
prostate epithelial cells, which contain the highest Zn^^ concentrations of the body, 
Zn^^ accumulates specifically in the mitochondria (Untergasser et al., 2000). Cortical 
neuronal cultures treated with sub-toxic Zn^^ concentrations display briefly enhanced 
[Zn^^]i which is then restored to normal. Inducing a collapse in A\j/m using carbonyl 
cyanide p-(trifluoromethoxy)phenylhydrazone (FCCP) during Zn^^ exposure, prevents 
the normalisation of [Zn^^]i levels. This is attributed to inhibition of mitochondrial 
Zn^^ influx. In the presence of kainate, the rapid influx of Zn^^ through Ca^^- 
permeable AMP A and/or kainate receptor-gated channels induced a sustained 
reduction in A\|/m accompanied by enhanced production of reactive oxygen species 
(ROS) (Sensi et al., 1999; Sensi et al., 2000). Slight increases in [Zn^^]i are also 
observed in neurons lacking Ca^^ permeable AMP A and/or kainate receptor-gated
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channels, reflecting Zn^^ entry through VSCC but without toxic effect (Sensi et ah, 
1999).
Intriguingly, Zn^^ entry as opposed to Ca^^ entry through the Ca^^-permeable AMP A 
and/or kainate receptor-gated channels appears to have a much greater toxic potency, 
as demonstrated by sustained enhancement of ROS production even following 
termination of Zn^^/kainate exposure, whereas levels are restored following Ca^^ 
exposure. This may be due to the presence of Ca^^ homeostatic mechanisms to permit 
recovery of Ca^^ levels, whereas there are no such mechanisms for Zn^^ (Sensi et ah,
1999).
Zn^^ influx into both isolated mitochondria and mitochondria of intact murine cortical 
neurons via the Ca^^ uniporter has been demonstrated (Jiang et ah, 2001; Malaiyandi 
et ah, 2005). However, a low capacity, uniporter- and A\j/m-independent mechanism 
of mitochondrial Zn^^ influx has also recently been proposed (Malaiyandi et ah,
2005). Furthermore, this group suggest a novel and as yet uncharacterised uniporter- 
independent mechanism of mitochondrial Zn^^ efflux (Malaiyandi et ah, 2005).
In isolated rat prostate and liver cell mitochondria, it has been proposed that 
mitochondrial Zn^^ uptake and accumulation may occur through a ligand-bound 
mechanism. Zn^^ chelated by citrate, aspartate, histidine or cysteine showed energy- 
independent uptake according to a putative Zn^^ transporter in the inner mitochondrial 
membrane which removes Zn^^ from the bound ligand. This permits Zn^^ 
accumulation in the mitochondria in the presence of low cytosolic Zn^^ concentrations 
(Guan et ah, 2003). This group postulated that metallothionein would similarly 
donate Zn^^ to the transporter (Guan et ah, 2003). The presence of this transporter 
however remains to be identified in neuronal cells.
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4.LL2 Metalloprotein-mitochondria Zri^^  shuttling
More recently it has been suggested that mitochondria provide a sink for Zn^^ under 
basal conditions (Sensi et al., 2002; Sensi et al., 2003b). Zn^^ transfer may be 
reversibly stimulated between the putative mitochondrial pool and Zn^^-containing 
metalloproteins (Sensi et al., 2003b). Accordingly, FCCP treatment induced the loss 
of mitochondrial Zn^^ to the cytosol, whereas DTD? treatment (oxidises Zn^^- 
containing metalloproteins; see chapter 1 and section 4.1.2.2) induced mitochondrial 
Zn^^ uptake (Sensi et al., 2003b). Zn^^ release from mitochondria was apparently 
Ca^^-dependent, since release was also induced by Ca^^ influx through NMDA 
receptors (Sensi et al., 2002). Bossy-Wetzel et al (2004) suggest that Zn^^ released 
from intracellular stores following exogenous NO application may also be transferred 
to the mitochondria (Bossy-Wetzel et al., 2004). As mentioned above, 
metallothioneins may provide a mitochondrial Zn^^ shuttle mechanism (Guan et al.,
2003). Zn^^-bound metallothionein may cross the mitochondrial membrane to supply 
a source of free Zn^ .^ Mitochondrial free Zn^^ may then be complexed with 
apothionein as a reversal of this process (Ye et al., 2001).
Sub-toxic Zn^^ concentrations, modelling those attained following oxidative Zn^^ 
release from metalloproteins (see section 4.1.2.2), induced a reduction of A\j/m and 
stimulated mPTP opening, concurrent with enhanced 0% consumption and reduced 
ROS production, indicative of Zn^^ translocation to mitochondria. Addition of DTDP 
alone to stimulate endogenous oxidative Zn^^ release also induced a loss of A\|/m 
(Sensi et al., 2003b). Higher Zn^^ concentrations, as expected in a toxic capacity 
however, decreased respiration and increased ROS production (Sensi et al., 2003b).
123
Recent experiments utilising mitochondria loaded with the high affinity Zn^^-selective 
probe, FluoZin-3, however suggest that strong oxidants (DTDP or H2O2) do not 
induce either mitochondrial Zn^^ release or Zn^^ relocation to the mitochondria, as 
indicated by an absence of fluorescence changes under these conditions (Malaiyandi 
et ah, 2005). Therefore the presence of an endogenous redox-sensitive mitochondrial 
Zn^^ pool remains speculative at present.
4. L I . 3 and mitochondrial permeability transition (MPT)
As mentioned above (section 4.1), MPT may play an important role in the cell death 
mechanism following cytotoxic insult including oxidative stress and ischaemia (Kim 
et ah, 2003b). lOnM Zn^^ has been shown capable of inducing mitochondrial 
swelling via stimulation of mPTP opening (Jiang et ah, 2001). Accordingly, mPTP 
opening in isolated rat mitochondria was accompanied by cytochrome c and AIF 
release (Jiang et ah, 2001). In an alternative model, ONOO' exposure also induced 
mPTP opening and cytochrome c release, attributed to the action of Zn^^ (see below) 
(Bossy-Wetzel et ah, 2004). It is suggested that the pro-apoptotic factor, Bax, may 
interact with the mPTP to promote mitochondrial depolarisation and apoptotic death, 
and this may be a site of Bcl-2 intervention (Marzo et ah, 1998). Zn^^-induced 
apoptosis in prostate epithelial cells was thus associated with decreased A\|/m, and was 
accompanied by reduced Bcl-2 protein expression (Untergasser et ah, 2000). This 
suggests that mitochondrial damage by Zn^^ may mediate a potential drive into 
apoptosis by downregulating anti-apoptotic proteins.
It should be noted however, that MPT is more likely associated with necrosis rather
than apoptosis. Indeed, the addition of the oxidant compound /-butylhydroperoxide to
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rat hépatocytes induced NADH and NADPH oxidation, generation of mitochondrial 
derived ROS, followed by MPT, mitochondrial depolarisation and cell death 
(Nieminen et al., 1997). Furthermore, in a model of rat hepatocyte 
ischaemia/reperfusion injury, MPT induction was shown to be a key mediator of 
necrotic death, since inhibition of mPTP opening with cyclosporin A attenuated MPT, 
mitochondrial depolarisation and cell death (Qian et al., 1997). It is also proposed 
that mitochondrial Ca^^ overload and ROS production might participate in MPT 
following excitotoxic neuronal insult (Isaev et al., 1996; Nieminen et al., 1996). 
Accordingly, data presented thus far suggest that Zn^^-induced HT-22 cell death is not 
apoptotic.
4.1.1,4 Inhibition of mitochondrial respiration
It is possible that mitochondrial Zn^^ uptake may have further consequences in 
addition to the induction of MTP. Accordingly, in isolated rat liver mitochondria,
Zn^^ inhibited respiration stimulated by a-ketoglutarate (a- KG), glutamate/malate 
and also by succinate, but to a much lesser extent. Glutamate/malate and a-KG are 
mitochondrial complex I substrates providing a source of NADH to the electron 
transport chain, whereas succinate is a complex II substrate providing a source of 
FADHi. Complex III (the cytochrome bc\ complex) subsequently receives the 
electrons from both these complexes (Nelson and Cox, 2000). Using isolated rat brain 
mitochondria Dinely et al (2003) demonstrated a loss of A\j/m and reduced O2 
consumption in cells respiring on complex I and II substrates, with ~200nM Zn^^ 
insults (Dineley et al., 2003). Zn^^ has been shown to bind to and reversibly inhibit 
the purified bc\ complex of bovine heart mitochondria, causing complete inhibition at
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concentrations above 5|4,M. The site of inhibition is proposed to be part of the bc\ 
complex proton channel (Link and von Jagow, 1995). Zn^^ is also suggested to bind 
the external surface of complex IV (cytochrome c oxidase complex) when the 
mitochondria are polarised, to inhibit proton passage through a proton exit path and 
therefore inhibit O2 consumption (Mills et al., 2002). However, Zn^^ inhibits 
respiration stimulated by complex I substrates more intensely than complex II 
substrates. This suggests that Zn^^ may inhibit a site upstream of the electron 
transport chain (Brown et al., 2000).
Subsequent investigation at an earlier stage of mitochondrial metabolism revealed 
Zn^^-induced inhibition of the a-ketoglutarate dehydrogenase complex (KGDHC) of 
the tricarboxylic acid (TCA) cycle (figure 4.1) (Brown et al., 2000). KGDHC 
catalyses the reaction:
a-ketoglutarate + coenzyme A + NAD^ ^ succinyl coenzyme A + CO2 + NADH
Gazaryan et al (2002) identified the site of Zn^^ inhibition as a catalytic disulphide of 
the lipoamide dehydrogenase (LADH) subunit using isolated porcine heart KGDHC. 
LADH is a member of the flavin-disulphide oxido-reductases group. It catalyses the 
reduction of NAD^ to NADH via the forward reaction:
NAD^ + dihydrolipoic acid ^ NADH + lipoic acid
It also catalyses the reverse reaction whereby NADH is oxidised to NAD^ (Gazaryan 
et al., 2002):
NADH + lipoic acid ^ NAD^ + dihydrolipoic acid
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The production of dihydrolipoic acid is important due to its ROS scavenging ability, 
and its participation in the production of further antioxidants including vitamins C and 
E (Packer et ah, 1997). Zn^^ addition potently inhibits both forward and reverse 
reactions, resulting in disruption to the TCA cycle and subsequent mitochondrial 
energy metabolism. Changes to dihydrolipoic acid levels may also have important 
implications via perturbation of antioxidant production (Gazaryan et al., 2002).
The reduction of molecular oxygen by NADH is additionally catalysed by the LADH 
subunit. This reaction generates both H2O2 and the superoxide anion, O2" . Gazaryan 
et al (2002) found this reaction to be augmented five-fold in the presence of Zn^^, 
thereby possibly contributing to cellular oxidative stress (Gazaryan et al., 2002).
Chronic exposure to enhanced Zn^^ concentrations will therefore inhibit 
mitochondrial respiration through the sustained inhibition of KGDHC activity in 
addition to the inhibition at the bc\ complex and complex IV, and promote cellular 
oxidative stress.
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Figure 4.1. Schematic representation of the TCA cycle.
Abbreviations: OAA, oxaloacetic acid. Adaptedfrom  Salway (2000).
4.1.2 Cellular oxidative stress
4.1.2,1 ROS in Zn ^-induced toxicity
Evidence exists implicating ROS generation and cellular oxidative stress specifically 
in Zn^-induced toxicity following both acute and chronic Zn^^ treatment. In murine 
cortical cell culture, sustained Zn^ exposure enhanced both ROS generation and lipid 
peroxidation. Antioxidants such as the vitamin E analogue, trolox, and the 
SOD/catalase mimetic, EUK-134, however improved cell viability (Kim et al., 1999a; 
Kim et al., 1999b; Pong et al., 2002).
128
Acute exposure directly induces PKC activation (Noh et al., 1999). Oxidative 
stress mediated by PKC -dependent activation of NADPH oxidase, an O2" generator, 
has been demonstrated following acute (15-30min) 300pM Zn^^ exposure in cortical 
neurons. Inhibition of PKC or NADPH oxidase limited both O2 *' production and 
Zn^^-induced cell death (Noh et al., 1999; Noh and Koh, 2000). Moreover, acute Zn^^ 
exposure induced DNA fragmentation associated with the activation of PARP and the 
poly(ADP-ribose) unit degrading enzyme, poly(ADP-ribose) glycohydrolase (PARG), 
and enhanced poly(ADP-ribosyl)ation (Kim and Koh, 2002). PARP utilises 
nicotinamide adenine dinucleotide (NAD^ in its mechanism of action and therefore 
sustained activation of PARP/PARG though excessive DNA damage depletes cellular 
NAD^ and thus ATP levels resulting in necrotic cell death (see chapter 5) (Szabo and 
Dawson, 1998; Kim and Koh, 2002).
DNA fragmentation, and therefore PARP/PARG activation, in this model of Zn^^ 
toxicity was attributed to increased O2 *', NO and ONOO production via Zn^^- 
mediated induction of NADPH oxidase and neuronal NOS (nNOS), since their 
respective inhibitors attenuated both poly(ADP-ribosyl)ation and cell death (Kim and 
Koh, 2002). Intriguingly, nNOS knockout mice demonstrated reduced poly(ADP- 
ribosyl)ation following ischaemia and reperfusion compared to wildtype mice, 
indicating a role for nNOS in PARP activation and cell death following ischaemic 
insult (Endres et al., 1998).
Conversely, NO-mediated protection against cytotoxic Zn^^ insults has been 
demonstrated in neocortical neurons following stimulation of inducible NOS (iNOS) 
or direct NO application (Snider et al., 2000). NO may inhibit both Zn^^ and Ca^^ 
entry through VSCC by oxidation of a redox modulation site affecting Ca^^ channel
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opening (Snider et al., 2000). However, Zn^^ (100-300pM) has also been shown to 
directly inhibit nNOS (Persechini et al., 1995; Snider et al., 2000). It is possible 
therefore, that there is interplay of further mechanisms which regulate the effects NO 
on Zn^^-induced toxicity.
Cytotoxic Zn^^exposure in a pig kidney-derived renal epithelial cell line, LLC-PKi, 
provides another example of a death mechanism associated with NADPH oxidase 
activity and oxidative stress. Both Zn^^-related ROS increases and cell death were 
attenuated with the antioxidant, N, A’-diphenyl-p-phenylenediamine (DPPD) 
(Matsunaga et al., 2005). Significantly, Zn^^ exposure also increased the 
phosphorylation and activation of ERKl/2 prior to injury, an effect attenuated by 
DPPD, suggesting a role for upstream ROS production in mediating this activation.
In agreement, the MAPK/EREC kinase inhibitor, U0126, was unable to attenuate ROS 
production, but did ameliorate cell viability (Matsunaga et al., 2005). Therefore, ROS 
generation induced via Zn^^-mediated NADPH oxidase activation may activate 
downstream ERKl/2 cascades (Matsunaga et al., 2005).
4.1.2.2 Oxidative mobilisation
As noted in chapter 1, Zn^^is abundantly found within Zn^^-containing
metalloproteins, most significantly metallothioneins. These proteins provide vital
stores for both Zn^^ sequestration and also its release. Metallothioneins also act as
OH* scavengers via their cysteine groups, and will additionally bind redox active
metals to limit their potential contribution to oxidative stress (Quesada et ah, 1996;
Oteiza et ah, 2004). As also mentioned in chapter 1, oxidative mobilisation of Zn^^
from Zn^^-containing metalloproteins represents a potential source of cytotoxic Zn^^
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during ischaemic insult, particularly in the absence of synaptic Zn^^ (Lee et ah, 2000; 
Frederickson et ah, 2002a).
Zn^^-induced metallothionein upregulation may provide significant cellular protection 
during oxidative stress (Quesada et ah, 1996; Andrews, 2000; Chimienti et ah, 2001a; 
Chung et ah, 2005). Indeed, H2O2 reacts preferentially with thiols of metallothioneins 
than other endogenous thiols such as glutathione, possibly to preserve levels of these 
antioxidants (Quesada et ah, 1996). However, the presence of partially-Zn^^ saturated 
metallothioneins may be required for optimal protection, by avoiding cytotoxic Zn^^ 
release from fully Zn^^-loaded proteins (Chimienti et ah, 2001a). Furthermore, the 
induction of metallothionein expression by factors such as copper, cadmium or H2O2 
relies on Zn^^-containing metallothionein for MTF-1 activation (Zhang et ah, 2003). 
These factors displace Zn^^ from metallothionein allowing it to coordinate with MTF- 
1 and regulate DNA-binding (figure 4.2) (Zhang et ah, 2003).
As detailed in chapter 1, metallothioneins co-ordinate seven Zn^^ ions in two thiolate 
clusters by sulphur ligands. This presents a redox-active environment for Zn^^ release 
in response to oxidative agents such as NO and NO metabolites including ONOO', or 
selenium compounds (Maret, 1995; Cuajungco and Lees, 1998; Jacob et ah, 1998; 
Maret and Vallee, 1998; Aravindakumar et ah, 1999). Indeed, relatively mild cellular 
oxidants in particular disulphides including glutathione disulphide (GSSG), can 
induce Zn^^ release via S-thiolation (Maret, 1994, 1995). The orientation of Zn^^ and 
sulphur within the thiolate cluster favours subsequent disulphide formation (Maret 
and Vallee, 1998).
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Figure 4.2. Illustrative diagram of oxidative zinc mobilisation.
Zinc is displaced from zinc-containing metalloproteins including metallothionein by 
ROS or heavy metals. Released zinc binds to MTF-1, which coordinates with MRE in 
the gene promoter region o f  DNA. MTF-1 then directs the downstream transcription 
o f target genes. Adapted from Zhang et al (2003).
The neuron specific metallothionein, MT-III, is proposed to be most susceptible to- 
and neuroprotective against NO attack due to the presence of S-nitrosylation motifs in 
its consensus sequence (Chen et al., 2002b). NO has a relatively short half-life 
therefore the production of S-nitrosothiols following the reaction of NO with 
abundant cellular thiols acts as an NO storage and transport agent (Myers et al., 1990). 
The reaction of S-nitrosothiols with MT-lIl induces rapid Zn^' release from Zn^ -
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thiolate bonds of both the a- and ^-domains via transnitrosation (Chen et ah, 2002b), 
whereas the direct attack of free NO on thiols induces slow Zn^^ release 
(Aravindakumar et ah, 1999). Under anaerobic conditions as may occur during 
ischaemia though, electrophilic NO addition is proposed to directly induce Zn^^ 
release from thiols without metallothionein S-nitrosylation (Aravindakumar et al.,
1999).
Regardless of the reaction mechanism, this evidence suggests that MT -III may act as 
an important and specific NO scavenger (Chen et al., 2002b). Accordingly, addition 
of MT-III to cerebellar neurons attenuated NO- and glutamate-induced neuronal death 
(Montoliu et al., 2000). Conversely, all three metallothionein isoforms, MT-I, -II and 
-III, released Zn^^ at the same rate and were equally protective against H2O2 insults 
(Chen et al., 2002b).
The effects of NO-mediated oxidative Zn^^ release from proteins were examined 
using a rat brain in vivo model. Administration of NO donors to the rat hippocampus 
induced enhanced Zn^^ staining in the somata, axons and dendrites of pyramidal 
neurons and intemeurons, and dentate granule cells, an effect attenuated by both 
TPEN and NaEDTA (Cuajungco and Lees, 1998). Extracellular Zn^^ chelation with 
NaEDTA implies that Zn^^ accumulates from an extracellular source. However, the 
blockade of Zn^^ staining was incomplete, suggesting that some intracellular Zn^^ 
mobilisation had also occurred. Furthermore, administration of sodium nitroprusside 
(SNP) also induced subsequent seizure-type activity, and enhanced Zn^^ staining in 
some of the hippocampal regions known to be affected following kainate-induced 
seizure (Cuajungco and Lees, 1998). This demonstrates that NO can induce the
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mobilisation of endogenous Zn^^ in vivo and enhance intracellular Zn^^ accumulation 
(Cuajungco and Lees, 1998).
Recently ONOO'-induced Zn^^ release has been demonstrated in cerebrocortical 
neurons following exogenous NMDA or NO application (Bossy-Wetzel et al., 2004; 
Zhang et al., 2004). Downstream cascades induced by Zn^^ release include; 
respiratory inhibition and 12-lipoxygenase (12-LOX) activation (mediates oxidation 
of arachidonic acid); increased ROS and O2 *' production augmenting ONOO 
generation; mitochondrial dysfimction including loss of A\|/m, mPTP opening, 
mitochondrial swelling and cytochrome c release; efflux through voltage-activated 
channels activated by p38 MAPK; and finally apoptotic death (Bossy-Wetzel et 
al., 2004; Zhang et al., 2004). This substantiates a role for endogenous Zn^^ in NO- 
mediated cell death pathways.
In addition to release from cytosolic proteins, oxidative species may also induce the 
release of Zn^^ from synaptic vesicles. Following infusion of a NO donor into the 
hippocampus, Frederickson et al (2002a) demonstrated a reduction in Zn^^-dependent 
TSQ fluorescence in presynaptic boutons, and enhanced Zn^^ staining in the 
hippocampal hilus and pyramidal cell layers (Frederickson et al., 2002a). This 
suggests that ROS may contribute to cytotoxic intracellular Zn^^ accumulation via 
mechanisms involving both the release of Zn^^ from intracellular proteins, and also 
release from synaptic vesicles.
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4.1.2.3 Zinc deficiency and oxidative stress
In contrast to the proposed toxic role for Zn^^ under pathological conditions, Zn^^ may 
also participate indirectly as an antioxidant. Exposure of rainbow trout gill cells to 
either lOOpM Zn^^ or 200pM H2 O2 increased metallothionein A and B, glutathione-S- 
transferase (GST) (detoxifies peroxide) and glucose-6-phosphate dehydrogenase 
(maintains NADPH reducing power) expression. These effects were inhibited in the 
presence of TPEN indicative of Zn^^ dependence.
Preconditioning cells with 24hr Zn^^ exposure prior to H2O2 treatment attenuated 
subsequent caspase 3 activation, DNA fragmentation and cell death, suggesting that 
Zn^^ may upregulate antioxidant protein expression in the absence of toxicity (Chung 
et al., 2005). Indeed, metallothioneins, GST and glucose-6-phoshate dehydrogenase 
all contain MRE in their promoter regions (Chung et al., 2005). Therefore sub-toxic 
Zn^^ treatment, or endogenous Zn^^ release following oxidant exposure may enhance 
transcription of antioxidant genes to prevent oxidative stress (Chung et al., 2005).
The presence of Zn^^ in enzymes and transcription factors involved in the antioxidant 
response suggests that zinc deficiency may also participate in oxidative stress. Z n ^ - 
dependent antioxidant mechanisms include Zn^^-mediated upregulation of 
metallothioneins via MTF-1 (described above and see chapter 1), as a structural 
component of Cu-Zn superoxide dismutase (SOD), and via specific Zn^^ binding to 
susceptible membrane sites thus shielding them against redox active metal binding 
(Oteiza et al., 2004). Unexpectedly, induction of Cu-Zn SOD occurs during Zn^^ 
depletion, but this enzyme assumes a novel peroxidase function which increases 
ONOO activity, oxidative stress and cell death (Oteiza et al., 2000; Ho and Ames, 
2002).
135
depletion is also associated with reduced cell growth and oxidative DNA 
damage, assessed by single-strand breaks, and the activation of the Zn^^-containing 
DNA repair proteins, p53 and apurinic endonuclease (APE). However, DNA binding 
of p53 is attenuated under conditions of zinc deficiency thus impairing DNA repair 
processes (Ho and Ames, 2002). Correspondingly, Zn^^ repletion attenuates DNA 
damage and restores cell growth. Zn^^ depletion could therefore be associated with 
enhanced cellular vulnerability to oxidative agents, enhanced oxidative stress and 
impaired DNA repair (Ho and Ames, 2002; Oteiza et al., 2004).
4.1.2.4 Antioxidants and free radical scavengers
As mentioned earlier, oxidative stress may be limited by the use of antioxidants.
These compounds could act indirectly by altering existing defence mechanisms, for 
example promoting anti-apoptotic factor expression such as Bcl-2 or inhibiting pro- 
apoptotic factor expression such as Bax. Alternatively, they may act directly as free 
radical scavengers. Flavonoids are a group of naturally occurring benzo-y-pyrone 
derivatives with antioxidant and free radical scavenging properties. Treatment of HT- 
22 cells with a fiavone extract prior to oxidative insult improves cell viability, with a 
concomitant increase in levels of phosphorylated Bcl-2 protein and a corresponding 
decrease in Bax protein levels (Choi et al., 2002).
An endogenous antioxidant and energy substrate, pyruvate, can act as an H2O2 
scavenger, causing its detoxification via non-enzymatic oxidative carboxylation 
(Bunton, 1949). In a neuroblastoma cell line model, apoptosis induced by 25pM 
H2O2 was attenuated in a dose-dependent manner by sodium pyruvate (Jagtap et al., 
2003). Similarly, using cultured murine striatal neurons, death induced by 30min
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H2O2 (300pM) exposure was fully prevented by 2mM sodium pyruvate addition. 
However, the protective effects of pyruvate were diminished or even reversed at high 
concentrations (Desagher et al., 1997), attributed to intracellular acidification via H^ 
co-transport by the specific H^-monocarboxylate co-transporter (Poole and Halestrap, 
1993). Other a-ketoacid energy substrate metabolites examined in this model 
including oxaloacetate and a-KG which also react with and scavenge H2O2 were also 
neuroprotective, whereas energy metabolite substrates alone such as lactate were 
ineffective (Desagher et al., 1997).
Other endogenous antioxidants include SOD, catalase, GSH, glutathione peroxidase, 
ascorbic acid (vitamin C), a-tocopherol (vitamin E), ^-carotene and vitamin A (Mates 
et al., 1999). SOD reacts with O2 *’ to yield H2O2 which is then detoxified by either 
catalase in peroxisomes, or glutathione peroxidase in the mitochondria or cytosol 
(Splittgerber and Tappel, 1979; DiGuiseppi and Fridovich, 1984). These antioxidants 
therefore provide a necessary defensive mechanism against cellular oxidative stress.
4.1.2.5 Glutathione
An important endogenous antioxidant is the cysteine-containing tripeptide, GSH. 
GSH is synthesized by the catalysed reaction of cystine or N-acetylcysteine with 
glutamate via y-glutamylcysteine synthetase, followed by glycine addition by GSH 
synthetase (Sagara et al., 1998). GSH negatively regulates y-glutamylcysteine 
synthetase activity (Meister, 1995). The influx of cystine via a cystine-glutamate 
antiport carrier is necessary for GSH production (Froissard et al., 1997).
137
GSH is important to the maintenance of cellular oxidant homeostasis including the 
protein thiol redox state (Meister, 1991) which is essential when considering Zn^^ 
binding to proteins such as metallothionein (Maret, 1995). Indeed, the glutathione 
redox couple is an important regulator of Zn^^-bound metallothionein, whereby GSSG 
induces Zn^^ release from metallothionein and GSH stimulates its uptake (figure 4.3) 
(Maret, 2000).
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Figure 4.3. Glutathione-regulated metallothionein redox balance.
Environmental influences including oxidative stress may perturb the glutathione 
redox cycle to a more oxidised state. Glutathione disidphide (GSSG) then induces 
zinc release from metallothionein, yielding zinc and apothionein (AP) allowing 
targeting o f downstream zinc-dependent processes. Adapted from Maret (1995).
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The reaction of GSH with free radicals leads to the production of GSSG (Meister, 
1995). GSSG is toxic and is therefore extruded from the cell when concentrations are 
excessive, causing GSH depletion (Srivastava and Bentier, 1969; Meister, 1995). In 
the presence of NADPH however, glutathione reductase converts GSSG into GSH 
(Carlberg and Mannervik, 1985). A further enzyme group, glutathione S'-transferases 
(GST), catalyse the reaction of ROS with GSH, allowing detoxification (Pickett and 
Lu, 1989). GSH can also form complexes with Zn^^ by cysteine residues and 
therefore sequester it against toxicity. However, Zn^^ inhibits both glutathione 
reductase and glutathione peroxidase (Mize and Langdon, 1962; Splittgerber and 
Tappel, 1979).
Perturbation of GSH levels may play an important role in the mechanism of both 
Zn^^-induced toxicity and ischaemic injury. Primary cortical astrocytes were thus 
shown to be susceptible to Zn^^-induced toxicity via ROS generation. This was 
attributed to a reduction in intracellular GSH following Zn^^ exposure. However, 
extracellular GSH addition inhibited Zn^^ influx, possibly by Zn^^ chelation, and 
subsequent cell death. Zn^^-induced toxicity was also attenuated by increased 
intracellular GSH (Kim et al., 2003a). Similarly, astrocytes were also found to be 
susceptible to glucose deprivation attributed to GSH depletion, which again was 
attenuated via enhanced intracellular GSH, or addition of the free radical scavengers, 
trolox or 1,3-dimethyl-2-thiourea (DMTU). Endogenous GSH depletion to -20%  by 
buthionine sulphoximine (BSO) was however, insufficient for astrocytic death, 
although the effects mediated by glucose deprivation including lipid peroxidation 
were increased (Papadopoulos et al., 1997). Significantly, GSH depletion preceded 
oxidative stress in this model (Papadopoulos et ah, 1997).
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In a model of Zn^^ cytotoxicity in mixed cortical cultures, exogenous Zn^^ induced a 
time-dependent decrease in intracellular GSH correlating with neuronal death. 
Inducing intracellular GSH depletion with diethylmaleate accordingly enhanced Zn^  ^
toxicity. However, Zn^^ influx, GSH depletion and subsequent death were attenuated 
by Zn^^ chelation with GSH, iV-acetylcysteine or pyruvate. Importantly, neither 
trolox, SOD, catalase, MK-801 nor the iNOS inhibitor, 7V-nitro-L-arginine (L- 
NAME), prevented cell death in this model, suggesting that oxidative stress may not 
be a key factor (Chen and Liao, 2003). However, GSH levels only dropped to 48% of 
control at a maximum, so the oxidative effects observed above may not have been 
relevant at this stage (Chen and Liao, 2003).
4.2 Chapter 4 research aims
Although there is evidence suggesting that Zn^^ may specifically mediate 
mitochondrial inhibition and oxidative stress via various mechanisms, the effects of 
Zn^^ independent of glutamate excitotoxicity have not been thoroughly examined. 
The aims of the present study are to:
1. Investigate the effect of Zn^^ on the mitochondria by examining A\|/m.
2. Subsequently determine whether Zn^^ induces ROS production.
3. Elucidate the effect of Zn^^ on intracellular GSH levels.
4. Determine whether antioxidants protect against Zn^^ cytotoxicity by blocking 
ROS formation.
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4.3 Methods
4.3.1 Reagents 
Cell culture
As detailed in section 2.3.1 Methods.
M itochondrial m em brane po ten tia l assay
Tetramethylrhodamine ethyl ester (TMRE) (3mM stock in 100% DMSO) was 
purchased from Molecular Probes (Leiden, The Netherlands) and carbonyl cyanide m- 
chlorophenylhydrazone (CCCP) (lOOmM stock in DMSO) was obtained from Sigma- 
Aldrich (Dorset, UK). Other reagents were obtained as detailed in section 2.3.1 
Methods.
TMRE/M ito Tracker Green dual staining
MitoTracker Green (MTG) (50pM stock in 100% DMSO) was obtained from 
Molecular Probes (Leiden, The Netherlands) and coverslips were purchased from 
BDH (Dorset, UK). All other reagents were obtained as detailed above or in section
2.3.1 Methods.
Cellular oxidative stress assays
Dihydroethidium (hydroethidine) (31.7mM stock in 100% DMSO), and 
monochlorobimane (MCB) (lOOmM stock in 100% DMSO) were obtained from 
Molecular Probes (Leiden, The Netherlands). NaH2P0 4 .2 H2 0  was bought from 
FISONS (Leicestershire, UK) and H2O2 was purchased from Fisher Scientific UK 
(Leicestershire, UK), lonomycin (2mM stock in 100% DMSO) was obtained from 
Calbiochem (Nottingham, UK). 2’,7’-Dichlorofluorescein diacetate (DCFH-DA)
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(25mM stock in 100% EtOH), rotenone (500|iM stock in 100% DMSO) and L- 
glutamate (IM stock in milliQ water) were bought from Sigma-Aldrich (Dorset, UK). 
Other reagents were purchased as detailed above or as per section 2.3.1 Methods.
Cytotoxicity assays
Trolox (lOOmM stock in 100% ethanol) and -diphenyl-1,4-phenylenediamine
(DPPD) (2mM stock in 100% ethanol) were purchased from Sigma-Aldrich (Dorset, 
UK). All other reagents were obtained as per section 2.3.1 Methods.
4.3.2 Cell culture
As detailed in section 2.3.2 Methods.
4.3.3 Mitochondrial membrane potential assay
HT-22 cells were seeded (5 x 10  ^cell well'^) in DMEM/10% PCS medium in 25cm^ 
tissue culture flasks and allowed 24hr recovery (37°C/5% CO2). Medium was 
replaced with DMEM/2% PCS prior to exposure to cytotoxic treatments (prepared in 
lOmM HEPES) for up to 2hr. Medium was then removed and cells washed once with 
1ml PBS (both the medium and the wash were retained). Cells were trypsinised, the 
resultant samples centrifuged (ISOOrpm, 3min) and the pellet resuspended in 1ml 
buffer (composition mM: NaCl 137; KCl 5; MgS0 4 ' 7 H2 0  1, NaHCOg 3; HEPES 20; 
CaCU 1.8; Glucose 25; Pyruvate.Na 1; pH 7.35). Tetramethylrhodamine ethylester 
(TMRE) is a mitochondrial probe sensitive to mitochondrial membrane potential 
(ATm). When polarised, TMRE accumulates in the mitochondrial matrix and is 
highly fluorescent. However, fluorescence dissipates following mitochondrial matrix
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depolarisation and thus represents a useful tool in the elucidation of A'Fm (Farkas et 
ah, 1989). Cells were incubated at 37°C with lOOnM TMRE (final concentration in 
PBS) for 40min prior to analysis with a Coulter Epics XL flow cytometer (Beckman 
Coulter; Expo32 ADC Cytometry List Mode Data Acquisition and Analysis software; 
excitation 549nm and emission 573nm). Results are expressed as the percentage 
mean (+S.E.M.) of HEPES-treated cell TMRE fluorescence.
4.3.4 TMRE/MitoTracker Green dual staining
Changes in A'Pm and confirmation of selective TMRE mitochondrial loading were 
analysed by confocal microscopy using a dual staining technique with 
tetramethylrhodamine ethyl ester (TMRE) and MitoTracker Green (MTG) 
(McClintock et ah, 2002). MTG is selectively uptaken into mitochondria and is 
reportedly insensitive to polarity changes (Pendergrass et ah, 2004). This technique 
therefore allows simultaneous identification of dye loading localisation and matrix 
polarisation status. HT-22 cells were seeded into 6 well plates (4.5 x 10  ^cell well"^) 
onto 32mm diameter ethanol-sterilised coverslips in DMEM/10% ECS medium and 
allowed 24hr recovery at 37°C (5% C02/95% humidity). Cells were washed once 
with 2ml weir^ buffer (composition mM: NaCl 137; KCl 5; MgS0 4 *7 H2 0  1, NaHCOs 
3; HEPES 20; CaCh 1.8; Glucose 25; Pyruvate.Na 1; pH 7.35) before incubating 
under reduced light levels with 1ml TMRE/MTG dual stain solution (final 
concentrations in buffer; lOOnM TMRE, lOOnM MTG) for 40min at 37°C. Cells 
were washed once with 1ml well'^ buffer before mounting the coverslips in a POC 
chamber. Fluorescence was then examined via a Zeiss 510 META confocal 
microscope with 488nm Argon and 543nm He-Ne laser lines and analysed with Zeiss
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multitracking software (Carl Zeiss Laser Scanning Microscope LSM 510 Version 3.2 
SP2, Carl Zeiss Ltd).
4.3.5 Cellular oxidative stress assays
4.3.5.1 D ichlorofluorescein fluorescence
2’,7’-Dichlorofluorescein diacetate (DCFH-DA) is a cell permeable probe utilised in 
the detection of ROS. Intracellular esterases cleave the diactetate group and 
consequent dye oxidation results in fluorescent dichlorofluorescein (DCF) production 
(Greenlund et ah, 1995; Wang and Joseph, 1999). Cells were seeded at 5 x 10"^  cells 
weir^ in black 96 well microtitre plates (Nunclon, SLS, Nottingham, UK) in 
DMEM/10% FCS for 24hr (37°C, 5% CO2). Medium was then replaced with 135pl 
buffer (composition mM: NaCl 110; KCl 5.4; MgS0 4 ' 7 H2 0  0.8; NaHCOg 3; HEPES 
10; NaH2P0 4 ' 2 H2 0  0.9; CaCL 1.8; Glucose 25; Pyruvate.Na 1; pH 7.4). Cells were 
incubated with 15pl ImM DCFH-DA for 30min, washed once with buffer and then 
exposed to test agents for up to 4hr. Fluorescence was measured using a fluorescence 
plate reader (Spectra Max Gemini XS, Molecular Devices; SOFTmax® PRO v. 4.0; 
excitation 485nm and emission 525nm). Results are presented as the mean (+S.E.M.) 
DCF fluorescence (indicative of ROS production).
4.3.5.2 H ydroethidine fluorescence
Dihydroethidium (hydroethidine) (HEt) is a fluorescent probe particularly sensitive to 
superoxide, being oxidised to fluorescent ethidium, a DNA interchelator. Thus, 
intracellular superoxide levels can therefore be determined by ethidium fluorescence 
(Howard et ah, 2002). Cells were seeded at a density of 5 x 10"^  cells well"  ^ into black
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96 well microtitre plates (Nunclon, SLS, Nottingham, UK) in DMEM/10% FCS 
medium. Following a 24hr recovery, medium was replaced with 135pl buffer 
(composition mM: NaCl 137; KCl 5; MgS0 4 *7 H2 0  1, NaHCOg 3; HEPES 20; CaCl2 
1.8; Glucose 25; Pyruvate.Na 1; pH 7.35). Under reduced lighting conditions, 15pl 
50pM HEt was then added to each well and cells exposed to test agents (prepared in 
buffer) for up to 2hr. When utilising rotenone, a 40min pre-incubation period at 37°C 
was employed. Immediately prior to plate reading, the buffer was aspirated and 
replaced with 150pl 1% v/v Triton X-100 in PBS. Absorbance was then measured on 
a fluorescence plate reader (Spectra Max Gemini XS, Molecular Devices;
SOFTmax® PRO v. 4.0; excitation 485nm, emission 590nm). Data are expressed as 
the percentage mean (+S.E.M.) of untreated cell HEt fluorescence.
4.3.5.3 M onochlorobim ane fluorescence
Monochlorobimane (MCB) is a fluorescent probe, reported to be selective for 
detecting reduced glutathione (GSH) levels (Rice et al., 1986; Sebastia et al., 2003). 
HT-22 cells were seeded (5 x 10  ^cell well'^) into black 96 well micro titre plates 
(Nunclon, SLS, Nottingham, UK) in DMEM/10% FCS and allowed a 24hr recovery. 
Cells were exposed to cytotoxic treatment (prepared in lOmM HEPES) for up to 6hr 
(with 6 replicate wells/treatment), before background fluorescence was measured on a 
fluorescence plate reader (Spectra Max Gemini XS, Molecular Devices; SOFTmax® 
PRO V. 4.0; excitation 355nm, emission 460nm). 5pi of 800pM MCB was added to 
each well under reduced light levels and plates incubated at 37°C for 30min. 
Fluorescence was measured again as per the previous settings. Data represent the 
percentage mean (+S.E.M.) of untreated cell MCB fluorescence.
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4.3.6 Cytotoxicity assays
All compound dilutions were prepared in lOmM HEPES. Cells were pre-incubated 
for Ihr with trolox or DPPD prior to cytotoxic exposure.
4 .3 .6 .1 L D H  release assay  
As detailed in section 2.3.3.2 Methods.
4.3.7 Statistical analyses
A one-way ANOVA, or a two-way ANOVA was performed with either a Fisher’s, 
Dunnett’s or Tukey-Kramer multiple comparisons post test where appropriate 
(GraphPad InStat v.3.05). P<0.05 was considered statistically significant.
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4.4 Results
4.4.1 Effect of on mitochondrial membrane potential (A'Fm)
Past studies have indicated that mitochondria may be a key target for Zn^^-induced 
toxicity and actively participate in the cell death mechanism via ROS production 
(Sensi et ah, 1999; Brown et ah, 2000; Sensi et ah, 2000; Gazaryan et ah, 2002; 
Dineley et ah, 2003). To elucidate whether mitochondria actively participate in Zn^^- 
induced HT-22 cell death, the effects of Zn^^ on A'Pm were examined using the 
mitochondrial specific, membrane potential-sensitive probe, TMRE. HT-22 cells 
were exposed to 200pM ZnS0 4  for up to 2hr prior to incubation with lOOnM TMRE. 
Fig. 4.4y4 and Fig. AAB {i-iii) demonstrate that 30min and Ihr Zn^^ exposures did not 
significantly affect TMRE fluorescence. Following 2hr Zn^^ exposure though, there 
was a significant decrease in TMRE fluorescence (indicative of decreased A'Fm)- Fig. 
AAB (iv) illustrates that the protonophore CCCP (lOpM), a known inducer of AT^ m 
collapse and positive control, induced a decrease in TMRE fluorescence versus 
untreated cells, whereas the CCCP vehicle control, 0.01% DMSO, had no effect.
Dual staining HT-22 cells with TMRE and MitoTracker Green (MTG) (mitochondrial 
probe insensitive to AYm), confirmed selective mitochondrial TMRE loading (Fig. 
4.5).
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Figure 4.4. induces AYm collapse.
HT-22 cells were exposed to either 200pM ZnS04 fo r  up to 2hr (A and B) or lOpM  
CCCP (lOmin) (B) before incubation with lOOnM TMRE for 40min. TMRE 
fluorescence was analysed via flow cytometry as described in Methods. (A) Data 
represent mean (±S.E.M.) o f at least 4 independent experiments. * = P<0.05 
represents difference from HEPES time-matched control (tM^o-way ANOVA followed 
by Fisher’s post hoc test). (B) Data are expressed as representative raw trace results.
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Figure 4.5. Mitochondrial dual staining with TMRE and MitoTracker Green.
HT-22 cells were loaded with lOOnM TMRE/lOOnM MTG dual stain for 40min. 
Images were captured from random fields o f view using confocal microscopy as 
detailed in Methods, and a profile trace through a representative cell was obtained 
using Zeiss multitracking software (Carl Zeiss Ltd). The profile across a cell is 
shown to demonstrate co-localisation o f MTG (green) and TMRE (red).
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4.4.2 exposure does not increase generation of reactive oxygen species 
(ROS)
Several groups have suggested a role for cellular oxidative stress in mediating death 
of various neuronal cell types during Zn^^ exposure (Kim et ah, 1999a; Noh and Koh,
2000). The Zn^^-induced collapse of A'Fm suggests that ROS may also contribute to 
HT-22 cell death. To determine whether Zn^^is capable of generating ROS directly, 
the intracellular ROS-specific fluorescent probe, 2 ’,7’-dichlorofluorescein diacetate 
(DCFH-DA), was utilised. HT-22 cells were pre-incubated with the probe before 
continuous exposure to the cytotoxic treatments for 4hr. Fig. 4.6 illustrates that none 
of the ZnS0 4  concentrations employed induced significant increases in DCF 
fluorescence over 4hr. 500pM H2O2 however, produced a significant increase in DCF 
fluorescence from Ihr.
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Figure 4.6. Exogenous does not induce ROS production.
HT-22 cells were pre-incubated in buffer with Im M  DCFH-DA at 37 °C, 5% CO2 fo r  
SOmin prior to the continuous exposure to lOOpM, 150pM and 200pMZnS04, or 
200pM  or SOOpM H202for 4hr. Increase in DCF fluorescence was determined as 
described in Methods at the indicated time points. Data represent the mean (±S.F.M.) 
o f four independent experiments. ** = P<0.01 signifies difference from HFPFS time- 
matched control by two-way ANOVA and Tukey-Kramer multiple comparisons post 
hoc test.
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4.4.3 exposure fails to enhance superoxide generation
The above observations suggest that Zn^^-induced toxicity does not involve the 
generation of ROS in HT-22 cells. To further determine whether death may be 
induced via the generation of superoxide the fluorescent superoxide-sensitive probe, 
hydroethidine (HEt), was used. 200pM ZnS0 4  did not induce significant increases in 
HEt fluorescence (indicative of superoxide generation) at either SOmin (Fig. 4.7^), 
ihr (Fig. A.IB) or 2hr (Fig. 4.7Q. The inhibitor of superoxide generation, rotenone 
(lOpM), significantly reduced HEt fluorescence at SOmin (Fig. 4.7^), Ihr (Fig. A.IB) 
and 2hr (Fig. 4.7Q. At 2hr (Fig. 4.7C) lOpM ionomycin, a Ca^^ ionophore and 
inducer of superoxide generation, had no effect on HEt fluorescence. At SOmin (Fig. 
4.7^) and Ihr (Fig. A.IB) though, lOpM ionomycin significantly increased HEt 
fluorescence. lOpM carbonyl cyanide m-chlorophenylhydrazone (CCCP), a 
protonophore and another inducer of superoxide generation, was only capable of 
inducing significant HEt fluorescence following Ihr exposure (Fig. A.IB). 0.05% 
DMSO (the vehicle for lOpM rotenone and lOpM ionomycin) alone had no 
significant effect on HEt fluorescence at any time point tested.
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Figure 4.7. Superoxide generation is not influenced by Zn^  ^exposure.
HT-22 cells were incubatedfor 30min (A), Ihr (B) or 2hr (C) with 200pMZnS04 , 
lOpM CCCP, lOpM rotenone (40min pre-incubation) or lOpM ionomycin in the 
presence or absence o f 5 pM  HEt. Increases in HEt fluorescence (indicative o f  
superoxide generation) were determined as detailed in Methods. Data represent the 
mean (±S.E.M.) o f four independent experiments. 100% HEt fluorescence is the level 
o f basal fluorescence obtained in untreated cells. * = P<0.05 and ** P = <0.01 
indicate difference from HEPES control by one-way ANOVA followed by a Dunnett’s 
post hoc test.
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4.4.4 exposure induces glutathione depletion
Previous studies in HT-22 cells have suggested that ROS levels remain minimal until 
the concentration of the endogenous intracellular antioxidant, glutathione (GSH), falls 
below 20% of normal (Tan et ah, 1998b). To determine whether Zn^^ exposure could 
deplete GSH levels, the fluorescent probe monochlorobimane (MCB) was utilised. 
HT-22 cells were incubated with 200pM ZnS0 4  or 5mM L-glutamate over 6hr. A 
significant decrease in MCB fluorescence was seen fi*om Ihr ZnS0 4  exposure (Fig. 
4.8). The positive control, 5mM L-glutamate also showed a significant decrease in 
MCB fluorescence at both 4hr and 6hr. Alone, HEPES (6hr) had no significant effect 
on MCB fluorescence versus untreated cells (data not shown).
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Figure 4.8. exposure reduces glutathione levels.
HT-22 cells were incubated with either 200jliM  ZnS04  or 5mM L-glutamate fo r  up to 
6hr. Following 30min incubation with 40pM MCB, fluorescence was determined as 
per Methods. Data are expressed as a percentage o f untreated cell MCB 
fluorescence. Data represent the mean (± S.E.M.) o f  at least four independent 
experiments. ** = P<0.01 denotes difference from HEPES alone by one-way ANOVA 
followed by a Dunnett’s post hoc test.
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4.4.5 Antioxidants delay Zn^^-induced death
The observed depletion of GSH suggests that cellular oxidative stress may still 
participate in Zn^^-induced HT-22 cell death despite an inability to detect ROS 
production directly. This hypothesis was examined with the use of antioxidants.
Cells were exposed to 200pM ZnS0 4  in the presence or absence of lOOpM trolox (a 
vitamin E analogue; standard effective concentration) or IpM DPPD (a free radical 
scavenger; standard effective concentration) for 6hr or 24hr. Fig. 4.9^ demonstrates 
that at 6hr, the presence of either lOOpM trolox or IpM DPPD significantly 
ameliorated cell death induced by 200pM ZnS0 4 . This effect was however, not 
reproduced at 24hr (Fig. 4.9.5) (confirmed by MTT assay; data not shown) suggesting 
that antioxidants only delay the onset of cell death. 0.1% EtOH alone (vehicle for 
both trolox and DPPD) did not affect LDH efflux at 6hr (Fig. 4.9^) or 24hr (Fig. 
4.95). Additionally, neither trolox (lOOpM) nor DPPD (IpM) alone significantly 
affected LDH efflux at either time point versus HEPES (Fig. 4.9^4 and 5). In the 
presence of 200pM ZnS0 4 , 0.1% EtOH had no effect on LDH efflux (data not 
shown).
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Figure 4.9. Antioxidants prevent Zn^-induced death at 6hr.
HT-22 cells were exposed for 6hr (A) or 24hr (B) to 200pM ZnS04 in the presence or 
absence o f lOOpMtrolox or IpMDPPD (both compounds have Ihrpre-incubation 
periods). Cell death was determined via LDH efflux into the culture medium (refer to 
Methods). Data represent the mean (± S. P.M.) o f  four independent experiments.
** = P<0.01 signifies difference from HEPES control by one-way ANO VA followed  
by a Dunnett’s post hoc test. ## = P<O.OJ signifies difference from 200pM ZnSÛ4 by 
one-way AN OVA followed by a Dunnett’s post hoc test.
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4.5 Discussion
Mitochondrial perturbation and oxidative stress have been associated with the 
pathology of ischaemic injury and excitotoxicity (Hyslop et al., 1995; Carriedo et al., 
1998; Togashi et al., 1998; Atlante et al., 2001). More recently however, both 
mitochondrial damage and ROS generation have also been implicated in Zn^^-induced 
death (Sensi et al., 1999; Noh and Koh, 2000; Sensi et al., 2000; Sensi et al., 2003b). 
This study aimed to examine whether similar mechanisms occurred during Zn^^- 
induced HT-22 cell death.
The mitochondria may present a key target for Zn^^-induced toxicity. Indeed, A\|/m 
collapse and associated ROS production has been demonstrated following Zn^^ 
exposure in cortical neuronal culture (Sensi et al., 1999; Sensi et al., 2000; Sensi et al., 
2003b). Accordingly, mitochondrial Zn^^ uptake has also been associated with mPTP 
opening, MPT, uncoupling of oxidative phosphorylation, matrix swelling and necrotic 
cell death (Remasters et al., 1998; Jiang et al., 2001; Kim et al., 2003b). Furthermore, 
Zn^^ inhibits specific mitochondrial components including the bc\ complex (complex 
III) (Link and von Jagow, 1995), complex IV (Mills et al., 2002) and the lipoamide 
dehydrogenase subunit of the TCA cycle a-ketoglutarate dehydrogenase complex 
(Gazaryan et al., 2002).
Examination of the role of mitochondria during Zn^^-induced HT-22 cell toxicity 
revealed a significant reduction of A\|/m following 2hr Zn^^ exposure. Av)/m was 
assessed by the mitochondrial-specific and membrane potential-sensitive fluorophore, 
TMRE. Appropriate mitochondrial probe localisation was confirmed by MTG/TMRE 
dual labelling. The positive control, CCCP, collapsed Av|/m by dissipation of the H^ 
gradient as detailed below. Although the specific site of inhibition in this paradigm
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requires elucidation, Zn^^ induced mitochondrial perturbation as indicated by A\|/m 
collapse in accordance with other models (Sensi et ah, 1999; Sensi et al., 2000; Sensi 
et al., 2003b).
To elucidate the potential involvement of cellular oxidative stress in mediating death 
as a result of mitochondrial dysfunction, the effects of Zn^^ exposure on direct ROS 
production were examined using the fluorescent probe, DCFH-DA. Unexpectedly, 
there was an inability to detect a significant increase in ROS following 4hr exposure 
to lOOpM, 150pM or 200pM Zn^^ insults. H2O2 was utilised as a positive control due 
to its action as a ROS directly and as a significant precursor of other ROS (Hyslop et 
al., 1995). H2O2 exposure significantly enhanced ROS levels by Ihr substantiating 
use of the DCF fluorescence assay for ROS detection.
In accordance with an absence of detectable ROS production, this study also 
established a lack of significant O2 *' generation following Zn^^ exposure for up to 2hr. 
Rotenone however, consistently depleted O2 *' generation over 2hr. Rotenone inhibits 
electron transfer from complex I to ubiquinone, thus disrupting the electron transport 
chain and blocking O2 consumption, therefore attenuating subsequent mitochondrial 
O2*' generation during the reduction of O2 at complex IV (Bates et al., 1994; Papa and 
Skulachev, 1997). Following Ihr exposure, the positive controls, ionomycin and 
CCCP, significantly enhanced O2 *’ production. Ionomycin also induced significant 
O2 *' production following 30min exposure. Ionomycin, a Ca^^ ionophore, increases 
mitochondrial matrix Ca^^ concentration, inducing A\{/m collapse and uncoupling the 
electron transport chain (Carriedo et al., 1998). The protonophore, CCCP, accepts H^ 
from the electron transport chain therefore dissipating the H^ gradient and uncoupling 
oxidative phosphorylation (Wallace and Starkov, 2000). In both instances, the
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electron transport chain is driven to re-establish A\|/m or the gradient respectively, 
thus enhancing O2 *' production at complex IV (Carriedo et ah, 1998; Wallace and 
Starkov, 2000). All of the control compounds induced the appropriate fluorescence 
changes suggesting that the system utilised was sensitive to O2" detection, further 
substantiating the inability of Zn^^ exposure to promote O2 " generation.
An alternative indicator for cellular oxidative stress may be intracellular depletion of 
the endogenous antioxidant GSH. Death mediated via GSH depletion has most 
frequently been examined during oxidative glutamate toxicity (Davis and Maher, 
1994). In this model, enhanced extracellular glutamate concentrations attenuate 
cystine uptake, thus reducing GSH production and permitting significant ROS 
generation (Froissard et ah, 1997; Tan et ah, 1998b; Tan et ah, 1998a; Ishige et ah,
2001). GSH depletion associated with ROS production and subsequent death is 
demonstrated in models of glucose deprivation in astrocytes (Papadopoulos et ah, 
1997), oxidative glutamate toxicity (Froissard et ah, 1997; Tan et ah, 1998b; Ishige et 
ah, 2001) and Zn^^-induced neuronal and astrocytic death (Chen and Liao, 2003; Kim 
et ah, 2003a).
During Zn^^-induced HT-22 cell death, significant GSH depletion was achieved from 
Ihr. The positive control, L-glutamate, also significantly reduced GSH when assessed 
at 4hr. This implies that GSH depletion may contribute to Zn^^ cytotoxicity.
However, the data obtained above suggest that no significant ROS generation occurs 
during this period, although the contribution of other ROS including NO, OH* and 
ONOO cannot be excluded. The demonstration that -80% GSH depletion induces 
only a 5-10 fold increase in ROS in a model of oxidative glutamate toxicity in HT-22 
cells may account for these findings (Tan et ah, 1998b). Accordingly, Tan et al
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(1998b) established that GSH depletion below 20% of the cellular content, possibly 
corresponding to the mitochondrial GSH pool (Meister, 1991; Sagara et al., 1998), 
induced an explosive 200-400 fold increase in ROS (Tan et al., 1998b). Accordingly, 
GSH levels fell to -28% following 6hr Zn^^ exposure in HT-22 cells which was 
probably insufficient to affect the mitochondrial GSH pool. This may then account 
for the lack of enhanced ROS or O2* detection during this period.
The fact that Zn^^ induced significant GSH depletion suggests that cellular oxidative 
stress may still occur. Indeed, GSH depletion preceding ROS production has been 
demonstrated in an astrocytic model of glucose deprivation (Papadopoulos et al.,
1997). Therefore, the ability of the antioxidant, trolox, and the free radical scavenger, 
DPPD, to attenuate Zn^^-induced death in HT-22 cells was examined. At 6hr, both 
compounds significantly limited death following Zn^^ insults, suggesting a role for 
oxidative stress in mediating Zn^^-induced death. Accordingly, Kim et al (1999a; 
1999b) established that trolox protected against neuronal death in mixed cortical 
cultures following 24hr Zn^^ exposure. Similarly, Matsunaga et al (2005) 
demonstrated inhibition of Zn^^-mediated ROS production and subsequent death in a 
pig kidney cell line following DPPD treatment. Intriguingly however, neither 
compound afforded significant protection following 24hr Zn^^ exposure in HT-22 
cells. This suggests that either oxidative stress may be an early event in the cell death 
pathway with other mechanisms predominating downstream, or simply that 
antioxidants mediate a delay in Zn^^-induced cell death.
These data contradict those obtained above, since the proposed mechanism of 
antioxidant action is through their ability to scavenge and neutralise ROS. The 
absence of detectable ROS generation following 4hr Zn^^ exposure suggests that
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trolox and DPPD may afford protection at 6hr by some other means that requires 
elucidation. It is also feasible that ROS production occurred during a narrow 
timeframe (i.e. 4-6hr) not captured in this study, which allowed for trolox- and DPPD- 
mediated protection.
Zn^^-induced GSH depletion may however provide an alternative explanation for the 
data observed above. GSH participates as an antioxidant both as a free radical 
scavenger (Meister, 1991, 1995) and a regulator of protein thiol redox state via the 
glutathione redox couple (GSH/GSSG) (Meister, 1991). Perturbation of cellular GSH 
may therefore have important downstream consequences including disruption to 
metallothioneins (Maret, 2000). Consequently, GSH depletion may reduce both 
cellular ROS and Zn^^ buffering capability. Physiological levels of ROS or O2 *’ 
production, sensitive to antioxidant treatment, may therefore mediate mitochondrial 
damage and HT-22 cell death through impaired ROS and Zn^^ buffering (Meister, 
1991).
Correspondingly, using human Jurkat T-lymphocytes treated with anti-Fas-APO 
antibody, van den Dobblesteen et al (1996) demonstrated intracellular GSH depletion 
in the absence of detectable ROS production. It was proposed that significant GSH 
depletion was capable of lowering the cellular reducing capacity to enable oxidative 
stress in the absence of ROS increases (van den Dobbelsteen et al., 1996). By 24hr 
however, GSH depletion in HT-22 cells below 20% (threshold for perturbation of the 
mitochondrial pool) may have occurred, accompanied by massive ROS production 
and a potential inability of the antioxidants to inhibit Zn^^-induced death. This would 
therefore favour the model that Zn^^ exposure induces intracellular GSH depletion 
with subsequent ROS production and cell death. It is equally possible however, that
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GSH levels do not decline further and that ROS generation was not relevant to Zn^^- 
induced death in this system. Chen and Liao (2003) similarly demonstrated a failure 
of the antioxidants trolox, SOD or catalase to attenuate neuronal death in mixed 
cortical cultures during 16hr Zn^^ exposure, despite a decrease in GSH to 48% of 
control by 5hr.
Although some groups support a role of ROS production in Zn^^-induced neuronal 
death (Kim et al., 1999b; Noh et al., 1999; Sensi et al., 2000), there is some evidence 
suggesting that oxidative stress may not be a key mechanism. For example, Sheline et 
al (2000) found that an inhibitor of H2O2 induced death, a-keto-butyrate, did not 
attenuate Zn^^-induced cortical neuronal death. In a similar chronic Zn^^ exposure 
model, Sheline et al (2003) found that neither the ROS scavenger, C3 
buckminsterfullerene, nor trolox were capable of preventing Zn^^-induced toxicity, 
and there was no detectable increase in ROS production. Therefore, there may be a 
mechanism involved in Zn^^-induced HT-22 death which is independent of cellular 
oxidative stress.
In summary, it appears that Zn^^ exposure induces mitochondrial perturbation and 
cellular oxidative stress in HT-22 cells. The contribution of A\|/m specifically to Zn^^- 
induced death however, requires further attention. This could be achieved by dual 
staining neurons with TMRE and the mitochondrial-selective Zn^^ fluorophore, 
RhodZin-3 (Sensi et al., 2003a), to monitor A\}/m in relation to mitochondrial Zn^^ 
accumulation. Inhibitors of mitochondrial Zn^^ influx and accumulation, for example 
Ru360 (Matlib et al., 1998), or TPEN (Cuajungco and Lees, 1996) could then be 
examined for their ability to preserve A\|/m. The role of MPT in Zn^^-induced death
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could also be examined with the use of mPTP inhibitors such as cyclosporin A (Qian 
et al., 1997). The potential involvement of other ROS including NO, OH* and 
ONOO in Zn^^ cytotoxicity could also be investigated further with the use of a NOS 
inhibitor such as L-Nitro-Arginine, although the lack of significant O2* detection 
suggests that these species are unlikely to be necessary for Zn^^-induced death. 
However, the ability of trolox and DPPD to delay cell death requires further 
investigation.
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CHAPTER 5 
ZINC-INDUCED ENERGY DYSFUNCTION
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5. 1 Energy dysfunction
As mentioned in chapter 4, Zn^^-induced mitochondrial dysfunction may be important 
to the HT-22 cell death mechanism, although the specific site of inhibition was not 
identified. It is possible that via mitochondrial perturbation, Zn^^ may therefore 
disrupt energy production. Indeed, Zn^-induced inhibition of the electron transport 
chain bc\ complex and complex IV, and the TCA cycle (KGDHC) has already been 
described (section 4.1.1.4). However, Zn^ ^  induced inhibition of the glycolytic 
enzymes, GAPDH (Krotkiewska and Banas, 1992; Maret et al., 1999), fructose 1,6- 
diphosphatase (Maret et al., 1999) and phosphofructokinase (Ikeda et al., 1980) has 
also been demonstrated (figure 5.1). This suggests that Zn^^ may mediate energy 
dysfunction during the cell death mechanism.
Glucokinase" G lucose-G fhosphate
Phosphoglucose 
isomerase
Fructose-6-phosphate
Phosphofructokinase-1
Fructose-1,6-bis phosphate
Dihydroxyacetone-^
phosphate
Aldolase
Triose phosphate 
isomerase
► Glyceraldehyde-3-phosphate
Glyceraldehyde-3-phosphate 
dehydrogenase 
1,3-Bisphosphoglycerate
Phosphoglycerate kinase
3-Phosphoglycerate
Phosphoglycerate mutase 
2-Phosphoglycerate 
Enolase
Phosphoenolpyruvate
Pyruvate kinase
Lactates
Lactate 
dehydrogenase
Ma I ate
► Pyruvate^
Malic enzyme dehydrogenase 
Ma late <----------------► Oxaioacetate
Figure 5.1. Schematic representation of the glycolytic pathway.
Taken from Salway (2000).
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5.1.1 Pyruvate
Pyruvate is an intermediate of glucose energy metabolism and the end metabolite of 
glycolysis (figure 5.1), and is therefore an essential mitochondrial fuel (Yoo et al., 
2004). Prior to TCA cycle entry, pyruvate dehydrogenase mediates pyruvate 
carboxylation in the mitochondrial matrix, generating a supply of mitochondrial 
reducing equivalents for ATP synthesis (Yoo et al., 2004). During cerebral ischaemia 
and reperfusion, reduced pyruvate dehydrogenase activity may participate in lactic 
acidosis and cell death under conditions of high energy demand (Bogaert et al., 1994).
As described previously (section 4.1.2.4), pyruvate may also function as a cellular 
antioxidant (ODonnell-Tormey et al., 1987). Pyruvate addition follov^ing ischaemic 
insult maintains the redox status of ischaemic cells through conversion of pyruvate to 
lactate yielding NAD^ (Mongan et al., 2002; Sharma et al., 2003). This is important 
to maintain the redox ratio of GSH/GSSG as described in section 4.1.2.5 (Mongan et 
al., 2002; Sharma et al., 2003). During ischaemia, the lactate/pyruvate ratio increases, 
decreasing the downstream NAD^/NADH ratio through NADH accumulation 
(Sharma et al., 2003). This may induce an indirect block of GAPDH accompanied by 
an increase in upstream glycolytic intermediates, FBP, DHAP and glyceraldehyde-3 - 
phosphate (see section 5.1.3) (Tilton et al., 1991). Importantly, the lactate/pyruvate 
ratio dictates whether glycolysis proceeds normally, not the absolute concentration of 
these compounds (Tilton et al., 1991).
Pyruvate may also act as a free radical scavenger (Salahudeen et al., 1991; Desagher 
et al., 1997), as is proposed in the mechanism of protection against H202-induced 
apoptosis in a neuroblastoma cell line (Jagtap et al., 2003). However, this group 
failed to demonstrate direct reduction of ROS or oxidative damage following pyruvate
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addition. Nevertheless, the role of pyruvate directly and indirectly as an antioxidant 
may be important in the protection against post-ischaemic oxidative stress (Sharma et 
al., 2003).
5.1.1.1 Pyruvate and mitochondrial permeability transition (MPT)
As mentioned in section 4.1, MPT may play an important role in the cell death 
mechanism following ischaemic insult and Zn^^ exposure. By inhibiting MPT, 
pyruvate may therefore be an important protective agent through the attenuation of 
mitochondrial dysfunction.
Halestrap (1998) provides a summary of the mechanisms of MPT induction following 
ischaemia-reperfusion. In brief, during ischaemia glycolysis is driven in cells to 
maintain ATP levels, resulting in lactate accumulation and a subsequent decrease in 
intracellular pH. Induction of the NaVH^ antiporter to counter this increase leads to 
intracellular Na^ accumulation since ATP levels are insufficient to drive Na^ 
extrusion via the Na^/K^ ATPase. Na^ accumulation attenuates or even reverses the 
activity of the Na^/Ca^^ antiporter, allowing intracellular Ca^  ^accumulation. 
Reperfusion subsequently permits rapid O2 influx, which promotes mitochondrial 
ROS production as cells attempt to restore energy levels. Reperfusion also allows 
rapid mitochondrial Ca^^ accumulation. Enhanced ROS and mitochondrial Ca^^ are 
conditions that favour MPT. Furthermore, the low intracellular pH during ischaemia 
mediates an inhibitory block of MPT, which is removed following normalisation of 
pH following reperfusion (Halestrap et al., 1998).
Several characteristics of pyruvate allow it to attenuate MPT. Firstly, it is a good 
metabolic substrate and therefore preserves cellular ATP levels during ischaemia
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(Halestrap et al., 1998). Secondly, pyruvate maintains a low intracellular pH as a 
result of cellular entry accompanied by a proton via the H(+)-monocarboxylate 
transporter, and also via competition with lactate for transport via the H(+)- 
monocarboxylate transporter (Poole and Halestrap, 1993). Finally, the participation 
of pyruvate as a free radical scavenger not only detoxifies H2O2 (Desagher et al.,
1997), but also maintains the NAD^/NADH ratio required to attenuate protein thiol 
oxidation and maintain the GSH/GSSG ratio, thus avoiding MPT opening via ROS 
production (Halestrap et al., 1998; Mongan et al., 2002; Sharma et al., 2003).
Kerr et al (1999) demonstrated that perfusion of rat hearts with lOmM pyruvate 
during a model of ischaemia/reperfusion attenuated MPT. Furthermore, addition of 
pyruvate during the reperfusion period induced mPTP closure. This was attributed to 
lactate accumulation and attenuation of MPT as a result of intracellular pH decrease 
(Kerr et al., 1999). The addition of pyruvate (5mM) to astrocytes was equally 
protective against oxidative stress induced by exogenous H2O2 in the presence of 
copper. However, the inhibitor of mitochondrial pyruvate uptake, a-cyano-4- 
hydroxycinnamate (0.5mM) did not affect pyruvate-mediated protection suggesting 
that pyruvate acts at either an extracellular or a cytoplasmic site (Gyulkhandanyan et 
al., 2003).
5.1.1.2 Pyruvate and ischaemia
Evidence exists supporting a role for pyruvate as a protective agent following 
ischaemic insult. Pyruvate treatment has no known serious side effects, which is 
essential when considering its use as a potential therapeutic agent (Yoo et al., 2004). 
Pyruvate has been shown to afford neuronal protection following transient ischaemia
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and associated energy metabolism dysfunction. Using a rat brain in vivo model, 
intraperitoneal sodium pyruvate injection up to Ihr post-reperfiision provided almost 
complete protection to hippocampal and cortical neurons, and reduced overall rat 
mortality. Rat survival was sustained for more than 30 days after insult (Lee et al.,
2001). Significantly, pyruvate was incapable of ameliorating against cortical neuronal 
death when exposed to Ca^^ toxicity following ionomycin or glutamate addition. This 
implies that the protection afforded during transient ischaemia is specific to Zn^^- 
induced toxicity (Lee et al., 2001).
In astrocytic cultures subject to oxygen-glucose deprivation, addition of post- 
ischaemic pyruvate, but not glucose, attenuated glial death and preserved cellular 
morphological integrity. In addition, pyruvate attenuated apoptotic mechanisms 
including cytochrome c release, caspase 3 activation and PARP cleavage (Mongan et 
al., 2002; Sharma et al., 2003). Furthermore, pyruvate enhanced pyruvate 
dehydrogenase activity, possibly via inhibition of pyruvate dehydrogenase kinase or 
by enhanced pyruvate dehydrogenase phosphatase activity following increased 
mitochondrial Ca^^ storage. Regardless of the mechanism, cellular ATP levels are 
maintained following pyruvate addition through the supply of reducing equivalents 
(Sharma et al., 2003). The lack of protection with glucose suggests that glycolysis 
may have been impaired upstream of pyruvate production following oxygen-glucose 
deprivation, as detailed below (section 5.1.3) (Sharma et al., 2003).
In an alternative model of pressure-induced retinal ischaemia, pyruvate also afforded 
significant in vivo protection against neuronal death. In this paradigm, synaptic Zn^^ 
released from the neural retina accumulated in neurons displaying damage, a process 
attenuated by pyruvate (Yoo et al., 2004). Exogenous Zn^^ application (300-500pM)
171
in retinal cell culture induced the activation of the DNA repair enzyme, PARP (see 
below), NAD^ and ATP depletion, and necrotic cell death. This was prevented by the 
application of pyruvate or the PARP inhibitor niacinamide, but not lactate (Yoo et al., 
2004).
5.1.2 Poly(ADP-ribose) polymerase (PARP)
PARP is a zinc finger containing enzyme which binds DNA via two zinc finger motifs 
(Satoh and Lindahl, 1992). PARP is activated by broken DNA strands induced by 
compounds including O2 *’, NO and ONOO (chapter 4) (de Murcia and Menissier de 
Murcia, 1994; Zhang et al., 1994), and by acute toxic Zn^^ exposure (Kim and Koh, 
2002; Sheline et al., 2003). PARP activation cleaves NAD^ yielding nicotinamide 
and ADP ribose. Poly(ADP ribose) units are then catalytically transferred to target 
nuclear acceptor proteins including histones and PARP itself (de Murcia and 
Menissier de Murcia, 1994; de Murcia et al., 1994), implicating a role in DNA repair 
(Satoh and Lindahl, 1992). However, poly(ADP-ribosyl)ation is only transient, 
because PARG degrades the poly(ADP-ribose) units (Desnoyers et al., 1995). 
Sustained PARP/PARG activation through excessive DNA damage therefore depletes 
both cellular NAD^ and ATP levels, which may induce necrosis (Szabo and Dawson,
1998).
In an in vivo model of hypoglycaemia, Zn^^ depletion fi-om mossy fibres and 
accumulation in CAl pyramidal neurons occurred concomitant with poly(ADP- 
ribose) formation, an effect inhibited in the presence of Ca#EDTA (Suh et al., 2004). 
Furthermore, following transient focal ischaemia PARP upregulation was
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demonstrated, attributed to O2*’ and possibly ONOO'-mediated DNA damage 
(Narasimhan et al., 2003).
PARP is a likely candidate enzyme involved in the cell death mechanism following 
acute toxic Zn^^ insults. Indeed, acute cytotoxic Zn^^ exposure (350pM, 15min) in 
mixed cortical cell cultures induced significant ROS production and DNA nicking. 
Furthermore, poly(ADP-ribosyl)ation occurred concomitant with NAD^ and ATP 
depletion, and was attenuated by pyruvate and the PARP inhibitors, niacinamide, 
benzamide and 3-aminobenzamide. However, the effects of pyruvate and 
niacinamide were apparently independent of the level of poly(ADP-ribosyl)ation 
(Sheline et al., 2003). Moreover, poly(ADP-ribosyl)ation predominated in glial cells 
of the mixed cortical cultures. Death was also attenuated following acute Zn^^ 
toxicity in PARP-1 knockout mice, although the neuroprotective effects of pyruvate 
and niacinamide observed in the cell culture model were more pronounced (Sheline et 
al., 2003). This implies that pyruvate and niacinamide afford protection by some 
additional means to PARP inhibition. Indeed, as described above, pyruvate may also 
participate as a free radical scavenger (Salahudeen et al., 1991; Desagher et al., 1997). 
Furthermore, niacinamide also has additional functions as an inhibitor of iNOS and a 
free radical scavenger (Szabo and Dawson, 1998).
PARG inhibition may also prevent Zn^^-induced toxicity. For example, NAD^ and 
ATP depletion and cell death were attenuated in neuronal culture by PARG inhibition 
in the absence of reduced poly(ADP-ribosyl)ation. This suggests that it may be the 
attenuation poly(ADP-ribose) turnover rather than prevention of poly(ADP- 
ribosyl)ation which is protective against cell death (Ying et al., 2001; Kim and Koh, 
2002).
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It is possible that PARP activation mediated the Zn^^-induced death associated with 
acute ROS production as observed in chapter 4 (Kim et al., 1999a; Kim et al., 1999b; 
Sensi et al., 1999). Indeed, the PARP inhibitors, inosine, and DPQ (3,4-dihydro-5-[4- 
(l-piperidinyl)butoxy]-l(2H)-isoquinolinone) protected against Zn^^-induced injury in 
PC12 cells and mixed cortical cultures respectively (Kim and Koh, 2002; Shi et al.,
2002), and the PARP inhibitors niacinamide and 3-aminobenzamide were protective 
against neuronal ischaemia (Szabo and Dawson, 1998). Moreover, PARP inhibition 
may inhibit iNOS activity to prevent ROS-mediated death (Virag and Szabo, 2001).
Death associated with PARP activation is most likely to be necrotic due to its 
association with ATP depletion. In an in vivo model of transient focal ischaemia, 
PARP induction was largely absent in cells positive for apoptotic markers, although it 
was abundant in necrotic cells (Narasimhan et al., 2003). Indeed, when exposed to 
necrotic stimuli, fibroblasts from PARP knockout mice maintained ATP levels and 
were protected against necrosis, whereas they remained sensitive to apoptotic stimuli 
(Ha and Snyder, 1999). Importantly, as mentioned in chapter 3, PARP cleavage 
occurs during apoptosis to preserve ATP levels and prevent uncontrolled necrotic 
demise (Ha and Snyder, 1999), further substantiating the participation of PARP 
activation during necrotic death.
It is unlikely however, that PARP activation plays a prominent role in death during 
chronic Zn^^ treatment. Accordingly, in a chronic exposure paradigm (40pM Zn^^, 1- 
4hr), ROS production, DNA nicking and poly(ADP-ribosyl)ation did not occur and 
PARP-1 knockout mice maintained sensitivity to Zn^^-induced death, although the 
protective agents pyruvate, niacinamide, benzamide and 3-aminobenzamide were still 
effective against NAD^ and ATP depletion (Sheline et al., 2000; Sheline et al., 2003).
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This suggests that another NAD^ catabolising enzyme which does not require DNA 
nicking or ROS production for activation may be relevant to the chronic exposure 
model (Sheline et al., 2003).
In an alternative model of oxidative stress in rat hepatocytes, menadione treatment 
induced a decrease in NAD^ that was not attenuated by either niacinamide or 3- 
aminobenzamide treatment (Stubberfield and Cohen, 1988). It was subsequently 
shown that NAD^ depletion was accompanied by an increase in NADP^ and an 
increase in the total NADP^ and NADPH concentration, which was then followed by 
ATP depletion and cell death. It was proposed that NAD^ kinase mediated the 
generation of NADP^, allowing the increase in NADPH. The rapid increase in 
NADPH in response to the oxidant compound is required for GSSG reduction and 
therefore GSH repletion as a defence against oxidative stress (Stubberfield and 
Cohen, 1989). It is therefore possible that NAD^ kinase may participate in the 
chronic Zn^^ exposure paradigm via NAD^- and subsequently ATP depletion.
5.1.3 Zn^^-induced glycolytic inhibition
As mentioned in section 5.1, Zn^^ may participate in glycolytic inhibition via its 
effects on the glycolytic enzymes GAPDH (Krotkiewska and Banas, 1992; Maret et 
al., 1999), fructose 1,6-diphosphatase (Maret et al., 1999) and phosphofructokinase 
(Ikeda et al., 1980) (figure 5.1). This may be important to the Zn^^ toxic mechanism 
via reduced energy metabolism, in particular the inhibition of glycolysis. This 
hypothesis was examined by Sheline et al (2000) using murine cultured cortical 
neurons. 4hr Zn^^ (40pM) exposure induced an increase in the concentration of the 
glycolytic intermediates, dihydroxyacetone phosphate (DHAP) and fructose 1,6-
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bisphosphate (FBP), with a decrease in glyceraldehyde-3-phosphate and ATP levels. 
Extending the exposure to 24hr induced extensive neurodegeneration (Sheline et al., 
2000).
Zn^^ depleted intracellular NAD^ from 4hr but without a concomitant increase in 
NADH, possibly causing the indirect inhibition of GAPDH. Pyruvate (4mM) 
addition during Zn^^ treatment prevented NAD^ and ATP depletion, and inhibited cell 
death. DHAP and FBP levels were also normalised, substantiating the role of indirect 
GAPDH inhibition. Pyruvate addition also enhanced lactate levels, an effect resulting 
from the likely conversion to lactate by lactate dehydrogenase and accompanied 
NAD^ production from NADH (Sheline et al., 2000). Following conversion to acetyl 
co-enzyme A, pyruvate could also restore ATP levels via direct entry into the TCA 
cycle (Massieu et al., 2001). Significantly, Chen and Liao (2003) demonstrated that 
pyruvate, but not lactate, ameliorated neuronal viability in a Zn^^ toxicity paradigm 
through Zn^^ chelation. This was associated with reduced Zn^^ influx and subsequent 
inhibition of GSH depletion (Chen and Liao, 2003).
Sheline et al (2000) additionally determined that inhibition of NAD^ depletion via the 
co-addition of the competitive NAD^ catabolising enzyme inhibitors, benzamide, 3- 
aminobenzamide or niacinamide, or the alternative energy substrate, oxaioacetate, 
during toxic Zn^^ exposure also ameliorated cell viability. The absence of NADH 
increase during NAD^ depletion implied that NAD^ loss may result from the actions 
of NAD^ catabolising enzymes, hence inhibitors afforded protection (Sheline et al.,
2000). Indeed niacinamide and 3-aminobenzamide also reduced NAD^ depletion and 
cell death of mixed cortical cultures following acute Zn^^ exposure (Kim and Koh,
2002). In a model of apoptotic death following oxidative Zn^^ mobilisation.
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niacinamide, benzamide and PARP inhibitors also afforded significant 
neuroprotection, attributed to attenuation of energetic dysfunction (McLaughlin et al.,
2001). Figure 5.2 illustrates the proposed mechanism of Zn^^-induced glycolytic 
inhibition.
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Figure 5.2. Proposed mechanism of Zn^-induced death via NAD^ depletion.
Z«“ may reduce energy metabolism via the activation o f an unknown NAD^ 
catabolizing enzyme (potentially PARP, or NAD kinase) (A). Niacinamide, 
benzamide and 3-aminobenzamide may inhibit the unknown enzyme, allowing 
subsequent recovery o f  NAD levels. Through conversion to lactate, pyruvate may 
also restore NAD levels (B). Abbreviations: FBP, fructose 1,6-bisphosphate; 
DHAP, dihydroxyacetone phosphate ; G-3-P, glyceraldehyde-3-phosphate; 1,3-BPG, 
1,3-bisphosphoglycerate (Adapted from Sheline et al (2000)).
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Niacinamide can function as an NAD^ precursor, an inhibitor of iNOS, a free radical 
scavenger and an inhibitor of NAD^-catabolising enzymes (Szabo and Dawson,
1998). This suggests that it may attenuate death through actions as an antioxidant and 
an inhibitor of energetic dysfunction. Furthermore, both benzamide and 3- 
aminobenzamide have also been shown to have antioxidant abilities in addition to 
their action as NAD^-catabolising enzyme inhibitors (Czapski et ah, 2004). 
Oxaioacetate on the other hand, may inhibit Zn^^-induced toxicity through its 
conversion to pyruvate (Salway, 2000), although it may also participate as a free 
radical scavenger (Desagher et ah, 1997). This supports the findings of Desagher et al 
(1997) (chapter 4), demonstrating that oxaioacetate offered significant neuronal 
protection following H2O2 insult (Desagher et ah, 1997).
In a glial cell paradigm, CAl astrocytes demonstrated relative insensitivity to 
enhanced extracellular Zn^^ concentrations compared to their neuronal counterparts, 
accumulating higher [Zn^^ji prior to apoptotic death. Similar to neuronal cells 
however, the addition of either pyruvate, niacinamide or benzamide significantly 
attenuated astrocytic death (Sheline et ah, 2000; Sheline et ah, 2004). This suggests 
that during Zn^^-induced death, energy dysfunction may occur in accordance with 
ROS production, since the protective agents pyruvate, niacinamide or benzamide, can 
attenuate both of these effects.
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5.2 Chapter 5 research aims
The participation of energy inhibition in the Zn^^ cytotoxic mechanism is a relatively 
recent hypothesis. Indeed, it appears that separate toxic pathways exist between the 
acute and chronic Zn^^ exposure paradigms. Although the precise sites of Zn^^- 
mediated energy inhibition require further elucidation, pyruvate appears to be a 
significant protective agent against a variety of cytotoxic insults, including ischaemia 
and Zn^^-induced death.
The aims of the present study are to:
1. Determine the effects of NAD^ catabolising enzyme inhibitors on Zn^^ 
cytotoxicity.
2. Examine the effects of pyruvate, oxaioacetate and lactate on Zn^^-induced 
death,
3. Establish whether pyruvate or oxaioacetate chelate Zn^^ extracellularly.
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5.3 Methods
5.3.1 Reagents 
Cell culture
As detailed in section 2.3.1 Methods.
Cytotoxicity assays
Pyruvate.Na (IM  stock in milliQ water) was purchased from BDH (Dorset, UK), and 
Na2S0 4  was obtained from May & Baker (Essex, UK). Oxaioacetate (IM  stock in 
IM NaOH), niacinamide (lOOmM stock in milliQ water) and benzamide (IM  stock in 
100% EtOH) were purchased from Sigma-Aldrich (Dorset, UK). All other reagents 
were obtained as detailed in section 2.3.1 Methods.
H T-22 cell m orphology
Reagents were obtained as detailed above or in section 2.3.1 Methods.
Zinc chelation assay
All reagents were purchased as above or as detailed in section 2.3.1 Methods.
5.3.2 Cell culture
As detailed in section 2.3.2 Methods.
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5.3.3 Cytotoxicity assays
5 .33 .1  M T T  reduction assay  
As detailed in section 2.3.3.1 Methods.
5.3.4 HT-22 cell morphology
HT-22 cells (5 x 10"^  cells ml'^) were seeded into 6 well plates in DMEM/10% PCS 
medium and incubated overnight (37°C/ 5% C O f 95% humidified atmosphere). 
Medium was replaced with DMEM/2% PCS medium and cells exposed to the 
cytotoxic treatments (prepared in lOmM HEPES) for up to 24hr. Using a phase 
contrast light microscope (Nikon TMS, Nikon) on a x 10 objective, images of the 
cells were captured directly with a Nikon COOLPIX 990 3.2 megapixel digital 
camera (Nikon).
5.3.5 Zinc chelation assay 
As detailed in section 2.3.4.2 Methods.
5.3.6 Statistical analyses
A one-way ANOVA was performed with a Dunnett’s post test where appropriate 
(GraphPad InStat v.3.05). P<0.05 was considered statistically significant.
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5.4 Results
5.4.1 Pyruvate limits Zn^^-induced toxicity
Certain groups have found that the addition of alternative energy sources (Desagher et 
ah, 1997; Sheline et ah, 2000) or inhibitors of NAD^ catabolism (Sheline et ah, 2000) 
during Zn^^ exposure can attenuate the death of various neurons. To establish 
whether similar treatment may have a protective effect in HT-22 cells, cells were 
exposed to 200|xM ZnS0 4  for 6hr or 24hr in the presence or absence of pyruvate (Fig. 
5.3^ and B respectively), or the NAD^ catabolising enzyme inhibitors, benzamide and 
niacinamide (24hr only) (Fig. 5.35). Fig. 5.3^ demonstrates that lOmM pyruvate 
almost completely reversed the Zn^^-induced cytotoxicity at 6hr, whereas 5mM 
pyruvate failed to produce any significant effect. Fig. 5.35 illustrates that during 24hr 
exposure, neither benzamide nor niacinamide (3mM; standard effective concentration) 
offered significant neuroprotection versus 200pM Zn^^ insults. However, significant 
neuroprotection was afforded by both 5mM and lOmM pyruvate. None of the 
compounds examined in the absence of Zn^^ affected MTT reduction (Fig. 5.3^4 and 
5). Additionally, 0.3% EtOH alone (vehicle for benzamide) had no effect on MTT 
reduction (Fig. 5.35). In the presence of 200|rM ZnS0 4 , 0.3% EtOH had no effect on 
MTT reduction (data not shown).
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Figure 5.3. Attenuation of Zn^Mnduced toxicity by pyruvate, but not by 
niacinamide or benzamide.
(A) HT-22 cells were treated for 6hr with 200juMZnS04  in the presence or absence o f  
5mM or lOmMpyruvate. Cell viability was estimated via MTT reduction as detailed 
in Methods (see section 2.3.3.1). Data represent the mean (± S.E.M.) o f  five 
independent experiments. * * = P< 0.01 signifies difference from HEPES (I mM) 
control by one-way ANOVA followed by a Dunnett ’s post hoc test. # = P<0.05 
signifies difference from 200pM ZnS04  alone by one-way ANOVA followed by a 
Dunnett’s post hoc test. (B) HT-22 cells were treatedfor 24hr with 200pM ZnS04  in 
the presence or absence o f 3mM niacinamide, 3mM benzamide, or 5mM or lOmM  
pyruvate. Cell viability was estimated via the MTT reduction assay described in 
Methods. Data represent the mean (± S.E.M.) o f  four independent experiments. ** = 
P<0.01 denotes difference from HEPES (ImM) control (one-way ANOVA followed by 
a Dunnett’s post hoc test). ## = P<0.01 signifies difference from 200pM  ZnS04  alone 
by one-way ANOVA followed by a Dunnett's post hoc test.
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5.4.2 Oxaloacetate rescues against Zn^^-induced toxicity
To determine whether further alternative energy sources could also protect against 
Zn^^-induced toxicity, the effects of oxaloacetate were examined. HT-22 cells were 
exposed to 200pM ZnS0 4  in the presence or absence of oxaloacetate (prepared in 
equimolar NaOH to neutralize acidity). 5mM oxaloacetate did not significantly affect 
MTT reduction in the presence of 200pM ZnS0 4  at either 6hr (Fig. 5.4.4) or 24hr (Fig. 
5.45). lOmM oxaloacetate however, significantly attenuated Zn^^-induced toxicity 
during a 24hr 200pM ZnS0 4  exposure (Fig. 5.45), although it failed to have an effect 
at 6hr (Fig. 5.4^4). In the absence of 200pM ZnS0 4 , neither concentration of 
oxaloacetate affected MTT reduction at 6hr or 24hr (Fig. 5.4^ 4 and 5  respectively).
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Figure 5.4. Oxaloacetate limits Zn^-induced toxicity.
HT-22 cells were incubated for 6hr (A) or 24hr (B) with 200pM ZnS04 in the 
presence or absence o f  5mM or lOmM oxaloacetate. Cell viability was estimated via 
MTT reduction as detailed in Methods (see section 2.3.3.1). Data represent mean 
(±S.E.M) o f four independent experiments. ** = P<0.01 indicates difference from  
HEPES (ImM) control by one-way ANOVA followed by a Dunnett’s post hoc test. ## 
= P<0.01 indicates difference from 200pM ZnS04 exposure alone by one-way 
ANOVA followed by a Dunnett’s post hoc test.
186
5.4.3 Lactate fails to significantly reduce Zn^^-induced death
The effect of another potential alternative energy source, lactate (Desagher et ah, 
1997; Sheline et ah, 2000), on Zn^^-induced death was also examined in HT-22 cells. 
Cells were incubated with 200pM ZnS0 4  in the presence or absence of 5mM or 
lOmM lactate. However, neither concentration of lactate examined afforded 
significant neuroprotection versus 200pM ZnS0 4  insults at either 6hr or 24hr. In the 
absence of ZnS0 4 , 5mM lactate had no significant affect on MTT reduction versus 
HEPES at either 6hr or 24hr. lOmM lactate alone significantly enhanced MTT 
reduction versus HEPES following a 6hr exposure (Fig. 5.5^), although this was not 
reproduced following a 24hr exposure (Fig. 5.55).
187
B .
125-1
C
g
Ü
3 100-
■oo
\- 75-
1-S
o 50-L_
"c
ou 25-
55
0-
y  . y XT
Figure 5.5. Lactate fails to prevent Zn^-induced death.
HT-22 cells were incubated fo r 6hr (A) or 24hr (B) with 200pM ZnS04  in the 
presence or absence ofSmMor lOmM lactate. Cell viability was estimated via MTT 
reduction as described in Methods (see section 2. 3.3.1). Data represent mean 
(±S.E.M) o f four independent experiments. * = P<0.05 and ** = P<0.01 signifies 
difference from HEPES (ImM) control (one-way ANOVA followed by a Dunnett’s 
post hoc test).
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5.4.4 Pyruvate and oxaloacetate afford protection against Zn^-induced toxicity
Images of HT-22 cells were captured to observe directly the effects of 200pM Z11SO4 
in the presence of either lOmM pyruvate or lOmM oxaloacetate for up to 24hr. 
Following Ihr exposure to 200pM ZnS0 4 , cellular detachment was apparent in either 
the presence or absence of lOmM oxaloacetate (Fig. 5.6A), although many more cells 
remained intact in the presence of oxaloacetate by 3hr (Fig. 5.65). At both 6hr (Fig. 
5.6C) and 24hr (Fig. 5.6D), the majority of cells had detached and become rounded 
following oxaloacetate treatment similar to 200pM ZnS0 4  exposure alone, although 
intact cells were still evident. At all time points examined, cells treated in the 
presence of lOmM pyruvate maintained a similar morphological appearance to ImM 
HEPES time-matched controls.
A, Ihr exposure
+ lOmM Oxaloacetate Ihr
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Figure 5.6. Digitised images demonstrating the effects of alternative energy 
sources on Zn^-induced death.
HT-22 cells were incubated with 200pMZnS04 fo r  Ihr(A), 3hr(B), 6hr(C) or 24hr 
(D) in the presence or absence o f 1 OmM oxaloacetate or 1 OmMpyruvate. Images 
were capturedfrom random fields o f view using phase contrast microscopy as 
described in Methods.
5.4.5 Neither pyruvate nor oxaloacetate inhibit Zn^  ^influx
It is possible that pyruvate and oxaloacetate may afford protection to HT-22 cells via 
the simple extracellular chelation of Zn^'. However, increases in Fluozin-3 
fluorescence were not significantly affected by the co-addition of either lOmM 
pyruvate or lOmM oxaloacetate with 200pM ZnSOi (Fig. 5.7).
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Figure 5.7. influx is not impeded by pyruvate or oxaloacetate.
HT-22 cells were exposed to 200pM ZnS04 fo r 30min in the presence or absence o f  
1 OmM pyruvate or 1 OmM oxaloacetate. Increase in cell population FluoZin-3 
fluorescence (indicative o f [Zn ] )  was determined as described in Methods (see 
section 2.3.4.2). Data represent mean (+S.E.M.) o f  six experiments. * P<0.05 
signifies difference from HEPES (ImM) control by one-way ANOVA and a Dunnett’s 
post hoc test.
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5.5 Discussion
It has been demonstrated that Zn^^-induced HT-22 cell death is likely to be necrotic 
following mitochondrial perturbation, with a potential involvement of cellular 
oxidative stress. However, the downstream consequences of mitochondrial 
dysfunction have not been addressed. Several lines of evidence support a role for 
cellular energy inhibition in the Zn^^ cytotoxic mechanism. These include Zn^^- 
induced inhibition of the glycolytic enzymes GAPDH (Krotkiewska and Banas, 1992; 
Maret et al., 1999), fructose 1,6-diphosphatase (Maret et al., 1999) and 
phosphofructokinase (Ikeda et al., 1980), the TCA cycle KGDHC (Brown et al., 
2000), and the electron transport chain bc\ complex (Link and von Jagow, 1995) and 
complex IV (Mills et al., 2002).
More recently however, evidence suggests a specific role for Zn^^-induced glycolytic 
inhibition during the mechanism of Zn^^ toxicity (Sheline et al., 2000; Kim and Koh, 
2002; Kelland et al., 2004; Sheline et al., 2004). Furthermore, when utilised, pyruvate 
appears to consistently ameliorate against both Zn^^-induced death (Sheline et al., 
2000; Kelland et al., 2004) and ischaemic injury (Lee et al., 2001; Yoo et al., 2004). 
The aim of this study was therefore to determine whether Zn^^-induced HT-22 cell 
toxicity could be attenuated by inhibition of energy dysfunction.
Both pyruvate and oxaloacetate afforded significant HT-22 cell protection following 
24hr Zn^^ exposure. Pyruvate also afforded significant protection at 6hr. This 
suggests that glycolytic inhibition may therefore be an important mechanism in this 
model of Zn^^-induced toxicity. Correspondingly, Sheline et al (2000) determined 
that 3mM oxaloacetate significantly attenuated neurodegeneration whereas 4mM 
pyruvate almost completely prevented cortical neuronal death following 24hr Zn^^
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exposure. Lactate however, did not afford significant protection against Zn^^-induced 
HT-22 cell death at either 6hr or 24hr, corroborating the findings of both Sheline et al 
(2000) and Yoo et al (2004). Unexpectedly, 6hr lactate (lOmM) exposure alone 
significantly enhanced HT-22 cell viability. This may be through its function as an 
energy substrate following conversion to pyruvate, or simply an experimental artefact.
The protection afforded by pyruvate in the cortical neuronal model was attributed to 
the normalisation of NAD^ levels, which were notably depleted following Zn^^ 
exposure, via the conversion of pyruvate to lactate by lactate dehydrogenase (Sheline 
et al., 2000). The lack of protection afforded by lactate during Zn^^ exposure in the 
HT-22 cell paradigm may therefore result from a shift in the reaction equilibrium, 
thus attenuating normalisation of NAD^ levels. Oxaloacetate is an alternative energy 
substrate. Its protective effects may be through restoration of energy levels following 
direct entry into the TCA cycle, or via its conversion to pyruvate (Salway, 2000). 
Oxaloacetate may also act as a free radical scavenger (Desagher et al., 1997).
As detailed earlier (section 5.1.1), pyruvate may mediate several protective strategies. 
These include participation as an antioxidant (O'Donnell-Tormey et al., 1987; 
Salahudeen et al., 1991), through maintenance of cellular redox status via the 
lactate/pyruvate ratio (Mongan et al., 2002; Sharma et al., 2003), as a TCA cycle 
energy substrate following conversion to acetyl co-enzyme A (Massieu et al., 2001), 
or via direct Zn^^ chelation (Chen and Liao, 2003). As demonstrated in chapter 4, 
Zn^^-induced HT-22 cell death may involve cellular oxidative stress, and therefore 
both pyruvate and oxaloacetate may mediate dual protective effects as energy 
substrates and antioxidants.
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Although the precise mechanism of pyruvate- and oxaloacetate-mediated protection 
against Zn^^-induced injury was not fully elucidated in this model, neither pyruvate 
nor oxaloacetate attenuated death through the simple chelation of extracellular Zn^ .^ 
Neither compound significantly affected the increase in [Zn^^ji during 30min Zn^^ 
exposure, demonstrating that Zn^^ influx had not been impeded. These data therefore 
support the hypothesis that oxaloacetate and pyruvate exert their protective effects 
intracellularly via a mechanism that requires further elucidation.
In a cortical neuronal model, Sheline et al (2000) proposed that Zn^^ mediated indirect 
GAPDH inhibition through NAD^ depletion. Indeed during ischaemia, lactate 
accumulation increases the lactate/pyruvate ratio which subsequently reduces the 
NAD^/NADH ratio according to the reaction:
NAD+ NADH
Lactate-----------------------------  ► Pyruvate
Lactate dehydrogenase
NAD^ depletion induces an indirect GAPDH block, and associated increase in the 
glycolytic intermediates FBP, DHAP and glyceraldehyde-3-phosphate, and decreased 
ATP production (Tilton et al., 1991), similar to that demonstrated during Zn^^- 
induced toxicity (Sheline et al., 2000). However, Sheline et al (2000) did not reveal a 
concomitant increase in NADH following NAD^ depletion, establishing the 
hypothesis that Zn^^ mediates the activation of an NAD^ catabolising enzyme which 
contributes to the effects observed.
Indeed, non-specific inhibition of NAD^ catabolising enzymes with niacinamide, 
benzamide or 3 -aminobenzamide attenuated NAD^ depletion and cell death following
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both Zn^^-induced toxicity (Sheline et ah, 2000; Kim and Koh, 2002; Sheline et ah, 
2004), and ischaemia (Szabo and Dawson, 1998; Yoo et ah, 2004). Sheline et al
(2003) therefore proposed that the DNA repair enzyme, PARP, may mediate NAD^ 
catabolism during acute Zn^^ toxicity.
Indeed, PARP activation and poly(ADP-ribosyl)ation has been revealed in models of 
both Zn^^-induced death (Kim and Koh, 2002; Sheline et ah, 2003; Yoo et ah, 2004), 
and ischaemic injury (Narasimhan et ah, 2003). However, PARP activation was only 
observed under conditions of ROS generation (Sheline et ah, 2003). Accordingly, in 
contrast to the acute exposure paradigm, PARP-1 knockout mice were not protected 
against neuronal death following chronic Zn^^ treatment (Sheline et ah, 2003). 
However, niacinamide and benzamide were equally protective in both chronic and 
acute Zn^^ cortical neuronal exposure models, suggesting the role of an alternative 
NAD^ catabolising enzyme which mediates death during chronic Zn^^ treatment. 
(Sheline et ah, 2000; Sheline et ah, 2003).
In contrast, in the current model of Zn^^-induced HT-22 cell toxicity, neither 
niacinamide nor benzamide afforded significant protection against cell death. This 
implies that Zn^^ may not activate NAD^ catabolising enzymes in this system, but 
may directly inhibit other components of the glycolytic pathway, such as GAPDH as 
mentioned earlier. However, it is also possible that Zn^^ may induce NAD^ kinase 
activation. This enzyme induces NAD^ depletion during the conversion of NAD^ to 
NADPH, associated with subsequent ATP depletion and cell death (Stubberfield and 
Cohen, 1989). Therefore the involvement of NAD^ kinase in Zn^^-induced HT-22 
cell death requires further investigation, possibly with the use of RNAi to 
downregulate the expression of this enzyme.
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It should also be remembered that niacinamide and benzamide might have protective 
functions in addition to being NAD^ catabolising enzyme inhibitors. Most 
significantly, niacinamide may participate as an antioxidant via iNOS inhibition and 
both compounds act as free radical scavengers (Szabo and Dawson, 1998; Czapski et 
al., 2004). It is possible therefore, that niacinamide and benzamide mediate protection 
via detoxification of ROS in the models mentioned above. As noted in chapter 4, 
despite the inability to detect significant ROS production, the antioxidants DPPD and 
trolox were very effective at delaying Zn^^-induced HT-22 cell death. However, the 
lack of protection afforded by niacinamide and benzamide here suggests that their 
antioxidant capabilities may not be as potent as trolox and DPPD.
The role of Zn^^ in HT-22 cell energy dysfunction therefore requires further 
investigation. The inability of niacinamide or benzamide to prevent toxicity 
contradicts evidence favouring the role of NAD^ catabolising enzymes as mediators 
of Zn^^-induced death, although the participation of NAD^ kinase cannot be excluded. 
The protection afforded by oxaloacetate but more significantly pyruvate, implies that 
energy inhibition has occurred, although the site of inhibition remains to be 
elucidated. However, as demonstrated in chapter 4, antioxidants delay the induction 
of Zn^^-induced death. Although both pyruvate and oxaloacetate have antioxidant 
properties (O'Donnell-Tormey et al., 1987; Salahudeen et al., 1991; Desagher et al.,
1997), their role in limiting cellular oxidative stress in the HT-22 cell model remains 
to be determined. This could be examined via the cellular oxidative stress assays as 
detailed in section 4.3.5.
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The ability of pyruvate and oxaloacetate to attenuate mitochondrial dysfunction via 
MPT could also be elucidated using a dual staining technique with the red 
mitochondrial membrane potential-sensitive dye, tetramethylrhodamine methyl ester 
(TMRM), and the green intracellular fluorescent dye, calcein, and confocal 
microscopy (Nieminen et ah, 1997). Calcein only enters mitochondria when mPTPs 
are open, conditions which allow TMRM to leave the mitochondria. Therefore 
mitochondria undergoing MPT are green, whereas polarised mitochondria are red. It 
is clear however, that regardless of its mechanism of action, pyruvate is an important 
inhibitor of Zn^^-induced HT-22 cell death.
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6. GENERAL DISCUSSION
The participation of Zn^^ in the neuronal cytotoxic process during ischaemic insults is 
a relatively recent finding (Tonder et ah, 1990; Koh et ah, 1996), and consequently 
mechanisms mediating Zn^^-induced death remain to be fully established. Indeed, the 
toxic effect of exogenous Zn^^ in the CNS was initially determined in dorsal root 
ganglion cells (Gaskin et ah, 1978), but it was not until later that endogenous release 
of potentially cytotoxic Zn^^ concentrations were observed from the hippocampal 
mossy fibres (Assaf and Chung, 1984; Howell et ah, 1984).
Since this time, a simple model of Zn^^ release from presynaptic glutamatergic 
synaptic vesicles and uptake into susceptible postsynaptic neurons has been proposed 
(Frederickson, 1989; Koh et ah, 1996). However, this hypothesis was complicated by 
the discovery of cytotoxic Zn^^ accumulation in postsynaptic neurons in the absence 
of vesicular Zn^^ (Lee et ah, 2000). Therefore a novel proposal of Zn^^ mobilisation 
following oxidation of Zn^^-containing metalloproteins was also suggested (Palmiter 
and Findley, 1995; Aizenman et ah, 2000; Lee et ah, 2000), although recently Zn^^ 
release from mitochondrial stores following A\{/m collapse has additionally been 
postulated (Sensi et ah, 2003b).
Evidence suggests that Zn^^ accumulation is required for toxicity during ischaemia 
(Koh et ah, 1996; Suh et ah, 2000b; Calderone et ah, 2004). Indeed, during Zn^^- 
induced HT-22 cell injury, Zn^^ accumulation was demonstrated directly with the use 
of FluoZin-3, and indirectly with the extracellular and intracellular Zn^^ chelators, 
Ca*EDTA and TPEN respectively. However, Frederickson et al (2002b) have 
recently suggested that Ca#EDTA may sequester both intracellular and extracellular 
Zn^\ Ca.EDTA may maintain a steep extracellular Zn^^ gradient allowing passive
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removal of intracellular free Zn^^ via efflux processes, or exocytosis from synaptic 
vesicles. Therefore caution is warranted when utilising this compound as an 
extracellular Zn^^ chelator, due to potential perturbation of intracellular Zn^^ 
processes (Frederickson et al., 2002b).
There is much controversy over the precise intracellular and extracellular Zn^^ 
concentrations achieved during ischaemic insult. Assaf and Chung (1984) 
demonstrated extracellular concentrations up to 300pM following K^- or kainate- 
induced depolarisation of hippocampal slices, whereas in a similar model Kay (2003) 
suggested a much lower concentration (~24nM). Furthermore, Canzoniero et al 
(1999) proposed that [Zn^^]i exceeding 250-3OOnM were required for Zn^^-induced 
death.
Difficulties associated with assessing Zn^^ concentrations include disadvantages 
related to the specific Zn^^ probes utilised (Sensi et al., 1997; Cheng and Reynolds, 
1998; Dineley et al., 2002), and limitations to particular techniques used to obtain the 
Zn^^ data (Suh et al., 2000a). Furthermore, it is difficult to control against potential 
external sources of contaminating Zn^^ which may contribute to misleading results 
(Kay, 2004). For example Kay (2004) suggested that Zn^^ may be present in 
glassware, plastic cultureware and plastic lab items, and even following treatment of 
these items with 2mM EDTA or 10% nitric acid for up to two days the source of 
contamination may not be removed. In the present study, high exogenous Zn^^ 
concentrations were utilised in accordance with evidence suggesting its 
pathophysiological relevance (Assaf and Chung, 1984; Choi et a l, 1988; Koh and 
Choi, 1994; Canzoniero et a l, 1999). In addition, although the measures suggested by 
Kay (2004) were not undertaken here, the same preparatory techniques were used for
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all experiments therefore the level of potential Zn^^ contamination should be 
consistent throughout, and is unlikely to reach pM concentrations regardless.
Although Ca^^-permeable AMPA and/or kainate receptor-gated channels are proposed 
to be a major route of Zn^^ entry during ischaemic neuronal injury (Sensi et al., 1999; 
Weiss and Sensi, 2000), HT-22 cells lack ionotropic glutamate receptors therefore an 
alternative entry route is utilised in this model. Neither L- nor T-type Ca^^ channels 
appeared to mediate Zn^^ influx however, and depolarisation did not enhance Zn^^- 
induced death suggesting that entry may also be independent of VSCC. This could be 
established with the non-specific Ca^^ channel inhibitor, Gd^^. As postulated in 
section 2.5 Discussion, a transporter such as ZIP may therefore mediate Zn^^ influx in 
HT-22 cells. The ability of Cu^^, Fe^ "^  and Cd^^ to impede Zn^^ accumulation could 
examine this possibility. Additionally, putative ZIP transporter expression could be 
downregulated in HT-22 cells using RNAi to investigate its role in mediating Zn^^ 
uptake.
The mode of death following both Zn^^ cytotoxicity and ischaemic injury is a 
contentious issue. Both apoptosis and necrosis have been described (Charriaut- 
Marlangue et al., 1996; Lobner et al., 1997; Kim et al., 1999a), sometimes 
simultaneously (Gwag et al., 1995), under different conditions and in various toxic 
models. Many researchers have also suggested that Zn^^ inhibits caspases and 
therefore apoptosis (Perry et al., 1997; Truong-Tran et al., 2000; Wei et al., 2004). In 
HT-22 cells, Zn^^ appeared to induce necrosis due to the absence of caspase activation 
and the appearance of irregular chromatin condensation. However, the role of other 
cysteine proteases, including calpains and cathepsins were not examined. Indeed, a 
calpain-dependent caspase-independent model of apoptosis has been described (Chen
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et al., 2001; Chen et al., 2002a), and cathepsins may participate significantly during 
ischaemic injury (Hetman et al., 1995; Seyfried et al., 2001). The use of specific 
inhibitory compounds against these proteases, or possibly Western blot analysis of the 
specific substrate cleavage fragments may help identify the role of these enzymes 
during Zn^^-induced toxicity.
Importantly, the intensity of the insult appears to mediate the mode of death in several 
toxic paradigms (Bonfoco et al., 1995; Charriaut-Marlangue et al., 1996; Lobner et 
al., 1997; Kim et al., 2000). Therefore reducing the Zn^^ toxic insult in HT-22 cells 
whilst extending exposure duration may induce apoptotic death. Significantly, ATP 
levels may determine whether apoptosis or necrosis predominates (Eguchi et al.,
1997). As suggested in section 3.5 Discussion, Zn^^ exposure in HT-22 cells may 
mediate either primary or secondary necrosis (Hirsch et al., 1998; Lemaire et al.,
1998). It is therefore necessary to elucidate the effect of Zn^^ on cellular ATP levels. 
Furthermore, the participation of early apoptosis could be examined with the use of 
apoptotic markers such as initiator caspase activation (although the effector caspase, 
caspase 3, showed no activity following 3hr exposure).
Zn^^-induced death in HT-22 cells therefore appears to be necrotic, although the 
precise targets of Zn^^ cytotoxicity remain to be elucidated. The mitochondria may 
however, present a key site of Zn^^-mediated cytotoxicity. Indeed, the mPTP and 
MPT may play an integral role to the Zn^^-induced death mechanism (Lemasters et 
al., 1998; Lemasters, 1999; Kim et al., 2003b). Mitochondrial Zn^^ influx, similar to 
the effects of Ca^^, induced Ai|/m collapse and enhanced ROS production in several 
models (Sensi et al., 1999; Sensi et al., 2000; Sensi et al., 2003b). Conversely 
however, in HT-22 cells A^m collapse was not accompanied by a detectable increase
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in ROS production. Significantly, neither increased generation of ROS nor O2 *' were 
specifically detected following up to 4hr Zn^^ exposure, despite protection afforded 
by antioxidants at 6hr. It was proposed that declining GSH levels contributing to 
reduced ROS and Zn^^ buffering might allow basal ROS production to induce HT-22 
cell death by 6hr (Meister, 1991). This is supported by the findings of van den 
Dobbelsteen et al (1996), who suggested that the severe GSH depletion observed in 
apoptotic human Jurkat T-lymphocytes in the absence of detectable ROS was 
sufficient to lower the reducing capacity of the cell thus promoting oxidative stress 
without an increase in ROS generation. However, the inability of antioxidants to 
protect against 24hr Zn^^ exposure suggests that the antioxidants may only act to 
delay Zn^^-induced death in the HT-22 cell paradigm.
GSH depletion may play an important role during cell death in the absence of 
detectable ROS in other systems. Indeed, significant GSH depletion was observed in 
apoptotic rat thymocytes prior to cell lysis. Treatment with the nitroxide-radical 
antioxidant, 2,2,6,6-tetramethyl- Ipiperidinyl-1 -oxyl (TEMPO), following etoposide 
exposure attenuated DNA fragmentation associated with an increase in intracellular 
GSH. However, there was an inability to detect free radical production directly in this 
model (Slater et al., 1995b). It was therefore suggested that ROS production was not 
crucial to cell death, despite the involvement of an oxidative mechanism which 
mediated GSH depletion (Slater et al., 1995a).
There are several mechanisms by which GSH depletion may occur. Firstly, as 
detailed in section 4.1.2.5, the oxidation of GSH following interaction with free 
radicals forms GSSG (+ 2H ^ (Meister, 1995). GSSG is cytotoxic and is therefore 
extruded from the cell causing intracellular GSH depletion (Srivastava and Beutler,
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1969; Meister, 1995). Using human Jurkat T-lymphocytes however, van den 
Dobbelsteen et al (1996) demonstrated that anti-Fas/APO-1 antibody treatment 
induced GSH efflux through a selective GSH-specific membrane transporter in the 
absence of oxidation (van den Dobbelsteen et al., 1996). A further mechanism of 
intracellular GSH depletion is the inhibition of GSH generation. It has thus been 
shown that Zn^^ inhibits glutathione reductase, which converts GSSG into GSH (Mize 
and Langdon, 1962; Carlberg and Mannervik, 1985). However, Zn^^ may also have 
as yet unidentified effects on the GSH synthesis enzymes, y-glutamylcysteine 
synthetase and GSH synthetase (Sagara et al., 1998).
Further investigation is therefore required to conclude the participation of ROS in 
Zn^^-induced HT-22 cell death. For example, the potential effect of restoring 
intracellular GSH during initial Zn^^ exposure should be examined. Moreover, other 
determinants of oxidative stress such as lipid peroxidation should be investigated at 
all time points. In addition, as suggested in section 4.5 Discussion, the contribution of 
A\|/m collapse to Zn^^-induced death should be examined further.
Inhibition of energy metabolism is another potential mechanism of Zn^^-induced 
toxicity (Sheline et al., 2000; Kim and Koh, 2002; Kelland et al., 2004; Sheline et al., 
2004). Direct inhibition of key glycolytic enzymes (Ikeda et al., 1980; Krotkiewska 
and Banas, 1992; Maret et al., 1999), the TCA cycle (KGDHC) (Brown et al., 2000), 
and the electron transport chain bc\ complex (Link and von Jagow, 1995) and 
complex IV (Mills et al., 2002) by Zn^^ has been demonstrated. However, indirect 
glycolytic inhibition by NAD^ depletion has also been postulated, through the Zn^^- 
induced activation of an NAD^ catabolising enzyme, possibly PARP, or NAD^ 
kinase. The inability of the NAD^ catabolising enzyme inhibitors, niacinamide and
204
benzamide, to attenuate Zn^^-induced toxicity in HT-22 cells suggests that indirect 
glycolytic inhibition may not be a relevant mechanism in this paradigm. However, 
both pyruvate and oxaloacetate protected against Zn^^-induced death in HT-22 cells 
without extracellular Zn^^ chelation, similar to other models (Sheline et al., 2000; 
Kelland et al., 2004; Sheline et al., 2004), suggesting that inhibition of glycolysis may 
have occurred. It should be remembered though, that cellular oxidative stress may 
participate in Zn^^-induced HT-22 cell toxicity, and niacinamide, benzamide, 
pyruvate and oxaloacetate all possess antioxidant properties. The protection mediated 
by pyruvate and oxaloacetate, but not niacinamide or benzamide following Zn^^ 
exposure, may therefore result from their dual-fimctionality as ROS scavengers and 
energy substrates.
Further experiments to elucidate the site of Zn^^-mediated energy inhibition should 
focus initially on the potential accumulation of upstream intermediates following 
glycolytic inhibition as revealed by Sheline et al (2000), although preliminary trials 
(data not shown) suggest that this does not occur. The effects of direct PARP 
inhibition, possibly using antisense oligonucleotide expression, could also be 
examined during Zn^^-induced HT-22 cell death to validate the unlikely role of this 
enzyme. In a similar way, the involvement of NAD^ kinase could also be determined. 
Significant efforts were made in the determination of ATP levels during Zn^^-induced 
HT-22 cell toxicity, although due to time constraints reliable data were never 
obtained. Therefore, the action of Zn^^ exposure on ATP concentrations is necessary 
in future experiments to confirm the effects of energy dysfunction (and the 
involvement of apoptosis or necrosis as described earlier).
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Importantly, the role of pyruvate-mediated protection in this model requires further 
examination. For example, inhibition of lactate dehydrogenase to prevent 
normalisation of NAD^ levels should attenuate protection if indirect glycolytic 
inhibition had occurred. Furthermore, if pyruvate enters the TCA cycle directly as an 
energy substrate, addition of acetyl co-enzyme A should also attenuate death. In 
addition, the protective role of oxaloacetate should be elucidated. For example, does 
malate provide similar protection through conversion to pyruvate?
As mentioned in section 5.1.1.1, pyruvate may prevent the inhibition of energy 
metabolism by blocking MPT thus attenuating mitochondrial dysfunction. In models 
of ischaemia/reperfusion, increased mitochondrial Ca^^ load and ROS production are 
associated with mPTP opening and MPT following removal of the inhibitory block 
mediated by cellular lactate accumulation and low intracellular pH (Halestrap et al., 
1998; Kerr et al., 1999). Pyruvate was shown to attenuate MPT via its function as an 
energy substrate to maintain ATP levels during ischaemia (Halestrap et al., 1998), an 
ROS scavenger and antioxidant (Desagher et al., 1997; Halestrap et al., 1998; Mongan 
et al., 2002), and through the sustained reduction of intracellular pH (Poole and 
Halestrap, 1993). Furthermore, treatment with the mitochondrial pyruvate uptake 
inhibitor, a-cyano-4-hydroxycinnamate, suggests that pyruvate mediates protection at 
an extracellular or cytoplasmic site (Gyulkhandanyan et al., 2003).
The role of pyruvate in the protection against mitochondrial perturbation therefore 
requires further investigation in the HT-22 cell model. The effect of pyruvate on 
Zn^^-induced A\j/m collapse could be determined with the use of TMRE and flow 
cytometric analysis (see section 4.3.3). Furthermore, the participation of Zn^^- 
induced MPT and its potential attenuation by pyruvate could be elucidated with a dual
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staining technique using the red mitochondrial membrane potential-sensitive dye, 
TMRM, and the green intracellular fluorescent dye, calcein, via confocal microscopy 
(Nieminen et ah, 1997). This technique functions on the ability of calcein to only 
enter mitochondria when mPTPs are open, under which conditions TMRM leaves the 
mitochondria, thus permitting distinction of mitochondria undergoing MPT. These 
data will be necessary to determine the mechanism by which pyruvate attenuates 
Zn^^-induced HT-22 cell death.
Intriguingly, the mechanism of Zn^^-induced toxicity in HT-22 cells appears to be 
very similar to that demonstrated in rat oligodendrocyte progenitor cells. In this 
model, pyruvate (5-lOmM) significantly attenuated Zn^^-induced death, in the 
absence of protection mediated by the antioxidants, trolox, DPPD and PEN, or the 
pan-caspase inhibitor zVAD-fmk following 24hr Zn^^ exposure. Furthermore, Zn^^ 
influx was via a postulated Zn^^ transporter mechanism (Kelland et al., 2004). These 
data support the pathological relevance of the Zn^^-induced death mechanisms 
detailed in the HT-22 cell model.
In summary, although there is substantial evidence implicating Zn^^ in ischaemic 
injury, the mechanisms of Zn^^-induced death remain controversial and often depend 
on the toxic model. The data presented in this thesis utilising the HT-22 cell 
paradigm provide some important evidence regarding the mechanisms of Zn^^- 
induced death in hippocampal neuronal cells. However, as described, there are many 
more potential avenues for further research. The most important of these appears to 
be the involvement of mitochondria in Zn^^-cytotoxicity.
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The finding that oxaloacetate, and more significantly pyruvate, attenuated Zn^^- 
induced HT-22 cell death has important therapeutic implications. In a rat in vivo 
model of transient ischaemia, intraperitoneal injection of sodium pyruvate up to Ihr 
post-reperlusion preserved hippocampal and cortical neuronal viability almost 
completely (Lee et al., 2001). Furthermore, rat survival was observed for more than 
30 days post-insult. In an alternative model of pressure-induced retinal ischaemia, 
pyruvate was protective against both neuronal death induced by endogenous Zn^^ 
accumulation, as well as death induced following exogenous Zn^^ exposure to the 
same cells in vitro (Yoo et al., 2004).
The fact that pyruvate has no known serious side effects (Yoo et al., 2004) suggests 
that it may therefore have an important therapeutic role against Zn^^-induced neuronal 
death following ischaemic injury, such as stroke, epilepsy or mechanical head trauma.
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